Return to Top Page

職歴と研究歴

 

さたまさたか

佐田政隆

 

所属機関

 

徳島大学大学院医歯薬学研究部
循環器内科学分野

〒770-8503 徳島市蔵本町3-18-15
TEL: 088-633-7851 
FAX: 088-633-7891 

E-mail: masataka.sata@tokushima-u.ac.jp
 

 

経歴

昭和57年3月  県立熊本高校卒業
昭和63年3月  東京大学医学部医学科卒業
昭和63年5月  医師免許取得
昭和63年6月  東京大学医学部附属病院医員(研修医)
平成2年6月  関東逓信病院循環器内科専修医
平成3年6月  東京大学医学部附属病院医員(第二内科)
平成5年4月  東京大学大学院医学系研究科入学(第一臨床医学専攻)
平成6年10月   米国 Case Western Reserve大学 Ikebe博士の研究室に留学(大学院委託研究)
平成7年12月   米国 Massachusetts 大学 Ikebe 博士の研究室に留学(大学院委託研究)
平成8年9月  東京大学大学院医学系研究科休学
平成8年10月   米国Tufts大学聖エリザベス病院 Walsh博士の研究室に留学
平成10年9月   東京大学大学院医学系研究科復学(内科学専攻)
平成11年3月   同上卒業
平成11年4月   東京大学医学部附属病院循環器内科医員

平成12年12月   科学技術振興事業団さきがけ研究21研究員
平成14年 5月  
東京大学大学院医学系研究科 器官病態内科学(循環器内科) 文部科学教官助手

        (科学技術振興事業団さきがけ研究21研究員兼任)

平成1610月   東京大学大学院医学系研究科先端臨床医学開発講座客員助教授

平成194月   東京大学大学院医学系研究科先端臨床医学開発講座客員 准教授

平成204月   徳島大学大学院ヘルスバイオサイエンス研究部循環器内科学 教授

平成214月  徳島大学病院超音波センター長 兼任

平成274月   徳島大学大学院医歯薬学研究部循環器内科学分野 教授(大学の改組により名称変更)

 

 

 

所属学会

日本内科学会(認定制度研修医指導医、四国支部評議員)、日本循環器学会(四国支部評議員)、日本心臓病学会(特別正会員、評議員)、日本血管生物医学会(理事)、日本心血管内分泌代謝学会(評議員)、日本心血管インタ−ベンション学会、日本動脈硬化学会(評議員)、日本高血圧学会(評議員、専門医制度の指導医)、日本脈管学会 (理事)、日本炎症・再生医学会(監事)、日本臨床分子医学会、日本心不全学会、日本肥満学会、日本抗加齢医学会(評議員)、日本心脈管作動物質学会(理事)、日本NO学会(理事)、日本老年医学会(代議員、指導医)、日本性機能学会(理事、ED診療ガイドライン改定委員)、日本川崎病学会、日本心臓リハビリテーション学会(理事)、 国際心血管薬物療法学会日本部会(副理事長)、American Heart Association (Circulation, Basic Science, Arteriosclerosis, Thrombosis Vascular Research), International Society for Heart Research (日本支部理事), American Association for the Advancement of Science

 

社会活動

 

社団法人日本循環器学会
医療安全委員会 委員

学術委員会 高血圧/動脈硬化部会 委員

国内交流委員会 委員

専門医編集委員会 委員

予防委員会 委員

血管機能検査ガイドライン作成班員

日本心臓病学会
Journal of Cardiology Associate Editor

日本動脈硬化学会

総務委員

教育・研修委員
     

日本心臓リハビリテーション学会
学会ステートメント策定部会副部会長

日本性機能学会  
ED ガイドライン改定委員

科学技術振興機構 
さきがけ「炎症の慢性化機構の解明と制御」研究領域アドバイザー 
 

 

資格

医師免許、保険医、国民健康保険医、認定内科医、 総合内科専門医、循環器専門医、日本高血圧学会認定高血圧専門医、日本脈管学会認定脈管認定医、日本動脈硬化学会動脈硬化専門医

 

受賞

・平成5年 日本循環器学会Young Investigator's Awardの優秀賞

・平成10American College of Cardiology 総会での

Young Investigator's Award (Molecular and Cellular Cardiology Section) First Prize

・平成11年 日本血管細胞生物学会Young Investigator's Awardの優秀賞

・平成11年度 東京都医師会医学研究賞奨励賞

・平成12年度 成人血管病研究振興財団 岡本研究奨励賞

平成13年 日本心臓病学会 Young Investigator's Award の最優秀賞

平成14年 日本循環器学会八木賞

・平成14年 The Japanese Vascular Biology Organization  Young Investigator's Award

平成15年 日本循環器学会佐藤賞

平成15年 日本炎症・再生医学会奨励賞

平成25年 日本臨床分子医学会学会賞

 

英文論文 (Peer-Reviewed Papers)

  1. Sata, M., Kimura, K., Yagi, N., Nanba, S., Tojo, A., Hirata, Y., Matsuoka, H. & Sugimoto, T. A case of membranous nephropathy complicated by interstitial nephritis due to Sjö gren's syndrome. J. Nephrol. 1991;4:251-254.

  2. Sata, M., Momomura, S., Takenaka, K., Aoyagi, T., Takahashi, T., Serizawa, T. & Sugimoto, T.. Dynamic left ventricular outflow tract obstruction 4 years after aortic valve replacement. Am. Heart J. 1992;124:1085-1088.

  3. Sata, M., Sugiura, S., Yamashita, H., Momomura, S. & Serizawa, T. Dynamic interaction between cardiac myosin isoforms modifies velocity of actomyosin sliding in vitro. Circ. Res. 1993;73:696-704.

  4. Yamashita, H., Sugiura, S., Sata, M., Serizawa, T., Iizuka, M., Shimmen, T. & Momomura, S. Depressed sliding velocity of isolated cardiac myosin from cardiomypathic hamsters: evidence for an alteration in mechanical interaction of actomyosin. Mol. Cell Biochem.. 1993;119:79-88.

  5. Yamashita, H., Sata, M., Sugiura, S., Momomura, S., Serizawa, S. & Iizuka, M. ADP inhibits the slidingvelocityof fluorescent actin filaments on cardiac and skeletal myosins. Circ. Res. 1994;74:1027-1033.

  6. Matsumoto, A., Hirata, Y., Momomura, S., Fujita, H., Yao. A., Sata, M. & Serizawa, T. Increased nitric oxide production during exercise. Lancet. 1994;343:849-850.

  7. Sata, M., Yamashita, H., Sugiura, S., Fujita, H., Momomura, S. & Serizawa, T. A new in vitro motility assay technique to evaluate calcium sensitivity of the cardiac contractile proteins. Pflugers Arch., Eur. J. Physiol. 1995;429:443-445.

  8. Sata, M., Sugiura, S., Yamashita, H., Fujita, H., Momomura, S. & Serizawa, T. A novel cardiotonic agent MCI-154 directly sensitizies the cardiac contractile system. Circ. Res. 1995;76:626-633.

  9. Sata, M., Sugiura, S., Yamashita, H., Aoyagi, T., Momomura, S & Serizawa, T. Pimobendan directly sensitizes reconstituted thin filament sliding on cardiac myosin. Eur. J. Pharmacol. -Molcular Pharmacology section 1995;290:55-59.

  10. Matsumoto, A., Hirata, Y., Momomura, S., Suzuki, E., Yokoyama, I., Sata, M., Ohtani, Y. & Serizawa, T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am. Heart J. 1995;129:139-145.

  11. Sugiura, S., Yamashita, H., Sata, M., Momomura, S., Serizawa, T., Oiwa, K., Chaen, S, Shimmen, T. & Sugi, H. Force-velocity relations of rat cardiac myosin isozymes sliding on algal actin cables in vitro. Biochem. Biophysic. Acta. 1995;1231:69-75.

  12. Sata, M., Sugiura, S., Yamashita, H., Momomura, S. & Serizawa, T. Coupling between myosin ATPase cycle and creatine kinase cycle facilitates cardiac actomyosin sliding in vitro: A clue to mechanical dysfunction during myocardial ischemia. Circulation. 1996;93:310-317.

  13. Zhu, T., Sata, M. & Ikebe, M. Functional expression of mammalian myosin Iβ: Analysis of its motor activity. Biochemistry. 1996;35:513-522.

  14. Sata, M., Matsuura, M. & Ikebe, M. Characterization of the motor and enzymatic properties of smooth muscle long S1 and short HMM: Role of the two headed structure on the activity and regulation of myosin motor. Biochemistry. 1996;35:11113-11118.

  15. Sata, M. & Ikebe, M. Functional analysis of the mutations in the human cardiac -myosin that are responsible for familial hypertrophic cardiomyopathy: Implication for the clinical outcome. J. Clin. Invest. 1996;98:2866-2873.

  16. Sata, M., Stafford, W.F. III, Mabuchi, K. & Ikebe. M. The motor domain and the regulatory domain of myosin solely dictate enzymatic activity and phosphorylation dependent regulation, respectively. Proc. Natl. Acad. Sci. USA. 1997;94:91-96.

  17. Ikebe, M., Kambara, T., Stafford, W.F. III, Sata, M., Katayama, E. & Ikebe, R. A hinge at the central helix of the regulatory light chain of myosin is critical for phosphrylation-dependent regulation of smooth muscle myosin motor activity. J. Biol. Chem. 1998; 273:17702-17707.

  18. Sata, M., Perlman, H., Muruve, D.A., Silver, M., Ikebe, M., Libermann, T.A., Oettgen, P. & Walsh, K. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. USA. 1998;95:1213-1217.

  19. Sata, M. &Walsh, K. TNFソ regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nature Med. 1998;4:415-420.

  20. Perlman, H.R., Sata, M., Sedlak, T., Branellec, D. & Walsh, K. Bax-mediated cell death by the Gax homeoprotein requires mitogen-activation but is independent of cell cycle activity. EMBO J. 1998,13:3576-3586.

  21. Sata, M. & Walsh, K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 1998,102:1682-1689.

  22. Sata, M. & Walsh, K. Endothelial cell apoptosis induced by oxidized LDL is associated with the downregulation of the cellular caspase inhibitor FLIP. J. Biol. Chem. 1998,273:33103-33106.

  23. Matsuomoto, A., Momomura, S., Sugiura, S., Fujita, H., Aoyagi, T., Sata, M., Omata, M., Hirata, Y. Effect of inhaled nitric oxide on gas exchange in patients with congestive heart failure. A randomized, controlled trial. Annal. Int. Med. 1999, 130: 40-44.

  24. Walsh, K. & Sata, M. Is extravasation a Fas-regulated process? Mol. Med. Today 1999,7:61-67.

  25. Walsh, K. & Sata, M. Negative regulation of inflammation by Fas ligand expression on the vascular endothelium Trends Cardiovasc Med. 1999,9:34-41.

  26. Luo, Z., Sata, M., Nguyen, T., Kaplan, J.M., Akita, G.Y., Walsh, K. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia following balloon injury in immunologically-primed animals. Circulation 1999, 99: 1776-1779.

  27. Cheema, Z.F., Wade, S.B., Sata, M., Walsh, K., Sohrabji, F., Miranda, R.C. Fas/Apo [Apoptosis]-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase dependent cell death and activation of NF-κB. J. Neuroscience 1999, 19: 1754-1770.

  28. Sata, M., Walsh, K. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: Implication for accelerated vasculopathy by immunosuppressive therapy. Biochem Biophys Res Commun. 1999, 263: 430-432.

  29. Sata, M., Suhara, T., Walsh, K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas Ligand induced cell death : Implications for vascular disease and therapy Arterioscler. Thromb. Vasc. Biol. 2000, 20: 309-316.

  30. Eto Y, Yonekura K, Sonoda M, Arai N, Sata M, Sugiura S, Takenaka K, Gualberto A, Hixon ML, Wagner MW, Aoyagi T. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training Circulation 2000;101:2134-2137

  31. Perlman, H., Sata, M., Krasinski, K., Dorai, T., Buttyan, R., Walsh, K. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res. 2000, 45: 570-578.

  32. Sata, M., Walsh, K. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow restricted vessels. J. Mol. Cell. Cardiol. 2000, 32: 1395-1400.

  33. Sata, M., Kakoki, M., Nagata, D., Nishimatsu, H., Suzuki, E., Aoyagi, T., Sugiura, S., Kojima, H., Nagano, T., Kangawa, K., Matsuo, H., Omata, M., Nagai, R., Hirata, Y. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cGMP-independent mechanism. Hypertension. 2000, 36: 83-88.

  34. Nagata D, Suzuki E, Nishimatsu H, Yoshizumi M, Mano T, Walsh K, Sata M, Kakoki M, Goto A, Omata M, Hirata Y. Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res. 2000, 87:699-704.

  35. Sata, M., Maejima, Y., Adachi, F., Fukino, K., Saiura, A., Sugiura, S., Aoyagi, T., Imai, Y., Kurihara, H., Kimura, K., Omata, M., Makuuchi, M., Hirata, Y., Nagai, R. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J. Mol. Cell. Cardiol. 2000, 32: 2097-2104.

  36. Saiura, A., Sata, M., Hirata, Y., Nagai, R., Makuuchi, M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nature Medicine. 2001, 7: 382-383.

  37. Sata, M., Luo, Z., Walsh, K. Augmented Fas ligand expression on the allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia J. Immunol. 2001, 66: 6964-6971.

  38. Nishimatsu, H., Suzuki, E., Nagata, D., Moriyama, N., Satonaka, H., Walsh, K., Sata, M., Kangawa, K., Matsuo, H., Goto, A., Kitamura, T., Hirata, Y. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta . Circ. Res. 2001, 89: 63-70.

  39. Sata, M., Nishimatsu, H., Suzuki, E., Sugiura, S., Yoshizumi, M., Ouchi, Y., Hirata, Y., Nagai, R.. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J.  2001, 15: 2530-2532.

  40. Sata, M., Sugiura, S., Yoshizumi, M., Ouchi, Y., Hirata, Y., Nagai, R.. Acute and chronic smooth muscle cell apoptosis after mechanical vascular injury can occur independently of the Fas-death pathway. Arterioscler. Thromb. Vasc. Biol. 2001. 21: 1733-1737.

  41. Saiura, A., Sata, M., Hirata, Y., Nagai, R., Makuuchi, M. Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation. Eur. J. Pharmacol. 2001. 433: 163-168.

  42. Sata, M., Saiura, A., Kunisato, A., Tojo, A., Okada, S., Tokuhisa, T., Hirai, H., Makuuchi, M., Hirata, Y., Nagai, R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nature Medicine. 2002. 8: 403-409.

  43. Nishimatsu, H., Hirata, Y., Shindo, T., Kurihara, H., Kakoki, M., Nagata, D., Hayakawa, H., Satonaka, H., Sata, M., Tojo, A., Suzuki, E., Kangawa, K., Matsuo, H., Kitamura, T., Nagai, R. . Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury. studies on transgenic/knockout mice of adrenomedullin gene. Circ. Res. 2002. 90: 657-663.

  44.  Sata, M., Hirata, Y., Nagai, R.  Role of Fas/FasL interaction in ischemia-induced collateral vessel growth.  Hypertension Research. 2002.25:577-582.

  45. Sata, M.,Takahashi, A., Tanaka, K., Washida M.,Ishizaka N.,Ako J.,Yoshizumi M.,Ouchi Y.,Taniguchi T., Hirata, Y., Yokoyama M.,Nagai R.,Walsh K.  Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21waf1-dependent pathway. Arterioscler. Thromb. Vasc. Biol.  2002.22:1305-1309

  46. Imai, Y, Shindo, T., Maemura, K., Sata, M., Saito, Y., Kurihara, Y., Akishita, M., Osuga, J., Ishibashi, S., Tobe, K., Morita, H., Oh-hashi, Y., Suzuki, T., Maekawa, H., Kangawa, K., Minamino, N., Yazaki, Y., Nagai, R., Kurihara, H. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin Overexpression. Arterioscler. Thromb. Vasc. Biol.  2002.22:1310-1315

  47. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002. 8; 856-863.

  48. Sata, M., Nagai, R. Phosphatidylinosotol 3-Kinase. A Key Regulator of Vascular Tone? Circ. Res. 2002. 2002. 91; 273-275.

  49. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis- the missing link of adipo-vascular axis - J Biol Chem. 2002. 277: 37487-37491.

  50. Sata, M. Biphasic Effect of Statins on Angiogenesis. Circulation. 2002;106:e47.

  51. Natori T, Sata M, Washida M., Hirata, Y, Nagai R., Makuuchi, M. G-CSF stimulates angiogenesis and promotes tumor growth: Potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun.  2002. 297: 1058-1061.

  52. Ishizaka N, Saito K, Mitani H, Yamazaki I, Sata M, Usui S, Mori I, Ohno M, Nagai R. Iron overload augments angiotensin II- induced cardiac fibrosis and promotes neointima formation. Circulation.2002. 106:1840-1846.

  53. Saiura A, Sugawara Y, Harihara Y, Sata M, Hamakubo T, Kodama T, Makuuchi M. Gene expression profile during acute rejection in rat-to-mouse concordant cardiac xenograft by means of DNA microarray. Transpl Int. 2002; 15: 535-540.

  54. Nitobe J, Yamaguchi S, Okuyama M, Nozaki N, Sata M, Miyamoto T, Takeishi Y, Kubota I, Tomoike H. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res. 2003, 57: 119-128.

  55.  Lee, P., Sata, M., Lefer, D.J., Factor, S.M., Walsh, K., Kitsis, R.N. Fas pathway is a critical mediator of cardiac myocyte death and myocardial infarction during ischemia/reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003, 284: H456-H463.

  56. Nishimatsu H, Hirata Y, Shindo T, Kurihara H, Suzuki E, Sata M, Satonaka H, Takeda R, Nagata D, Kakoki M, Hayakawa H, Kangawa K, Matsuo H, Kitamura T, Nagai R. Endothelial responses of the aorta from adrenomedullin transgenic mice and knockout mice. Hypertens Res. 2003, Suppl:S79-84.

  57. Sata, M., Tanaka, K, Nagai, R. Origin of smooth muscle progenitor cells: Different conclusions from different models Circulation. 2002. 107: e106-e107.

  58. Kumano K, Chiba S, Kunisato A, Sata M, Saito T, Nakagami-Yamaguchi E, Yamaguchi T, Masuda S, Shimizu K, Takahashi T, Ogawa S, Hamada Y, Hirai H. Notch1 but not notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003. 18: 699-711.

  59. Abe, M., Sata, M., Nishimatsu H, Nagata D, Suzuki E, Terauchi Y, Kadowaki, T, Minamino, N., Kangawa, K., Matsuo, H., Hirata, Y., Nagai, R. Adrenomedullin augments collateral development in response to acute ischemia. Biochem Biophys Res Commun. . 2003. 306:10-15.

  60. Yamazaki S, Miki K, Hasegawa K, Sata M, Takayama T, Makuuchi M. Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol. 2003: 39: 17-23.

  61. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling and lesion formation. Trends Cardiovasc Med. 2003. 13:249-253.

  62. Saiura A, Sata M, Washida M, Sugawara Y, Hirata Y, Nagai R, Makuuchi M. Little evidence for cell fusion between recipient and donor-derived cells. J Surg Res 2003. 113: 222-227.

  63. Sata, M., Tanaka, K., Ishizaka N., Hirata, Y., Nagai R. Absence of p53 leads to accelerated neointimal hyperplasia after vascular injury. Arterioscler. Thromb. Vasc. Biol.  2003. 23:1548-1552.

  64. Fukino K., Sata M., Seko Y., Hirata Y., Nagai R. Genetic background influences therapeutic effectiveness of VEGF.  Biochem Biophys Res Commun. 2003. 310:143-147.

  65. Tanaka K., Sata M., Hirata Y., Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003. 93: 783-790.

  66. Matsui Y, Saiura A, Sugawara Y, Sata M, Naruse K, Yagita H, Kohro T, Mataki C, Izumi A, Yamaguchi T, Minami T, Sakihama T, Ihara S, Aburatani H, Hamakubo T, Kodama T, Makuuchi M. Identificaton of gene expression profile in tolerizing murine cardiac allograft by co-stimulatory blockade. Physiol Genomics. 2003. 15: 199-208.
  67. Natori T, Sata M, Washida M., Hirata, Y, Nagai R., Makuuchi, M. Nicotine enhances neovascularization and promotes tumor growth. Mol Cells. 2003. 16: 143-146.
  68. Sata, M. Molecular strategies to treat vascular diseases; Circulating vascular progenitor cell as a potential target for prophylactic treatment of atherosclerosis. Circ J. 2003 ;67: 983-991.
  69. Sata, M., Nagai, R. Inflammation, angiogenesis, and endothelial progenitor cells: How do EPCs find their place? J. Mol. Cell. Cardiol. 2004. 36: 459-463.
  70. Sekiya, M., Osuga, J.I., Okazaki, H., Yahagi, N., Harada, K., Shen, W.J., Tamura, Y., Tomita, S., Iizuka, Y., Ohashi, K., Okazaki, M., Sata, M., Nagai, R., Fujita, T., Shimano, H., Kraemer, F.B., Yamada, N., Ishibashi, S. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lepob/ob mice. J Biol Chem. 2004.  279: 15084-15090.
  71.   Sata, M., Nishimatsu, H., Osuga, J.I., Tanaka, K., Ishizaka, N., Ishibashi, S., Hirata, Y., Nagai, R. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. Hypertension. 2004. 43: 1214-1220.
  72. Hiasa, K., Ishibashi, M., Ohtani, K., Inoue S, Zhao Q, Kitamoto, S., Sata, M., Ichiki, T., Takeshita, A., Egashira, K. Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway. Next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004. 109: 2454-2461.
  73. Hiasa, K., Egashira, K., Kitamoto, S., Ishibashi, M., Inoue, S., Ni, W., Zhao, Q., Nagata, S., Katoh, M., Sata, M., Takeshita, A. Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor. Basic Res Cardiol. 2004. 99: 165 -172 .
  74. Sata, M., Nagai, R. Origin of neointimal cells in autologous vein graft. Arterioscler Thromb Vasc Biol. 2004. 24: 1147 - 1149.
  75. Takahashi, H., Yanagi. Y., Tamaki. Y., Muranaka. K., Usui. T., Sata, M., Contribution of bone marrow derived cells to choroidal neovascularization. Biochem Biophys Res Commun. 2004. 320: 372-375.
  76. Nagata, D., Takeda, R., Sata, M., Satonaka, H., Suzuki, E., Nagano, T., Hirata, Y. AMP-activated protein kinase inhibits angiotensin II- stimulated vascular smooth muscle cell proliferation. Circulation. 2004. 110: 444-451.
  77. Ogawa, H., Oohashi, T., Sata, M., Bekku, Y., Hirohata, S., Nakamura, K., Yonezawa, T., Kusachi, S., Shiratori, Y., Ninomiya, Y. Lp3/Hapln3, a novel link protein which colocalizes with versican and is coordinately upregulated by platelet-derived growth factor in arterial smooth muscle cells. Matrix Biol. 2004.23:287-298.
  78. Saiura, A., Sata, M., Hiasa, K., Kitamoto, S., Washida, M., Egashira, K., Nagai, R., Makuuchi, M. Anti-monocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy. Arterioscler Thromb Vasc Biol. 2004.24:1886-1890.
  79. Ohtani, K., Egashira, K., Hiasa, KI., Zhao, Q., Kitamoto, S., Ishibashi, M., Usui, M., Inoue, S., Yonemitsu, Y., Sueishi, K., Sata, M., Shibuya, M., Sunagawa, K. blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation. 2004. 110:2444-2452.
  80. Saito, K., Ishizaka, N., Aizawa, T., Sata, M., Iso-O, N., Noiri, E., Ohno, M., Nagai, R. Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin ii-induced hypertensive rats. Hypertens Res. 2004. 8:599-607.
  81. Shoji, M., Sata, M., Fukuda, D., Tanaka, K., Sato, T., Iso, Y., Shibata, M., Suzuki, H., Koba, S., Geshi, E., Katagiri, T. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone marrow-derived progenitors to arterial remodeling. Cardiovasc Pathol. 2004. 13:306-312.
  82. Sata, M., Nagai, R. Mouse models of vein graft. Arterioscler Thromb Vasc Biol. 2004. 24: e185 - e187.
  83. Kobayashi, N., Yasu, T., Ueba, H., Sata, M., Hashimoto, S., Kuroki, M., Saito, M., Kawakami, M. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol. 2004. 32:1238-1245.
  84. Ishizaka, N., Saito, K., Noiri, E., Sata, M., Mori, I., Ohno, M., Nagai, R. Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin ii-treated and untreated rats. Nephron Physiol. 2004;98: 107-113.
  85. Yamamoto, T., Sata, M., Fukuda, D., Takamoto, S. The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy. Basic Res Cardiol.  2005. 100: 84-91.
  86. Hirata, Y., Sata, M., Motomura, N., Takanashi, M., Suematsu, Y., Ono, M., Takamoto, S. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun. 2005. 327: 609-614.
  87. Fukuda, D., Sata, M., Tanaka, K., Nagai, R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005. 111: 926-931.
  88. Natori, T., Sata, M., Nagai, R., Makuuchi, M. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomed Pharmacother. 2005. 59: 56-60.
  89. Higashikuni, Y., Sata, M., Nagai, R. Reversible left ventricular hypertrophy after Tako-Tsubo-like cardiomyopathy. Acta Cardiol. 2005. 60: 77-79.
  90. Kim-Kaneyama JR, Suzuki W, Ichikawa K, Ohki T, Kohno Y, Sata M, Nose K, Shibanuma M. Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo. J Cell Sci. 2005. 118: 937-949.
  91. Iwata, H., Sata, M., and Nagai, R. Complete aspiration of thrombi from an occluded coronary artery. Heart. 2005. 91: 530
  92. Ishizaka, N., Saito, K., Noiri E, Sata, M., Ikeda, H., Ohno, A., Ando, J., Mori, I., Ohno, M., Nagai, R. Administration of angiotensin II induces iron deposition and upregulation of TGF-β1 mRNA in the rat liver. Am J Physiol Regul Integr Comp Physiol. 2005  288: R1063 - R1070.
  93. Saito, K., Ishizaka, N., Aizawa, T., Sata, M., Iso-o, N., Noiri, E., Mori, I., Ohno, M., Nagai, R. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-1 in the heart. Am J Physiol Heart Circ Physiol. 2005. 288: H1836 - H1843.
  94. Kitamura, T., Sata, M., Motomura, N., Takamoto, S. Seeding of recipient bone marrow cells reduces neointimal hyperplasia of deendothelialized rat aortic allograft. Int Heart J. 2005. 46: 303-312.
  95. Tanaka, K., Sata. M., Fukuda, D., Suematsu, Y., Motomura, N., Takamoto, S., Hirata, Y., Nagai, R. Age-associated Aortic Stenosis in ApoE-deficient Mice. J Am Coll Cardiol. 2005. 46. 134-141.
  96. Guleng, B., Tateishi, K., Ohta, M., Kanai, F., Jazag, A., Ichijo, H., Tanaka, Y., Washida, M., Morikane, K., Fukushima, Y., Yamori, T., Tsuruo, T., Kawabe, T., Miyagishi, M., Taira, K., Sata, M., Omata, M. Blockade of the stromal cell–derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor–independent manner. Cancer Res 2005. 65, 5864-5871.
  97. Ohta, M., Tateishi, K., Kanai, F., Ueha, S., Guleng, B., Washida, M., Tanaka, Y., Ijichi, H., Ikenoue, T., Sata, M., Sudo, T., Shiina, S., Kawabe, T., Matsushima, K., Omata, M. Reduced p38 mitogen-activated protein kinase in donor grafts accelerates acute intestinal graft-versus-host disease in mice. Eur J Immunol. 2005. 35: 2210-2221.
  98. Sahara, M., Sata, M., Matsuzaki, Y., Tanaka, K., Morita, T., Hirata, Y., Okano, H., Nagai, R. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells 2005. 23: 874-878.
  99. Sata, M., Fukuda, D., Tanaka, K., Kaneda, Y., Yashiro, H., Shirakawa, I. The role of circulating precursors in vascular repair and lesion formation. J. Cell. Mol. Med. 2005.  9: 557-568.
  100. Sata, M., Tanaka, K., Nagai, R. Circulating Osteoblast-Lineage Cells. N. Engl. J. Med. 2005. 353: 737-738.
  101. Saito K, Ishizaka N, Hara M, Matsuzaki G, Sata M, Mori I, Ohno M, Nagai R. Lipid accumulation and transforming growth factor-β upregulation in the kidneys of rats administered angiotensin II. Hypertension, 2005. 46:1180-1185.
  102. Ohta, M., Tateishi, K., Kanai, F., Watanabe, H., Kondo, S., Guleng, B., Tanaka, Y., Asaoka, Y., Jazag, A., Imamura, J., Ijichi, H., Ikenoue, T., Sata, M., Miyagishi, M., Taira, K., Tada, M., Kawabe, T., Omata, M. p53-Independent Negative Regulation of p21/Cyclin-Dependent Kinase–Interacting Protein 1 by the Sonic Hedgehog-Glioma-Associated Oncogene 1 Pathway in Gastric Carcinoma Cells. Cancer Res 2005 65: 10822-10829.
  103. Yamamoto, T., Sata, M., Fukuda, D., Takamoto, S. The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy. J Surg Res 2006. 132:62-68.
  104. Takeda R, Nishimatsu H, Suzuki E, Satonaka H, Nagata D, Oba S, Sata M, Takahashi M, Yamamoto Y, Terauchi Y, Kadowaki T, Kangawa K, Kitamura T, Nagai R, Hirata Y. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol, 2006. 17:113-121.
  105. Yamazaki S, Miki K, Takayama T, Hasegawa K, Sata M, Midorikawa Y, Aburatani H, Makuuchi M. Hepatic gene induction in murine bone marrow after hepatectomy. J Hepatol. 2006. 44:325-333.
  106. Tateishi K, Ohta M, Guleng B, Kanai F, Tanaka Y, Asaoka Y, Jazag A, Imamura J, Imamura T, Ijichi H, Ikenoue T, Kawakami T, Fukushima Y, Washida M, Sata M, Miyagishi M, Taira K, Yoshida H, Kawabe T, Omata M. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors. Int J Cancer.  2006. 118:2237-2246.
  107. Sainz, J., Sata, M. Targeting bone marrow to treat vascular diseases: Accelerated vascular healing by colony stimulating factor. Cardiovasc Res. 2006. 70:3-5.
  108. Sata, M. The role of circulating vascular progenitors in angiogenesis, vascular healing and pulmonary hypertension: Lessons from animal models. Arterioscler Thromb Vasc Biol. 2006. 26:1008-1014.
  109. Sainz, J., Sata, M. Maintenance of Vascular Homeostasis by Bone Marrow-derived Cells. Arterioscler Thromb Vasc Biol.  2006. 26:1196-1197.
  110. Nishimura S, Nagai S, Sata M, Katoh M, Yamashita H, Saeki Y, Nagai R, Sugiura S. Expression of green fluorescent protein impairs the force-generating ability of isolated rat ventricular cardiomyocytes. Mol Cell Biochem. 2006. 286:59-65.
  111. Ohtani, K., Egashira, K., Ihara, Y., Nakano, K., Funakoshi, K., Zhao, G., Sata, M., Sunagawa, K. Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells. Hypertension. 2006. 48:664-670.
  112. Abe, M., Sata, M., Suzuki, E., Takeda, R., Takahashi, M., Nishimatsu, H., Nagata, D., Kangawa, K., Matsuo, H., Nagai, R., Hirata Y. Effects of adrenomedullin on acute ischemia-induced collateral development and mobilization of bone marrow-derived cells. Clin Sci (Lond).  2006. 111:381-387.
  113. Yoshioka M, Yuasa S, Matsumura K, Kimura K, Shiomi T, Kimura N, Shukunami C, Okada Y, Mukai M, Shin H, Yozu R, Sata M, Ogawa S, Hiraki Y, Fukuda K. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med. 2006. 12:1151-1159.
  114. Hanajiri K, Maruyama T, Kaneko Y, Mitsui H, Watanabe S, Sata M, Nagai R, Kashima T, Shibahara J, Omata M, Matsumoto Y. Microbubble-induced increase in ablation of liver tumors by high-intensity focused ultrasound. Hepatol Res. 2006. 36:308-314.
  115. Sumi, M., Sata, M., Toya, N., Yanaga, K., Ohki, T., Nagai, R.  Transplantation of adipose stromal cells, but not mature adipocytes, augments ischemia-induced angiogenesis.  Life Sci.  2007. 80:559-565.
  116. Wakayama, K., Shimamura, M., Sata, M., Sato, N., Kawakami, K., Fukuda, H., Tomimatsu, T., Ogihara, T., Morishita, R. Quantitative measurement of neurological deficit after mild (30 min) transient middle cerebral artery occlusion in rats. Brain Res. 2007. 1130:181-187.
  117.  Sainz, J., Sata, M. CXCR4, a key modulator of vascular progenitor cells. Arterioscler Thromb Vasc Biol.  2007. 27: 263-265.
  118. Sahara, M., Sata, M., Morita, T., Nakamura, K., Hirata, Y., Nagai, R.  Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation  2007. 115: 509-517.
  119. Inoue, T., Sata, M., Hikichi, Y., Sohma, R., Fukuda, D., Uchida, T., Shimizu, M., Komoda, H., Node, K. Mobilization of CD34-Positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation  115: 553-561.
  120. SumiM., Sata, M., Miura, S.I., Rye, K.A., Toya, N., Kanaoka, Y., Yanaga, K., Ohki, T., Saku, K., Nagai, R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol.  2007. 27: 813-818.
  121. Kojima, I., Tanaka, T., Inagi, R., Kato, H., Yamashita, T., Sakiyama, A., Ohneda, O., Takeda, N.,  Sata, M., Miyata, T., Fujita, T., Nangaku, M. Protective role of HIF-2α against ischemic damage and oxidative stress in the kidney.  J Am Soc Nephrol. 2007. 18: 1218-1226
  122. Suzuki, T., Nishi, T., Nagino, T., Sasaki, K., Aizawa, K., Kada, N., Sawaki, D., Munemasa, Y., Matsumura, T., Muto, S., Sata, M., Miyagawa, K., Horikoshi, M., Nagai, R. Functional interaction between the transcription factor Kruppel-like factor 5 and poly(ADP-ribose) polymerase-1 in cardiovascular apoptosis. J Biol Chem. 2007. 282: 9895-9901
  123. Iwata, H., Sta, M. Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases. Frontiers in Bioscience 2007. 12: 4157-4167
  124. Shirakawa, I., Sata, M., Saiura, A., Kaneda, Y., Yashiro, H., Hirata, Y., Makuuchi, M., Nagai, R. Atorvastatin attenuates transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation. Biomed Pharmacother. 2007. 61. 154-159
  125.  Tanaka, K., Sata, M. Therapeutic application of bone marrow-derived progenitor cells for vascular diseases: Magic bullets having the good without the bad. Int. J. Gerontol. 2007. 1. 10-21
  126.  Nakamura, K., Sata, M., Iwata, H., Sakai, Y., Hirata, Y., Kugiyama, K., Nagai, R. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in ischemic heart  Clin Sci (Lond).  2007. 112. 607-616
  127. Sumi, A., Sata, M., Hashimoto, A., Imaizumi, T., Yanaga, K., Ohki, T., Mori, T., Nagai, R. OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis. Biomed Pharmacother. 2007. 61. 209-215
  128. Aihara, K, Azuma, H., Akaike, M., Ikeda, Y., Sata, M.,  Takamori, N., Yagi, S., Iwase, T., Sumitomo, Y., Kawano, H., Yamada, T., Fukuda, T., Matsumoto, T., Sekine, K., Sato, T., Nakamichi, Y., Yamamoto, Y., Yoshimura, K., Watanabe, T., Nakamura, T., Oomizu, A., Tsukada, M., Hayashi, H., Sudo, T., Kato, S., Matsumoto, T.  Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice. J. Clin. Invest. 2007. 117. 1514-1526

  129. Shimamura, M., Sato, N., Sata, M., Wakayama, K, Ogihara, T., Morishita, R. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Brain Res. 2007. 1151. 188-194.
  130. Yamada, T., Kondo, T., Numaguchi, Y., Tsuzuki, M., Matsubara, T., Manabe, I., Sata, M., Nagai, R., Murohara, T. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol.  2007. 11. 2363-2369.

  131.  Fukuda, D., Sata, M.  Renin-angiotensin system: a potential modulator of endothelial progenitor cells. Hypertens Res. 2007. 30. 1017-1018.

  132. Shimamura, M., Sato, N., Sata, M., Kurinami, H., Takeuchi, D., Wakayama, K, Hayashi, T., Iida, H., , Morishita, R. Delayed post-ischemic treatment with fluvastatin improved cognitive impairment after stroke in rats. Stroke.  2007. 38. 3251-3258.

  133. Fukuda, D., Sata, M., Ishizaka, N., Nagai, R. A critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol.  2008. 28. 90-96.

  134. Sainz, J., Sata, M. Open sesame! CXCR4 blockade recruits neutrophils into the plaque. Circ Res. 2008. 102. 154-156.

  135. Tanaka, K., Sata, M., Natori, T., Kim-Kaneyama, J-R., Nose, K., Shibanuma, M., Hirata, H., Nagai, R. Circulating progenitor cells contribute to neointimal formation in non-irradiated chimeric mice. FASEB J  2008. 22. 428-436.

  136. Huang, P-H., Sata, M., Nishimatsu, H., Sumi, M., Hirata, Y., Nagai1, R. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother.  2008. 62. 46-52.

  137. Matsumoto, M., Sata, M., Fukuda, D., Tanaka, K., Soma, M., Hirata, Y., Nagai, R. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis  2008. 197. 524-533.

  138. Shimazaki, M., Nakamura, K., Kii, I. Kashima, T., Amizuka, N., Li, M., Fukuda, K., Nishiyama, T, Kitajima, S., Saga, Y., Fukayama, M., Sata, M., Kudo, A. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp. Med.. 2008. 205. 295-303.

  139. Imaizumi, S., Miura, S., Nakamura, K., Kiya, Y., Uehara, Y., Zhang, B., Matsuo, Y., Urata, H., Ideishi, M., Rye, K.A., Sata, M., Saku, K. Anti-arrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol. 2008. 51. 1604-1612.

  140. Hirata Y., Kiyosue A., Takahashi M., Satonaka H., Nagata D., Sata M., Suzuki E., Nagai R. Progression of renal dysfunction in patients with cardiovascular disease. Curr. Cardiol. Rev. 2008.4.198-202.

  141. Kumano, K., Masuda, S., Sata, M., Saito, T., Lee, S.Y., Sakata-Yanagimoto,  M., Tomita, T., Iwatsubo, T.,  Natsugari, H., Kurokawa, M., Ogawa, S., Chiba, S. Both Notch1 and Notch2 contribute to the regulation of  melanocytehomeostasis. Pigment Cell Res  2008. 21. 70-78.

  142. Fukuda, D., Sata, M.  Role of bone marrow renin angiotensin system in the pathogenesis of atherosclerosis. Pharmacol Ther. 2008. 21. 70-78.

  143. Iwata, H., Sata, M. The origin of the cells that contribute to neointima growth. Circulation. 2008.117.3060-3061.

  144. Tanaka, K., Sata, M. Potential role of statins in re-endothelialization. Immun., Endoc. & Metab. Agents in Med. Chem. 2008.8.151-155.

  145. Tanaka,K., Sata,M.  Contribution of circulating vascular progenitors in lesion formation and vascular healing:lessons from animal models. Curr Opin Lipidol. 2008.19.498-504.

  146. Nakamura K, Koibuchi N, Nishimatsu H, Higashikuni Y, Hirata Y, Kugiyama K, Nagai R, Sata M.  Candesartan ameliorates cardiac dysfunction observed in ACE2-deficient mice. Hypertens Res. 2008.31.1953-1961.

  147.  Inoue T, Matsuoka H, Higashi Y, Ueda S, Sata M, Shimada K, Ishibashi Y, Node K. Flow-Mediated Vasodilation as a Diagnostic Modality for Vascular Failure. Hypertens Res. 2008.31.2105-2113.

  148. Yokoyama U, Minamisawa S, Quan H, Akaike T, Jin M, Otsu K, Ulucan C, Wang X, Baljinnyam E, Takaoka M, Sata M, Ishikawa Y. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol. 2008.295.H1547-1555.

  149. Wakayama K, Shimamura M, Sata M, Koibuchi N, Sato N, Ogihara T, Morishita R. A model of cerebrovasucular injury in rats. J Neuroscience Methods. 2008.175.187-195.

  150. Kim-Kaneyama JR, Wachi N, Sata M, Enomoto S, Fukabori K, Koh K, Shibanuma M, Nose K. Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Biochem Biophys Res Commun. 2008.376.682-687.

  151. Enomoto, S., Sata, M., Fukuda, D., Nakamura, K., Nagai, R. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother. 2009.63.19-26.

  152. Kusunose K, Yamada H, Todoroki T, Nishio S, Niki T, Yamaguchi K, Koshiba K, Yagi S, Iwase T, Soeki T, Wakatsuki T, Akaike M, Kitagawa T, Sata M.  Platypnea-orthodeoxia syndrome associated with patent foramen ovale and aortic ectasia. Echocardiography. 2009.26.114-117.

  153. Meguro K, Iida H, Takano H, Morita T, Sata M, Nagai R, Nakajima T.  Function and Role of Voltage-Gated Sodium Channel (NaV1.7) Expressed in Aortic Smooth Muscle Cells. Am J Physiol Heart Circ Physiol.  2009.296.H211-219.

  154.  Ono Y, Nakaya Y, Bando S, Soeki T, Ito S, Sata M. Telmisartan Decreases Plasma Levels of Asymmet-rical Dimethyl-L-Arginine and Improves Lipid and Glucose Metabolism and Vascular Function. Int Heart J. 2009.50.73-83.

  155. Nagata D, Kiyosue A, Takahashi M, Satonaka H, Tanaka K, Sata M, Nagano T, Nagai R, Hirata Y.  A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell. Hypertens Res. 2009.32.133-139.

  156. Hanajiri K, Mitsui H, Maruyama T, Hashimoto N, Sata M, Omata M.  Echographic detection of diethylnitrosamine-induced liver tumors in rats and the effect of the intratumoral injection of an inhibitor of c-Jun N-terminal kinase. J Gastroenterol Hepatol. in press

  157. Fukuda D, Enomoto S, Nagai R, Sata M. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. Biomed Pharmacother. in press

  158. Fukuda D, Enomoto S, Shirakawa I, Nagai R, Sata M. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.  Eur J Pharmacol.  2009.612.87-92.

  159. Sainz, J., Sata M.  When p66ShcA is away, mice EPCs sweetly play.  Cardiovasc Res.  2009.82.388-389.

  160. Aihara K, Azuma H, Akaike M, Kurobe H, Takamori N, Ikeda Y, Sumitomo Y, Yoshida S, Yagi S, Iwase T, Ishikawa K, Sata M, Kitagawa T, Matsumoto T.  Heparin Cofactor U is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors. J Atheroscler Thromb. 2009.16.127-134.

  161. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ. Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow-Derived Endothelial Progenitor Cells. Arterioscler Thromb Vasc Biol. 2009.29.1179-1184.

  162. Kusunose K, Yamada H, Nishio S, Tomita N, Niki T,Yamaguchi K, Koshiba K, Yagi S, Taketani Y, Iwase T, Soeki T, Wakatsuki T, Akaike M, Sata M.  Clinical Utility of Single Beat E/e' Obtained by Simultaneous Recording of Flow and Tissue Doppler Velocities in Atrial Fibrillation with Preserved Systolic Function.  J Am Coll Cardiol Img. 2009.2.1147-1156.

  163. Iwata H, Nakamura K, Sumi M, Ninomiya M, Sakai Y, Hirata Y, Akaike M, Igarashi T, Takamoto S, Nagai R, Sata M.  Local delivery of synthetic prostacycline agonist augments collateral growth and improves cardiac function in a swine chronic cardiac ischemia model.  Life Sci. 2009.85.255-261.

  164. Tokudome T, Kishimoto I, Yamahara K, Osaki T, Minamino N, Horio T, Sawai K, Kawano Y, Miyazato M, Sata M, Kohno M, Nakao K, Kangawa K. Impaired Recovery of Blood Flow Following Hind-Limb Ischemia in Mice Lacking Guanylyl Cyclase-A, a Receptor for Atrial and Brain Natriuretic Peptides. Arterioscler Thromb Vasc Biol. 2009.29.1516-1521.

  165. Tanaka K, Sata M. Role of vascular progenitor cells in cardiovascular disease. Curr Pharm Des. 2009.15.2760-2768.

  166. Kim HJ, Yoo EK, Kim JY, Choi YK, Lee HJ, Kim JK, Jeoung NH, Lee KU, Park IS, Min BH, Park KG, Lee CH, Aronow BJ, Sata M, Lee IK.  Protective Role of Clusterin / Apolipoprotein J Against Neointimal Hyperplasia via Antiproliferative Effect on Vascular Smooth Muscle Cells and Cytoprotective Effect on Endothelial Cells. Arterioscler Thromb Vasc Biol. 2009.29.1558-1564.

  167. Takaoka, M., Nagata, D., Kihara, S., Shimomura, S., Kimura, Y., Tabata, Y., Saito, Y., Nagai, R., Sata, M. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res. 2009.105.906-911.

  168. Aihara KI, Azuma H, Akaike M, Sata M, Matsumoto T.  Heparin Cofactor II as a Novel Vascular Protective Factor Against Atherosclerosis. J Atheroscler Thromb. 2009.16.523-531.

  169. Hirata Y, Soeki T, Akaike M, Sakai Y, Igarashi T, Sata M.  Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.  Biomed Pharmacother. 2009.63.781-786.

  170. Enomoto S, Sumi M, Kajimoto K, Nakazawa Y, Takahashi R, Takabayashi C, Asakura T, Sata M.  Long-term Patency of Small-diameter Vascular Graft Made from Fibroin, a Silk-based Biodegradable Material. J Vasc Surg. 2010.51.155-164.

  171.  Sainz J, Sata M. When EPC says: I2 shall limit neointima formation!  Arterioscler. Thromb. Vasc. Biol.  2010.30.457-458.

  172. Sata M, Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. The Journal of Medical Investigation. 2010.57.12-25.

  173. Yagi S, Akaike M, Aihara K, Iwase T, Ishikawa K, Yoshida S, Ueda Y, Kusunose K, Niki T, Yamaguchi K, Koshiba K, Hirata Y, Munkhbaatar D, Taketani Y, Tomita N, Yamada H, Soeki T, Wakatsuki T, Matsumoto T, Sata M.  Ezetimibe ameliorates metabolic disorder and microalbuminuria in patients with hypercholesterolemia.  J Atheroscler Thromb.  2010.17.173-180.

  174. Sainz J, Sata M.  Is PIGF a Plaque Growth Factor?  Cardiovasc Research.  2010.86.4-5.

  175. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY, Sata M, Chen JW, Lin SJ. Intake of Red Wine Increases the Number and Functional Capacity of Circulating Endothelial Progenitor Cells by Enhancing Nitric Oxide Bioavailability.  Arterioscler Thromb Vasc Biol.  2010.30.869-877.

  176. Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, Sata M.  eNOS-independent Protective Action of Statin Against Angiotensin II-induced Atrial Remodeling via Reduced Oxidant Injury.  Hypertension.  2010.55.918-923.

  177. Iwata H, Sata M, Ando J, Fujita H, Morita T, Sawaki D, Takahashi M, Hirata Y, Takanashi S, Tabata M, Hirata Y, Nagai R Takanashi S, Hirata Y, Nagai R.  Impact of primitive cells in intracoronary thrombi on lesion prognosis: Temporal analysis of cellular constituents of thrombotic material obtained from patients with acute coronary syndrome.  Heart. 2010.96:748-755

  178. Yagi S, Akaike M, Fujimura M, Kimura T, Nishiuchi T, Iwase T, Aihara K, Yoshida S, Sumitomo-Ueda Y, Kusunose K, Niki T, Yamaguchi K, Koshiba K, Hirata Y, Dagvasumberel M, Taketani Y, Tomita N, Yamada H, Soeki T, Wakatsuki T, Matsumoto T, Sata M.  Congenital ventricular aneurysm manifesting as monofocal premature ventricular contractions.  Intern Med. 2010.49.907-912.

  179. Yamada H, Mishiro Y, Kusunose K, Sata M Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.  J Cardiovasc Pharmacol Ther.  2010.15.145-150.

  180. Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.  A phoshodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Arterioscler Thromb Vasc Biol.  2010. 30:1315-1324.

  181. Kusunose K, Yamada H, Iwase T, Nishio S, Tomita N, Niki T, Yamaguchi K, Koshiba K, Taketani Y, Soeki T, Wakatsuki T, Akaike M, Takao S, Harada M, Kagawa N, Kudo E, Sata M.  Cardiac Magnetic Resonance Imaging and 2D Speckle Tracking Echocardiography in Secondary Cardiac Amyloidosis.  Circ J. 2010;74: 1494-1496.

  182. Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R,  Sata M. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol.  2010.30:1576-1582.

  183. Sumitomo-Ueda Y, Aihara KI, Ise T, Yoshida S, Ikeda Y, Uemoto R, Yagi S, Iwase T, Ishikawa K, Hirata Y, Akaike M, Sata M, Kato S, Matsumoto T.  Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. Hypertension. 2010.56:430-436.

  184. Yoshida S, Aihara K, Azuma H, Uemoto R, Sumitomo-Ueda Y, Yagi S, Ikeda Y, Iwase T, Nishio S, Kawano H, Miki J, Yamada H, Hirata Y, Akaike M, Sata M, Matsumoto T. Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis 2010. 212: 310-315.

  185. Iwase, T, Takao, S, Akaike, M, Adachi, K, Sumitomo-Ueda Y, Yagi S, Niki, T, Kusunose, K, Tomita, N, Hirata, Y, Yamaguchi, K, Koshiba, K, Taketani, Y, Yamada, H, Soeki, T, Wakatsuki, T, Aihara, KI, Harada, M, Nishitani, H, Sata, M. Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy. Heart Asia 2010.2:52-55.

  186. Higashikuni, Y, Sainz, J, Nakamura, K, Takaoka, M, Enomoto, S, Iwata, H, Sahara, M, Tanaka, K, Koibuchi, N, Ito, S, Kusuhara, H, Sugiyama, Y, Hirata, Y, Nagai, N, Sata, M. The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function. Arterioscler Thromb Vasc Biol. 2010;30:2128-2135.

  187. Iwata, H, Manabe, I, Fujiu, K, Yamamoto, T, Takeda, N, Eguchi, K, Furuya, A, Kuro-o, M, Sata, M, Nagai, R. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation . 2010;122;2048-2057.

  188. Huang PH, Tsai HY, Wang CH, Chen YH, Chen JS, Lin FY, Lin CP, Wu TC, Sata M, Chen JW, Lin SJ.  Moderate intake of red wine improves ischemia-induced neovascularization in diabetic mice-Roles of endothelial progenitor cells and nitric oxide. Atherosclerosis. 2010;212:426-435.

  189. Yagi S, Akaike M, Iwase T, Kusunose K, Niki T, Yamaguchi K, Koshiba K, Yoshida S, Sumitomo-Ueda Y, Aihara K, Hirata Y, Dagvasumberel M, Taketani Y, Tomita N, Yamada H, Soeki T, Wakatsuki T, Matsumoto T, Sata M Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis.  Intern Med. 2010;49:2309-2312.

  190. Fukuda, D, Enomoto, S, Hirata, Y, Nagai, R, Sata, M. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.  Biomed Pharmacother 2010;64:712-717.

  191. Sato, M., Nakazawa, Y., Takahashi, R., Tanaka, K., Sata, M., Aytemiz, D., Asakura, T. Small-diameter vascular grafts of Bombyx mori silk fibroin prepared by a combination of electrospinning and sponge coating. Mater Lett. 2010; 64:1786-1788.

  192. Nakazawa Y, Sato M, Takahashi R, Aytemiz D, Takabayashi C, Tamura T,  Enomoto S, Sata M, Asakura T.  Development of small-diameter vascular grafts based on silk fibroin fibers from bombyx mori for vascular regeneration. J Biomater Sci Polym Ed. 2011;22: 195–206

  193. Kusunose K, Yamada H, Nishio S, Mizuguchi Y, Choraku M, Maeda Y, Hosokawa S, Yamazaki N, Tomita N, Niki T, Yamaguchi K, Koshiba K, Soeki T, Wakatsuki T, Akaike M, Sata M.  Validation of longitudinal peak systolic strain by speckle tracking echocardiography with visual assessment and myocardial perfusion SPECT in patients with regional asynergy. Circ J. 2011;75:141-147.

  194. Yagi S, Akaike M, Aihara KI, Iwase T, Yoshida S, Sumitomo-Ueda Y, Ikeda Y, Ishikawa K, Matsumoto T, Sata, M. High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. Hypertens Res. 2011;34:74-78.

  195. Kim-Kaneyama JR, Takeda N, Sasaki A, Miyazaki A, Sata M, Hirabayashi T, Shibanuma M, Yamada G, Nose K.  Hic-5 deficiency enhances mechanosensitive apoptosis and modulates vascular remodeling. J Mol Cell Cardiol.  2011 ;50:77-86.

  196. Ise, T., Aihara, K., Sumitomo-Ueda, Y., Yoshida, S., Ikeda, Y., Yagi, S., Iwase, T., Yamada, H., Akaike, M., Sata, M., Matsumoto, T.  Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors. Hypertens Res. 2011; 34:225-231.

  197. Hirata, Y., Sata, M.  CAVI, a new parameter that detects arterial stiffness change after smoking. Circ J. 2011;3:548-549.

  198. Tanaka, K., Nagata, D., Hirata, Y., Tabata, Y., Nagai, R., Sata, M.  Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice. Atherosclerosis.  2011;215:366-373.

  199. Yagi, S., Akaike, M., Aihara, KI., Iwase, T., Sumitomo-Ueda, Y., Yoshida, S., Matsumoto, T., Sata, M.  Bosentan improves systemic sclerosis-related peripheral circulation insufficiency. Int J Cardiol. 2011;147:472-475.

  200. Yagi, S., Akaike, M., Iwase, T., Kusunose, K., Niki, T., Yamaguchi, K., Koshiba, K., Taketani, Y., Tomita, N., Yamada, H., Soeki, T., Wakatsuki, T., Sata, M.  Acute hemodynamic effects of adaptive servo ventilation in patients with pulmonary hypertension. Int J Cardiol. 2011;148:125-127.

  201. Hashizume, S., Akaike, M., Azuma, H., Ishikawa, K., Yoshida, S., Sumitomo-Ueda, Y., Yagi, S., Ikeda, Y., Iwase, T., Aihara, K., Abe, M., Sata, M., Matsumoto, T.  Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets. J Atheroscler Thromb.  2011;18:138-147.

  202. Hirata, Y., Sata, M.  Synergistic protection against vascular inflammation with a calcium channel blocker and a statin. Hypertens Res. 2011;34:441-442.

  203. Ichioka, M., Suganami, T., Tsuda, N., Shirakawa, I., Hirata, Y., Satoh-Asahara, N., Shimoda, Y., Tanaka, M., Kim-Saijo, M., Miyamoto, Y., Kamei, Y., Sata, M., Ogawa, Y.  Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans. Diabetes. 2011;60:819-826.

  204. Kusunose, K., Yamada, H., Tomita, N., Nishio, S., Niki, T., Yamaguchi, K., Koshiba, K., Yagi, S., Taketani, Y., Iwase, T., Soeki, T., Wakatsuki, T., Akaike, M., Sata, M.  Serial imaging changes during treatment of Takayasu arteritis with pulmonary artery stenosis. Int J Cardiol. 2011;148:e47-e50.

  205. Kusunose, K., Wakatsuki, T., Sata, M. Removal of pinched-off central venous catheter. Heart Asia. 2011;3:32.

  206. Hirata, Y., Kurobe, H., Akaike, M., Chikugo, F., Hori, T., Bando, Y., Nishio, C., Higashida, M., Nakaya, Y., Kitagawa, T., Sata, M.  Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011; 52:139-142.

  207. Sata, M., Fukuda, D.  Chronic inflammation and atherosclerosis: A critical role for renin angiotensin system that is activated by life-style related diseases. Inflamm Regen. 2011; 31:245-255.

  208. Yagi, S., Akaike, M., Aihara, KI., Iwase, T., Ishikawa, K., Yoshida, S., Sumitomo-Ueda, Y., Kusunose, K., Niki, T., Yamaguchi, K., Koshiba, K., Taketani, Y., Tomita, N., Yamada, H., Soeki, T., Wakatsuki, T., Matsumoto, T., Sata, M.  Effect of low-dose (1 mg/day) pitavastatin on left ventricular diastolic function and albuminuria in patients with hyperlipidemia. Am J Cardiol. 2011; 107:1644-1649.

  209. Bando, M., Soeki, T., Niki, T., Kusunose, K., Tomita, N., Yamaguchi, K., Koshiba, K., Taketani, Y., Iwase, T., Yamada, H., Wakatsuki, T., Akaike, M., Sata, M. Ventricular tachycardia in cardiac sarcoidosis controlled by radiofrequency catheter ablation. Intern Med. 2011; 50:1201-1206.

  210. Yagi, S., Sata, M. Pre-clinical data on the role of mineralocorticoid receptor antagonists in reversing vascular inflammation. Eur Heart J Suppl. 2011; 13: B15-B20.

  211. Yagi, T., Sato, M., Nakazawa, Y., Tanaka, K., Sata, M., Itoh, K., Takagi, Y., Asakura, T.  Preparation of double-raschel knitted silk vascular grafts and evaluation of short-term function in a rat abdominal aorta. J Artif Organs. 2011;14:89-99.

  212. Yamaguchi, K., Wakatsuki, T., Niki, T., Taketani, Y., Oezuka, H., Kusunose, K., Iwase, T., Yamada, H., Soeki, T., Sata, M.  Observation of short-term atorvastatin-induced changes in coronary arterial plaque properties using integrated backscatter intravascular ultrasound in a patient. JC Cases. 2011;3:e111-e114.

  213. Tomiyama, H., Higashi, Y., Takase, B., Node, K., Sata, M., Inoue, T., Ishibashi, Y., Ueda, S., Shimada, K., Yamashina, A.  Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens. 2011;24:770-774.

  214. Hirata, Y., Tabata, M., Kurobe, H., Motoki, T., Akaike, M., Nishio, C., Higashida, M., Mikasa, H., Nakaya, Y., Takanashi, S., Igarashi, T., Kitagawa, T., Sata, M.  Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011;58:248-255.

  215. Niki, T., Wakatsuki, T., Yamaguchi, K., Kusunose, K., Koshiba, K., Yagi, S., Taketani, Y., Iwase, T., Tomita, N., Yamada, H., Soeki, T., Akaike, M., Sata, M.  Comparison of chronic-stage histopathological findings among 3 coronary stents implanted in the same patient. Int J Cardiol. 2011; 150:e25-e27.

  216. Yamazaki, H., Yamaguchi, K., Iwase, T., Niki, T., Kusunose, K., Tomita, N., Taketani, Y., Yamada, H., Soeki, T., Wakatsuki, T., Fukunaga, Y., Nakanishi, H., Maruyama, H., Matsuoka, H., Sata, M. A patient who developed toe necrosis due to poor blood circulation after an interdigital tick bite. JC Cases. 2011; 4:e106-e109.

  217. Hirata, Y., Soeki, T., Yamada, H., Shiota, A., Shimabukuro, M., Sakai, Y., Nakayama, M., Matsumoto, K., Igarashi, T., Sata, M. A synthetic prostacycline agonist, ONO-1301, ameliorates ventricular remodeling after acute myocardial infarction via up-regulation of HGF in rat. Biomed Aging Pathol. 2011; 1: 90-96.

  218. Soeki, T., Niki, T., Kusunose, K., Bando, S., Hirata, Y., Tomita, N., Yamaguchi, K., Koshiba, K., Yagi, S., Taketani, Y., Iwase, T., Yamada, H., Wakatsuki, T., Akaike, M., Sata, M.  Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability. J Cardiol. 2011; 58:151-157.

  219. Shiota, A., Taketani, Y., Maekawa, Y., Yasutomo, K., Sata, M., Sakai, T., Mizuno, R., Isshiki, M., Yamamoto, H., Takeda, E. High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice. J Clin Biochem Nutr. 2011; 49: 109-114.

  220. Kimura, K., Takenaka, K., Ebihara, A., Uno, K., Iwata, H., Sata, M., Kohro, T., Morita, H., Yatomi, Y., Nagai, R. Reproducibility and diagnostic accuracy of three-layer speckle tracking echocardiography in a swine chronic ischemia model. Echocardiography. 2011; 28:1148-1155.

  221. Yamaguchi, K., Wakatsuki, T., Niki, T., Kusunose, K., Koshiba, K., Yagi, S., Taketani, Y., Iwase, T., Tomita, N., Yamada, H., Soeki, T., Akaike, M., Sata, M.  Local persistent hypercoagulability after sirolimus-eluting stent implantation in patients with stable angina. Int J Cardiol. 2011; 153:272-276.

  222. Kurobe, H., Aihara, KI., Higashida, M., Hirata, Y., Nishiya, M., Matsuoka, Y., Kanbara, T., Nakayama, T., Kinoshita, H., Sugano, M., Fujimoto, E., Kurobe, A., Sugasawa, N., Kitaichi, T., Akaike, M., Sata, M., Matsumoto, T., Kitagawa, T. Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress. J Atheroscler Thromb. 2011; 18:1080-1089.

  223. Higashikuni, Y., Takaoka, M., Iwata, H., Tanaka, K., Hirata, Y., Nagai, Y., Sata, M. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice. Hypertens Res. 2012; 35:62-69.

  224. Hirata, Y., Shimabukuro, M., Uematsu, E., Soeki, T., Yamada, H., Sakai, Y., Nakamura, M., Matsumoto, K., Igarashi, T., Sata, M. A synthetic prostacyclin agonist thrombozane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury. Eur J Pharmacol. 2012; 674: 352-358.

  225. Higashikuni, Y., Sainz, J., Nakamura, K., Takaoka, M., Enomoto, S., Hiroshi, I., Kimie, T., Sahara, M., Hirata, Y., Nagai, R., Sata, M. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response. Arterioscler Thromb Vasc Biol. 2012; 32:654-661.

  226. Shimabukuro, M., Masuzaki, H., Sata, M. Intensive Glucose Lowering in Cardiovascular Risk Management. Circ J. 2012; 76:593-595.

  227. Hara, T., Yamaguchi, K., Sata, M. Massive splenic infarction due to left ventricular apical thrombus in a patient with giant splenomegaly. Heart Asia. 2012;4:53

  228. Sahara, M., Sata, M., Morita, T., Hirata, Y., Nagai, R. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension. PLoS One. 2012; 7: e33367.

  229. Kanbara, T., Kurobe, H., Kitaichi, T., Sugano, M., Nakayama, T., Kinoshita, H., Iwase, T., Akaike, M., Abe, M., Sata, M., Matsumoto. T., Kitagawa, T. Autologous peripheral blood-derived mononuclear cells induced by erythropoietin improve critical ischemic limbs. Ann Vasc Dis. 2012; 5:52-60.

  230. Watanabe, Y., Nakamura, T., Ishikawa, S., Fujisaka, S., Usui, I., Tsuneyama, K., Ichihara, Y., Wada, T., Hirata, Y., Suganami, T., Izaki, H., Akira, S., Miyake, K., Kanayama, H., Shimabukuro, M., Sata, M., Sasaoka, T., Ogawa, Y., Tobe, K., Takatsu, K., and Nagai, Y. The Radioprotective 105/MD-1 complex contributes to diet-induced obesity and adipose tissue inflammation. Diabetes. 2012; 61:1199-209.

  231. Yagi, S., Aihara, K., Ikeda, Y., Akaike, M., Sata, M., Matsumoto, T. Effects of statins on cardiorenal syndrome. Int J Vasc Med. 2012; Article ID 162545: 7 pages

  232. Tomiyama, H., Kohro, T., Higashi, Y., Takase, B., Suzuki, T., Ishizu, T., Ueda, S., Yamazaki, T., Furumoto, T., Kario, K., Inoue, T., Koba, S., Watanabe, K., Takemoto, Y., Hano, T., Sata, M., Ishibashi, Y., Node, K., Maemura, K., Ohya, Y., Furukawa, T., Ito, H., Yamashina, A. A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery. Int Heart J. 2012; 53:170-175.

  233. Hara, T., Soeki, T., Niki, T., Kusunose, K., Yamaguchi, K., Taketani, Y., Iwase, T., Yamada, H., Wakatsuki, T., Akaike, M., Sata, M. Bicuspid aortic valve endocarditis complicated by perivalvular abscess. Journal of Medical Investigation. 2012;59(3.4)261-265

  234. Munkhbaatar, D., Shimabukuro, M., Nishiuchi, T. Ueno, J., Takao, S., Fukuda, D., Hirata, Y., Kurobe, H., Soeki, T., Iwase, T., Kusunose, K., Niki, T., Yamaguchi, K., Taketani, Y., Yagi, S., Tomita, N., Yamada, H., Wakatsuki, T., Harada, M., Kitagawa, T., Sata M. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol. 2012;11:106.

  235. Shiota, A., Shimabukuro, M., Fukuda, D., Soeki, T., Sato, H., Uematsu, E., Hirata, Y., Kurobe, H., Sakaue, H., Nakaya, Y., Masuzaki, H., Sata, M. Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects. Eur J Pharmacol. 2012; 692:84-90

  236.  Ikeda, Y., Aihara, KI., Yoshida, S., Iwase, T., Tajima, S., Izawa-Ishizawa, Y., Kihara, Y., Ishizawa, K., Tomita, S., Tsuchiya, K., Sata, M., Akaike, M., Kato, S., Matsumoto, T., Tamaki, T. Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMPK-eNOS signaling pathway. J. Biol. Chem. 2012; 287:34256-34263.

  237. Shiota, A., Shimabukuro, M., Fukuda, D., Soeki, T., Sato, H., Uematsu, E., Hirata, Y., Kurobe, H., Maeda, N., Sakaue, H., Masuzaki, H., Shimomura, I., Sata, M. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovascular Diabetol. 2012; 11:139.

  238. Kusunose, K., Yamada, H., Nishio, S., Tomita, N., Hotchi, J., Bando, M., Niki, T., Yamaguchi, K., Taketani, Y., Iwase, T., Soeki, T., Wakatsuki, T., Sata, M. Index-beat Assessment of Left Ventricular Systolic and Diastolic Function during Atrial Fibrillation using Myocardial Strain and Strain Rate. J Am Soc Echocardiogr. 2012; 25:953-959.

  239. Soeki, T., Kitani, M., Kusunose, K., Yagi, S., Taketani, Y., Koshiba, K., Wakatsuki, T., Orino, S., Kawano, K., Sata, M. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients. Hypertens Res. 2012; 35:1058-1062.

  240. Hayashi, S., Yamada, H., Nishio, N., Tomita, N., Hotchi, J., Bando, M., Nakagawa, M., Tamai, R., Hirota, D., Hirata, Y., Sata, M. Double-chambered right ventricle presenting significant outflow tract obstruction only in the right decubitus position. J Echorcardiogr. 2012; 10:146-147.

  241. Yamakawa, K., Shimabukuro, M., Higa, N., Asahi, T., Ohba, K., Arasaki, O., Higa, M., Oshiro, Y., Yoshida, H., Higa, T., Saito, T., Ueda, S., Masuzaki, H., Sata, M. Eicosapentaenoic acid supplement changes fatty acid composition and corrects endothelial dysfunction in hyperlipidemic patients. Cardiol Res Pract. 2012; Article ID 754181: 9

  242. Soeki, T., Sata, M. The role of epicardial adipose tissue in atrial fibrillation. Circ J. 2012; 76:2738-2739.

  243. Minami, T., Kuwahara, K., Nakagawa, Y., Takaoka, M., Kinoshita, H., Nakao, K., Kuwabara, Y., Yamada, Y., Yamada, C., Shibata, J., Usami, S., Yasuno, S., Nishikimi, T., Ueshima, K., Sata, M., Nakano, H., Seno, T., Kawahito, Y., Sobue, K., Kimura, A., Nagai, R., Nakao, K. Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. EMBO J. 2012; 31:4428-4440.

  244. Hirata, Y., Kurobe, Uematsu, E., Yagi, S., Soeki, T., Yamada, H., Fukuda, D., Shimabukuro, M., Nakayama, M., Matsumoto, K., Sakai, Y., Kitagawa, T., Sata, M. Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model. Eur J Pharmacol. 2013; 699:81-87.

  245. Hirata, Y., Kurobe, H., Nishio, C., Tanaka, K., Fukuda, D., Uematsu, E., Nishimoto, S., Soeki, T., Harada, N., Sakaue, H., Kitagawa, T., Shimabukuro, M., Nakaya, N., Sata, M. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Eur J Pharmacol. 2013; 699:106-111.

  246. Yamauchi, H., Motomura, N., Chung, UI., Sata, M., Takai, D., Saito, A., Ono, M., Takamoto, S. Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model. J Thorac Cardiovasc Surg. 2013; 145:522-530.

  247. Hara, T., Yamaguchi, K., Iwase, T., Kadota, M., Bando, M., Ogasawara, K., Bando, S., Ise, T., Niki, T., Ueda, Y., Tomita, N., Taketani, Y., Yamada, H., Soeki, T., Wakatsuki, T., Sata, M. Eosinophilic Myocarditis due to Churg-Strauss syndrome with markedly elevated Eosinophil Cationic Protein. Int Heart J. 2013; 54:51-53.

  248. Ise, T., Fujioka, K., Iwase, T., Hotchi, J., Akaike, M., Sata, M. Ulcer-like projection caused by a penetrating branch to the bronchial artery. J Am Coll Cardiol. 2013; 61:e147.

  249. Hara, T., Yamada, H., Takashima, A., Yamasaki, H., Ogasawara, K., Bando, S., Ise, T., Niki, T., Kusunose, K., Ueda, Y., Tomita, N., Yamaguchi, K., Taketani, Y., Iwase, T. Soeki, T., Wakatsuki, T., Horiguchi, H., Sakashita, N., Sata, M. Constrictive pericarditis with intrapericardial abscess. Circ J. 2013; 77:786-788.

  250. Tian, Z., Miyata, K., Tazume, H., Sakauguchi, H., Kadomatsu, T., Horio, E., Takahashi, O., Komohara, Y., Araki, K., Hirata, Y., Tabata, M., Takanashi, S., Takeya, M., Hao, H., Shimabukuro, M., Sata, M., Kawasuji, M., Oike, Y. Perivascular adipose tissue-secreted angiopoietin-like protein2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol. 2013; 57:1-12.

  251. Hara, T., Sata, M. Spectacular migration of a central venous catherter into the pulmonary artery. Heart Asia. 2013;5:42-43

  252. Fukuda, Y., Soeki, T., Sata, M. A novel doppler echocardiographic index integrating left and right ventricular function is superior to conventional indices for predicting adverse outcome of acute myocardial infarction. J Med Invest. 2013;60:97-105.

  253. Shimabukuro, M., Kozuka, C., Taira, T., Yabiku, K., Dagvasumberel, M., Ishida, M., Matsumoto, S., Yagi, Y., Fukuda, D., Yamakawa, K., Higa, M., Soeki, T., Yoshida, H., Masuzaki, H., Sata, M. Ectopic fat deposition and global cardiometabolic risk: New paradigm in cardiovascular medicine. J Med Invest. 2013;60:1-14.

  254. Kusunose, K., Yamada, H., Nishio, S., Tomita, N., Niki, T., Yamaguchi, K., Taketani, Y., Iwase, T., Soeki, T., Wakatsuki, T., Sata, M. Interval from the Onset of Transmitral Flow to Annular Velocity Is a Marker of LV Filling Pressure. JACC Cardiovasc Imaging. 2013;6:528-530.

  255. Shimabukuro, M., Hirata, Y., Tabata, M., Dagvasumberel, M., Sato, H., Kurobe, H., Fukuda, D., Soeki, T., Kitagawa, T., Takanashi, S., Sata, M. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1077-1084.

  256. Tomita, N., Yamada, H., Nishio, S., Tamai, R., Kusunose, K., Hayashi, S., Hotchi, J., Sata, M. Patent foramen ovale diagnosed by real-time three-dimensional contrast transesophageal echocardiography: A case report. JC Cases. 2013;7:e91-e92.

  257. Kawano, N., Yamaguchi, K., Niki, T., Yamamoto, T., Iwase, T., Taketani, T., Ise, T., Yamada, H., Soeki, T., Wakatsuki, T., Kawano, K., Kakutani, K., Sata, M. Two cases of acute myocardial infarction during combined chemotherapy in young patients with testicular cancer. JC Cases. 2013;7:e176-e180.

  258. Shimabukuro, M., Higa, N., Tagawa, T., Yamakawa, K., Sata, M., Ueda, S. Defects of vascular nitric oxide bioavailability in subjects with impaired glucose tolerance: A potential link to insulin resistance. Int J Cardiol. 2013;167:298-300.

  259. Yagi, S., Akaike, M., Aihara, KI., Fukuda, D., Ishida, M., Ise, T., Niki, T., Sumitomo-Ueda, Y., Yamaguchi, K., Iwase, T., Taketani, Y., Yamada, H., Soeki, T., Wakatsuki, T., Shimabukuro, M., Sata, M. Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems. Acta Cardiol Sin. 2013;29:201-207.

  260. Fukuda, D., Sata, M. Expanded roles of the renin-angiotensin system. Hypertens Res. 2013;36:586-587.

  261. Yoshida, S., Aihara, KI., Ikeda, Y., Sumitomo-Ueda, Y., Uemoto, R., Ishikawa, K., Ise, T., Yagi, S., Iwase, T., Mouri, Y., Sakari, M., Matsumoto, T., Takeyama, KI., Akaike, M., Matsumoto, M., Sata, M., Walsh, K., Kato, S., Matsumoto, T. Androgen Receptor Promotes Sex-Independent Angiogenesis in Response to Ischemia and Is Required for Activation of Vascular Endothelial Growth Factor Receptor Signaling. Circulation. 2013;128:60-71.

  262. Hara, T., Wakatsuki, T., Taketani, Y., Yamaguchi, K., Iwase, T., Sata, M. A case of successful use of microsnare to hold and pull the retrograde guidewire for the intervention to peripheral chronic total occlusion. Cardiovasc Interv Ther. 2013;28:287-290.

  263. Nakayama, T., Kurobe, H., Sugasawa, N., Kinoshita, H., Higashida, M., Matsuoka, Y., Yoshida, Y., Hirata, Y., Sakata, M., Maxfield, MW., Shimabukuro, M., Takahama, Y., Sata, M., Tamaki, T., Kitagawa, T., Tomita, S. Role of macrophage-derived hypoxia-inducible factor (HIF)-1α as a mediator of vascular remodeling. Cardiovasc Res. 2013;99:705-715.

  264. Shimamura, M., Nakagami, H., Sata, M., Takaoka, M., Azuma, J., Kiomy Osako, M., Koriyama, H., Kurinami, H., Wakayama, K., Miyake, T., Morishita, R. Unique remodeling processes after vascular injury in intracranial arteries: analysis using a novel mouse model. J Cereb Blood Flow Metab. 2013;33:1153-1159.

  265. Shimabukuro, M., Higa, M., Yamakawa, K., Masuzaki, H., Sata, M. Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: A randomized comparable study. Int J Cardiol. in press. doi:10.1016/j.ijcard.2012.05.109

  266. Tanaka, K., Sata, M. Blockade of CTP synthase regulates SMC and EC proliferation differentially. Arterioscler Thromb Vasc Biol. 2013;33:2286-2287 doi: 10.1161/​ATVBAHA.113.302315

  267. Hirata Y, Kurobe H, Higashida M, Fukuda D, Shimabukuro M, Higashikuni Y, Kitagawa T, Sata M. HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9. Atherosclerosis. 2013;231:227-233 doi:10.1016/j.atherosclerosis.2013.09.010

  268. Kurobe, H., Hirata, Y., Matsuoka, Y., Sugasawa, N., Higashida, M., Nakayama, T., Maxfield, MW., Shimabukuro, M., Kitagawa, T., Sata, M. Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model. J Surg Res.  2013;185:455-462  doi: 10.1016/j.jss.2013.05.002

  269. Sumi M, Tateishi N, Shibata H, Ohki T, Sata M. Quercetin glucosides promote ischemia-induced angiogenesis, but do not promote tumor growth. Life Sciences. 2013;93:814-819 doi:10.1016/j.lfs.2013.09.005

  270. Yagi, S., Akaike, M., Ise, T., Ueda, Y., Iwase, T., Sata, M. Renin-angiotensin-aldosterone system plays a pivotal role in cognitive impairment. Hypertens Res. 2013;36:753-758  doi: 10.1038/hr.2013.51

  271. Kurobe, H., Matsuoka, Y., Hirata, Y., Sugasawa, N., Maxfield, MW., Sata, M., Kitagawa, T. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. J Thorac Cardiovasc Surg. 2013;146:1501-1508. doi: 10.1016/j.jtcvs.2013.02.073

  272. Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I, Sata M. Toll-Like Receptor-2 Mediates Adaptive Cardiac Hypertrophy in Response to Pressure Overload Through Interleukin-1β Upregulation via Nuclear Factor κB Activation. J Am Heart Assoc. 2013;2:e000267  doi: 10.1161/JAHA.113.000267.

  273. Soeki, T., Niki, T., Uematsu, E., Bando, S., Matsuura, T., Kusunose, K., Ise, T., Ueda, Y., Tomita, N., Yamaguchi, K., Koshiba, K., Yagi, S., Fukuda, D., Taketani, Y., Iwase, T., Yamada, H., Wakatsuki, T., Akaike, M., Shimabukuro, M., Kishimoto, I., Kangawa, K., Sata, M. Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein. Heart Vessels. 2013;28:795-801. doi: 10.1007/s00380-013-0333-2

  274. Yamaguchi K, Wakatsuki T, Soeki T, Niki T, Taketani Y, Oeduka H, Kusunose K, Ise T, Iwase T, Yamada H, Sata M. Effects of telmisartan on inflammatory cytokines and the coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients. Circ J. 2013;78:240-247 doi: 10.1253/circj.CJ-13-0741

  275. Tamai R, Hara T, Yamada H, Nishio S, Bando M, Hotchi J, Hayashi S, Niki T, Kitagawa T, Sata M. Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography. J Med Ultrasonics. 2014;41:69-71 doi: 10.1007/s10396-013-0459-y

  276. Shimabukuro M, Higa M, Kinjo R, Yamakawa K, Tanaka H, Kozuka C, Yabiku K, Taira SI, Sata M, Masuzaki H. Effects of the brown rice diet on visceral obesity and endothelial function: the BRAVO study. Br J Nutr. 2014;111:310-320 doi: 10.1017/S0007114513002432

  277. Takaishi K, Kawahito S, Yamada H, Soeki T, Sata M, Kitahata H. Increase in prominence of electrocardiographic J waves after a single dose of propofol in a patient with early ventricular repolarisation. Anaesthesia. 2014;69:170-175 doi: 10.1111/anae.12448.

  278. Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Cardiovasc Res. 2014;101:236-246  doi: 10.1093/cvr/cvt245

  279.  Matsumoto S, Shimabukuro M, Fukuda D, Soeki T, Yamakawa K, Masuzaki H, Sata M. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice.   Cardiovasc Diabetol. 2014;13:30  doi:10.1186/1475-2840-13-30

  280. Sawada N, Jiang A, Takizawa F, Safdar A, Manika A, Tesmenitsky Y, Kang KT, Bischoff J, Kalwa H, Sartoretto JL, Kamei Y, Benjamin LE, Watada H, Ogawa Y, Higashikuni Y, Kessinger CW, Jaffer FA, Michel T, Sata M, Croce K, Tanaka R, Arany Z. Endothelial PGC-1α mediates vascular dysfunction in diabetes. Cell Metab. 2014;19:246-258 doi: 10.1016/j.cmet.2013.12.014

  281. Yagi S, Kadota M, Aihara K, Nishikawa K, Hara T, Ise T, Ueda Y, Iwase T, Akaike M, Shimabukuro M, Katoh S, Sata M. Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men. Diabetol Metab Syndr. 2014;6:27 doi:10.1186/1758-5996-6-27

  282. Nose H, Otsuka H, Otomi Y, Terazawa K, Takao S, Iwamoto S, Iwase T, Yamada H, Sata M, Harada M. The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease. J Med Invest. 2014;61:53-58

  283. Kusunose K, Chono T, Tabata T, Yamada H, Sata M. Echocardiographic image tracker with a speckle adaptive noise reduction filter for the automatic measurement of the left atrial volume curve. Eur Heart J Cardiovasc Imaging. 2014;15:509-514. doi: 10.1093/ehjci/jet196

  284. Kimura Y, Komaki M, Iwasaki K, Sata M, Izumi Y, Morita I. Recruitment of bone marrow-derived cells to periodontal tissue defects. Front Cell Dev Biol. 2014;2: 6 pages (Article 19). doi: 10.3389/fcell.2014.00019

  285. Hayashi S, Yamada H, Bando M, Hotchi J, Ise T, Yamaguchi K, Iwase T, Soeki T, Wakatsuki T, Tamaki T, Sata M. Augmentation index does not reflect the risk of coronary artery disease in elderly patients. Circ J. 2014;78:1176-1182 doi: 10.1253/circj.CJ-13-1422

  286. Ise T, Iwase T, Masuda S, Yagi S, Akaike M, Nishio S, Niki T, Yamaguchi K, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Sata M. Acute pulmonary thromboembolism from deep vein thrombosis induced by trauma to the popliteal vein with a tennis racket. JC Cases. 2014;9:162-164  doi:10.1016/j.jccase.2014.01.001

  287. Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W, Sata M: Congenital long QT syndrome with compound mutations in the KCNH2 gene. Heart Vessels. 29: 554-559, 2014

  288. Yamada H, Kusunose K, Nishio S, Bando M, Hotchi J, Hayashi S, Ise T, Yagi S, Yamaguchi K, Iwase T, Soeki T, Wakatsuki T, Sata M. Pre-load stress echocardiography for predicting the prognosis in mild heart failure. JACC Cardiovasc Imaging. 7: 641-649, 2014

  289. Yagi S, Aihara K, Kondo T, Endo I, Hotchi J, Ise T, Iwase T, Akaike M, Matsumoto T, Sata M: High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients. Endocr J. 61: 727-733, 2014

  290. Saito K, Takeda S, Saito Y, Kawamura M, Yoshikawa Y, Yano H, Sata M: Electrocardiographic and chronobiological features of paroxysmal AV block recorded by ambulatory electrocardiography. J Med Invest. 61: 380-387, 2014

  291. Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels. 29: 653-658, 2014

  292. Kusunose K, Tomita N, Nishio S, Bando M, Hayashi S, Hotchi J, Iwase T, Yamada H, Sata M: Left main coronary artery compression syndrome with an incomplete atrioventricular septal defect presenting as angina induced by hyperthyroidism. Intern Med. 53: 2083-2085, 2014

  293. Hara T, Kishi-Tanaka K, Iwase T, Yamada H, Akaike M, Sata M: Utility of lower limb positive pressure test for diagnosis of diastolic heart failure: a case report. J Med Invest. 61: 404-408, 2014

  294. Nishio S, Kusunose K, Yamada H, Hotchi J, Hayashi H, Bando M, Saijo Y, Hirata Y, Abe M, Sata M: Multimodality imaging of biatrial myxomas in an asymptomatic patient. JC Case. 10: 85-87, 2014

  295. Takashima A, Ise T, Yagi S, Iwase T, Kimura S, Ueda Y, Nishikawa K, Ishii A, Niki T, Yamaguchi K, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Katoh S, Akaike M, Sata M: Cardiac rehabilitation reduces serum levels of oxidized low-density lipoprotein. Circ J. 78: 2682-2687, 2014

  296. Ishida M, Shimabukuro M, Yagi S, Nishimoto S, Kozuka C, Fukuda D, Soeki T, Masuzaki H, Tsutsui M, Sata M: MicroRNA-378 regulates adiponectin expression in adipose tissue: A new plausible mechanism. PLoS One. 9: e111537, 2014

  297. Yagi S, Hara T, Ueno R, Aihara K, Fukuda D, Takashima A, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M: Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J. 13: 112, 2014

  298. Soeki T, Koshiba K, Niki T, Kusunose K, Yamaguchi K, Yamada H, Wakatsuki T, Shimabukuro M, Minakuchi K, Kishimoto I, Kangawa K, Sata M: Effect of ghrelin on autonomic activity in healthy volunteers. Peptides. 62: 1-5, 2014

  299. Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M: Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension. Ther Clin Risk Manag. 11: 83-88, 2015

  300. Yamada H, Sata M: The role of pericardial fat: The good, the bad and the ugly. J Cardiol. 65: 2-4, 2015

  301. Kimura S, Ueda Y, Ise T, Yagi S, Iwase T, Nishikawa K, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Katoh S, Akaike M, Yasui N, Sata M: Impact of supervised cardiac rehabilitation on urinary albumin excretion in patients with cardiovascular disease. Int Heart J. 56: 105-109, 2015

  302. Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, Ise T, Kenya K, Hotchi J, Tobiume T, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Plasma microRNA-100 is associated with coronary plaque vulnerability. Circ J. 79: 413-418, 2015

  303. Minami Y, Nakajima T, Ikutomi M, Morita T, Komuro I, Sata M, Sahara M: Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence. Int J Cardiol. 186: 305-314, 2015

  304. Takashima A, Shimabukuro M, Tabata M, Fukuda D, Uematsu E, Ishibashi-Ueda H, Takanashi S, Sata M: Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens. Cardiovasc Pathol. 24(3): 194-197, 2015

  305. Hayashi S, Yamada H, Nishio S, Hotchi J, Bando M, Takagawa Y, Saijo Y, Hirata Y, Sata M: Age-and gender-specific changes of tricuspid annular motion velocities in normal hearts. J Cardiol. 65(5): 397-402, 2015

  306. Niki T, Soeki T, Yamaguchi K, Taketani Y, Yagi S, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Elevated concentration of interferon-inducible protein of 10 kD (IP-10) is associated with coronary atherosclerosis. Int Heart J. 56(3): 269-272, 2015

  307. Yagi S, Aihara K, Fukuda D, Takashima A, Hara T, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M: Effects of docosahexaenoic acid on the endothelial function in patients with coronary artery disease. J Atheroscler Thromb. 22(5): 447-454, 2015

  308. Hayashi S, Yamada H, Nishio S, Hotchi J, Takagawa Y, Saijo Y, Hirata Y, Sata M: Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease. J Cardiol. 65(6): 519-525, 2015  doi:10.1016/j.jjcc.2014.08.005

  309. Tanaka K, Sata M: Visualization of human coronary vasa vasorum in vivo. Circ J. 79(6): 1211-1212, 2015

  310. Yamada H, Sata M: Does echocardiographic epicardial adipose tissue thickness become a useful biomarker? J Atheroscler Thromb. 22(6): 555-556, 2015

  311. Kusunose K, Hotchi J, Takagawa Y, Nishio S, Ise T, Tobiume T, Yamaguchi K, Yagi S, Iwase T, Yamada H, Soeki T, Wakatsuki T, Sata M: Serial imaging changes during Immunogloblin G4-related disease with multiple pseudo tumors. Circulation. 131(21):1882-1883, 2015

  312. Hayashi S, Yamada H, Bando M, Saijo Y, Nishio S, Hirata Y, Klein AL, Sata M: Optimal analysis of left atrial strain by speckle tracking echocardiography: P-wave versus R-wave trigger. Echocardiography. 32(8): 1241-1249, 2015

  313. Kusunose K, Yamada H, Hotchi J, Bando M, Nishio S, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Kishi J, Sata M: Prediction of future overt pulmonary hypertension by six-minute walk stress echocardiography in connective tissue disease. J Am Coll Cardiol. 66(4): 376-384, 2015

  314. Yamazaki H, Yamaguchi K, Soeki T, Wakatsuki T, Niki T, Taketani Y, Kitaoka A, Kusunose K, Ise T, Tobiume T, Yagi S, Iwase T, Yamada H, Sata M: Impact of indoxyl sulfate, a uremic toxin, on non-culprit coronary plaque composition assessed by integrated backscatter intravascular ultrasound. Circ J. 79:1773-1779, 2015

  315. Bando M, Yamada H, Kusunose K, Fukuda D, Amano R, Tamai R, Torii Y, Hirata Y, Nishio S, Yamaguchi K, Soeki T, Wakatsuki T, Sata M: Comparison of carotid plaque tissue characteristics in patients with acute coronary syndrome or stable angina pectoris: assessment by iPlaque, transcutaneous carotid ultrasonography with integrated backscatter analysis. Cardiovasc Ultrasound. 13(1): 34, 2015

  316. Hara T, Yagi S, Akaike M, Sata M: Transdermal patch of bisoprolol for the treatment of hypertension complicated with aortic dissection. Int J Cardiol. 198: 220-221, 2015

  317. Shimabukuro M, Hasegawa Y, Higa M, Amano R, Yamada H, Mizushima S, Masuzaki H, Sata M: Subclinical carotid atherosclerosis burden in Japanese: comparison between Okinawa and Nagano residents. J Atheroscler Thromb. 22(8): 854-868, 2015

  318. Bando S, Fukuda D, Soeki T, Nishimoto S, Uematsu E, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis. Atherosclerosis. 242(1): 407-414, 2015

  319. Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, Komuro I, Nakamura F, Sata M: Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation. J Moll Cell Cardiol. 86: 121-135, 2015

  320. Nishio S, Kusunose K, Yamada H, Yamao M, Hirata Y, Mori K, Matsuoka S, Sata M: Echocardiographic screening for congenital heart disease in 8819 children: a report from local community events for children's healthcare. J Cardiol. 66(4):315-319, 2015

  321. Tomiyama H, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A: Reliability of measurement of endothelial function across multiple institutions and establishment of reference values in Japanese. Atherosclerosis. 242(2):433-442, 2015

  322. Yagi S, Aihara K, Akaike M, Fukuda D, Salim HM, Ishida M, Matsuura T, Ise T, Yamaguchi K, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M. Matsumoto T, Sata M: Predictive factors for efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus. Diabetes Metab J. 39(4):342-347, 2015

  323. Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M: Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis. 242(2): 639-646, 2015

  324. Hirata Y, Yamada H, Kusunose K, Iwase T, Nishio S, Hayashi S, BandoS, Amano R, Yamaguchi K, Soeki T, Wakatsuki T, Sata M: Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease. J Am Soc Echocardiogr. 28(10), 1240-1246, 2015

  325. Motoki T, Kurobe H, Hirata Y, Nakayama T, Kinoshita H, Rocco KA, Sogabe H, Hori T, Sata M, Kitagawa T: PPAR-gamma agonist attenuates inflammation in aortic aneurysm patients. Gen Thorac Cardiovasc Surg. 63(10), 565-571, 2015
    328. Tani A, Yamamoto S, Maegawa M, Kunimi K, Matsui S, Keyama K, Kato T, Uemura H, Kuwahara A, Matsuzaki T, Yasui T, Kamada M, Soeki T, Sata M, Irahara M: Arterial stiffness is increased in young women with endometriosis. J Obstet Gynaecol. 35(7), 711-715, 2015

  326. Shimabukuro M, Saito T, Higa T, Nakamura K, Masuzaki H, Sata M; Fukuoka diabetologists group: Risk stratification of coronary artery disease in asymptomatic diabetic subjects using multidetector computed tomography. Circ J. 79(11), 2422-2429, 2015

  327. Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T, Nishimoto S, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M: Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome. Nutr J. 14(1), 111, 2015

  328. Hatano M, Yamada H, Fukuda K, Yoshioka K, Funauchi M, Kuwana M, Sata M, Taniguchi M, Nakanishi N, Saito T, Saji T, Sasayama S: Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension. Heart Vessels. 30(6), 798-804, 2015

  329. Sawada N, Yamada H, Kusunose K, Hayashi S, Iwase T, Sata M: 3D transthoracic echocardiography provides accurate cross-sectional area of the RV outflow tract. JACC Cardiovasc Imaging. 8(11), 1343-1345, 2015

  330. Kato Y, Yokoyama U, Yanai C, Ishige R, Kurotaki D, Umemura M, Fujita T, Kubota T, Okumura S, Sata M, Ishikawa Y: Epac1 deficiency attenuated vascular smooth muscle cell migration and neointimal formation. Arterioscler Thromb Vasc Biol. 35(12), 2617-2625, 2015

  331. Hayashi S, Yamada H, Fukui M, Ito H, Sata M: Correlation between arteriosclerosis and periodontal condition assessed by lactoferrin and α-antitrypsin levels in gingival crevicular fluid. Int Heart J. 56(6), 639-643, 2015

  332. Bando M, Yamada H, Kusunose K, Hayashi S, Takagawa Y, Saijo Y, Nishio S, Ogasawara K, Sata M: Pulmonary embolism due to right atrial free-floating thrombus during echocardiographic examination: a case of a pulmonary saddle thrombus. J Echocardiogr. 13(4), 145-147, 2015

  333. Higashi Y, Azuma N, Takeishi Y, Minamino T, Kihara Y, Node K, Sata M, Fukumoto Y, Origasa H, Matsuo H, Naritomi H, Fujita M, Shimizu W: Effect of a low-intensity pulsed ultrasound device, SX-1001, on clinical symptoms in buerger disease with limb ischemia. Int Heart J. 56(6), 632-638, 2015

  334. Torii Y, Kusunose K, Yamada H, Nishio S, Hirata Y, Amano R, Yamao M, Bando M, Hayashi S, Sata M: Comparison of tricuspid annular plane systolic excursion in patients with atrial fibrillation vs sinus rhythm. Am J Cardiol. 117(2), 226-232, 2016

  335. Niki T, Wakatsuki T, Yamaguchi K, Taketani Y, Oeduka H, Kusunose K, Ise T, Iwase T, Yamada H, Soeki T, Sata M: Effects of the addition of eicosapentaenoic acid to strong statin therapy on inflammatory cytokines and coronary plaque components assessed by integrated backscatter intravascular ultrasound. Circ J. 80(2), 450-460, 2016

  336. Shimabukuro M, Saito T, Masuzaki H, Sata M: Screening of coronary artery disease in diabetic patients: who and how? – reply– Circ J. 80(2), 544, 2016

  337. Takashima A, Yagi S, Yamaguchi K, Takagi E, Kanbara T, Ogawa H, Ise T, Kusunose K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Kitagawa T, Sata M: Vegetation in the coronary sinus that concealed the presence of a coronary arteriovenous fistula in a patient with infectious endocarditis. Int J Cardiol. 207, 266-268, 2016

  338. Torii Y, Yamada H, Matsukuma S, Nishio S, Kusunose K, Abe M, Sata M: Left ventricular lipomatous hamartoma mimicking a calcified amorphous tumor. Circulation. 133(8):e408-e410, 2016

  339. Hayakawa Y, Kawada M, Nishikawa H, Ochiya T, Saya H, Seimiya H, Yao R, Hayashi M, Kai C, Matsuda A, Naoe T, Ohtsu A, Okazaki T, Saji H, Sata M, Sugimura H, SugiyamaY, Toi M, Irimura T: Report on the use of nonclinical studies in the regulatory evaluation of oncology drugs. Cancer Sci. 107(2):189-202, 2016

  340. Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M: Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice. Vascul Pharmacol. 79:16-23, 2016

  341. Soeki T, Sata M: Inflammatory biomarkers and atherosclerosis. Int Heart J. 57(2):134-139, 2016

  342. Nishimoto S, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Murata C, Kim-Kaneyama J, Sato F, Bando M, Yagi S, Soeki T, Hayashi T, Imoto I, Sakaue H, Shimabukuro M, Sata M: Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci Adv. 2(3), e1501332, 2016

  343. Kusunose K, Yamada H, Suzukawa R, Hirata Y, Yamao M, Ise T, Yagi S, Akaike M, Sata M: Effects of transthoracic echocardiographic simulator training on performance and satisfaction in medical students. J Am Soc Echocardiogr. 29(4), 375-377, 2016

  344. Kusunose K, Sato M, Yamada H, Saijo Y, Bando M, Hirata Y, Nishio S, Hayashi S, Sata M: Prognostic implications of non-invasive vascular function tests in high-risk atherosclerosis patients. Circ J. 80(4), 1034-1040, 2016

  345. Tanaka A, Inoue T, Kitakaze M, Oyama J, Sata M, Taguchi I, Shimizu W, Watada H, Ako J, Sakata Y, Anzai T, Uematsu M, Suzuki M, Eguchi K, Yamashina A, Saito Y, Sato Y, Ueda S, Murohara T, Node K: Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial. Cardiovasc Diabetol. 15(1):57, 2016

  346. Bando M, Yamada H, Kusunose K, Fukuda D, Amano R, Tamai R, Torii Y, Hirata Y, Nishio S, Satomi J, Nagahiro S, Sata M: Noninvasive quantitative tissue characterization of carotid plaque using color-coded mapping based on ultrasound integrated backscatter. JACC Cardiovasc Imaging. 9(5):625-627, 2016

  347. Shimabukuro M, Higa N, Masuzaki H, Sata M, Ueda S: Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men. Cardiovas Diabetol. 15(1): 77, 2016

  348. Oyama J, Tanaka A, Sato Y, Tomiyama H, Sata M, Ishizu T, Taguchi I, Kuroyanagi T, Teragawa H, Ishizaka N, Kanzaki Y, Ohishi M, Eguchi K, Higashi Y, Yamada H, Maemura K, Ako J, Bando YK, Ueda S, Inoue T,  Murohara T, Node K: Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. Cardiovasc Diabetol. 15(1):87, 2016

  349. Oyama J, Murohara T, Kitakaze M, Ishizu T, Sato Y, Kitagawa K, Kamiya H, Ajioka M, Ishiara M, Dai K, Nanasato M, Sata M, Maemura K, Tomiyama H, Higashi Y, Kaku K, Yamada H, Matsuhisa M, Yamashita K, Bando YK, Kashihara N, Ueda S, Inoue T, Tanaka A, Node K, PROLOGUE Study Investigators: The effect of sitagliptin on carotid artery atherosclerosis in type 2 diabetes: The PROLOGUE randomized controlled trial. PLoS Med. 13(6):e1002051, 2016

  350. Shimabukuro M, Okawa C, Yamada H, Yanagi S, Uematsu E, Sugasawa N, Kurobe H, Hirata Y, Kim-Kaneyama JR, Lei XF, Takao S, Tanaka Y, Fukuda D, Yagi S, Soeki T, Kitagawa T, Masuzaki H, Sato M, Sata M: The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: A study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe. J Nutr Biochem. 35:66-73, 2016

  351. Kadota M, Ise T, Yagi S, Iwase T, Akaike M, Ueno R, Kawabata Y, Hara T, Ogasawara K, Bando M, Bando S, Matsuura T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Sata M. Response prediction and influence of tolvaptan in chronic heart failure patients considering the interaction of the renin-angiotensin-aldosterone system and arginine vasopressin. Int Heart J. 57(4):461-465, 2016

  352. Shimabukuro M , Sato H, Izaki H, Fukuda D, Uematsu E,Hirata Y, Yagi S, Soeki T, Sakaue H, Kanayama H, Masuzaki H, Sata M: Depot- and gender-specific expression of NLRP3 inflammasome and toll-like receptors in adipose tissue of cancer patients. Biofactors. 42(4):397-406, 2016

  353. Ueda T, Nakata Y, Yamasaki N, Oda H, Sentani K, Kanai A, Onishi N, Ikeda K, Sera Y, Honda Z, Tanaka K, Sata M, Ogawa S, Yasui W, Saya H, Takita J, Honda H: ALKR1275Q perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN. Oncogene. 35(34):4447-4458, 2016

  354. Maruhashi T, Higashi Y, Kihara Y, Yamada H, Sata M, Ueda S, Odawara M, Terauchi Y, Dai K, Ohno J, Iida M, Sano H, Tomiyama H, Inoue T, Tanaka A, Murohara T, Node K: Long-term Effect of Sitagliptin on Endothelial Function in Type 2 Diabetes: A Sub-analysis of the PROLOGUE Study. Cardiovascular Diabetol. 15(1): 134, 2016

  355. Tanaka A, Murohara T, Taguchi I, Eguchi K, Suzuki M, Kitakaze M, Sato Y, Ishizu T, Higashi Y, Yamada H, Nanasato M, Shimabukuro M, Teragawa H, Ueda S, Kodera S, Matsuhisa M, Kadokami T, Kario K, Nishio Y, Inoue T, Maemura K, Oyama J, Ohishi M, Sata M, Tomiyama H, Node K; PROTECT Study Investigators: Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study. Cardiovasc Diabetol. 15(1): 133, 2016

  356. Takashima A, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Taketani Y, Shimabukuro M, Sata M: Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation. Atherosclerosis. 254:142-150, 2016

  357. Yang ZH, Bando M, Sakurai T, Chen Y, Emma-Okon B, Wilhite B, Fukuda D, Pryor BV, Wakabayashi Y, Sampson M, Yu ZX, Sakurai A, Zarzour A, Miyahara H, Takeo J, Sakaue H, Sata M, Remaley AT: Long-chain monounsaturated fatty acid-rich fish oil attenuates the development of atherosclerosis in mouse models. Mol Nutr Food Res. 60(10):2208-2218, 2016

  358. Takashima A, Yagi S, Yamaguchi K, Watanabe S, Yamamoto N, Ito H, Kadota M, Hara T, Yamazaki H, Ise T, Kusunose K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Sata M: Purulent pericarditis accompanying pericardial abscess induced by nocardia in an immunocompromised patient. Circ J. 80(11):2409-2411, 2016

  359. Tomiyama H, Miwa T, Kan K, Matsuhisa M, Nanasato M, Kitano T, Sano H, Ohno J, Iida M, Sata M, Yamada H, Maemura K, Tanaka A, Murohara T, Node K, Kamiya H: Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study. Cardiovascular Diabetology. 15(1):150, 2016

  360. Salim HM, Fukuda D, Yagi S, Soeki T, Shimabukuro M, Sata M: Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in streptozotocin-induced diabetic mouse. Front Cardiovasc Med. 3:43, 2016

  361. Sai K, Kajinami K, Akao H, Iwadare M, Sato-Ishida R, Kawai Y, Takeda K, Tanimoto T, Yamano T, Akasaka T, Ishida T, Hirata K, Saku K, Yagi S, Soeki T, Sata M, Ueno M, Miyazaki S, Shiraki A, Oyama J, Node K, Sugamura K, Ogawa H, Kurose K, Maekawa K, Matsuzawa Y, Imatoh T, Hasegawa R, Japanese Pharmacogenomics Data Science Consortium, Saito Y: A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients. Drug Metab Pharmacokinet. 31(6), 467-470, 2016

  362. Soeki T, Matsuura T, Bando S, Tobiume T, Uematsu E, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. J Cardiol. 68(6):472-477, 2016

  363. Takashima A, Yagi S, Ito H, Sata M: Nocardia identification at the genus level -reply- Circ J. 81(2), 271, 2017

  364. Nakaya Y, Fukuda D, Oyamada T, Ogawa K, Harada N, Nakagami H, Morishita R, Sata M, Sakaue H: A novel lipoprotein (a) lowering drug, D-47, decreases neointima thickening after vascular injury. J Med Invest. 64(1, 2): 64-67, 2017

  365. Kusunose K, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma). Am J Cardiol. 120(2):315-321, 2017

  366. Kusunose K, Torii Y, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Tobiume T, Yagi S, Soeki T, Wakatsuki T, Sata M: Clinical utility of longitudinal strain to predict functional recovery in patients with tachyarrhythmia and reduced LVEF. JACC Cardiovasc Imaging. 10(2)118-126,2017

  367. Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M: Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice. Vasc Pharmacol. 96-98:19-25,2017

  368. Takashima A, Ogata T, Yamada H, Wakatsuki T, Sata M: Intracardiac echocardiography-guided biopsy of a lipomatous cardiac tumor arising from the interatrial septum. Circ J. 81(10):1553-1555,2017

  369. Maimaituxun G, Shimabukuro M, Salim HM, Tabata M, Yuji D, Morimoto Y, Akasaka T, Matsuura T, Yagi S, Fukuda D, Yamada H, Soeki T, Sugimoto T, Tanaka M, Takanashi S, Sata M: Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery. PLoS One. 12(6): e0177170,2017

  370. Yamada H, Tanaka A, Kusunose K, Amano R, Matsuhisa M, Daida H, Ito M, Tsutsui H, Nanasato M, Kamiya H, Bando Y K, Odawara M, Yoshida H, Murohara T, Sata S, Node K: Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes. Cardiovascular Diabetology. 16(1):63,2017

  371. Bando S, Soeki T, Matsuura T, Tobiume T, Ise T, Kusunose K, Yamakoji, Yagi S, Fukuda D, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Muguruma C, Takayama, Kishimoto, Kanagawa, Sata M: Plasma Brain Natriuretic Peptide Levels Are Elevated in Patients with Cancer. PLoS One. 12(6):e0178607,2017

  372. Asakura M, Kim J, Asanuma H, Hamasaki T, Tsukahara K, Higashino Y, Ishikawa T, Nakama Y, Koba S, Maruyama Y, Tsujimoto M, Himeno H, Ookusa T, Fujino S, Shimizu M, Endo T, Yoda S, Muroya T, Murohara T, Ohte N, Suzuki H, Kohno T, Fukui K, Shiono T, Takase H, Uzui H, Nagai Y, Hashimoto Y, ,Ikeda S, Mizuno S, Tamita K, Fujita M, Satake K, Kinosita Y, Nunohiro T, Sakagami S, Higaki J, Morii I, Sawada R, Hiasa Y, Shigemasa T, Nakahama M, Sata M, Doi O, Ueda T, Yamada T, Yamauchi T, Yamaguchi H, Hayashi H, Morita Y, Kitakaze M: Does treatment of impaired glucose tolerance improve cardiovascular outcomes inpatients with previous myocardial infarction? .Cardiovascular Drugs and Therapy. 31(4):401-411,2017

  373. Tokushige A, Ueda S, Tomiyama H, Ohishi M, Kohro T,Higashi Y, Takase B,Suzuki T, Ishizu T, Yamazaki T, Furumoto T,Kario Kazuomi, Inoue T, Koba S, Takemoto Y, Hano T,Sata M, Ishibashi Y,Node Koichi, Maemura K,Ohya Y,Furukawa T,Ito H,Yamashina A: Association between Waist-to-Height Ratio and Endothelial Dysfunction in Patients with Morbidity: A Report from the FMD-J Study. Circ J. 81(12):1911-1918,2017

  374. Teramoto T, Kondo A, Kiyosue A, Harada-Shiba M, Ishigaki Y, Tobita K, Kawabata Y, Ozaki A, Baccara-Dinet MT, Sata M: Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale. Lipids in Health and Disease. 16(1):121,2017

  375. Shimabukuro M, Tanaka M, Sata M, Dai K, Shibata Y, Inoue Y, Ikenaga H, Kishimoto S, Ogasawara K, Takashima A, Niki T, Arasaki O, Oshiro K, Mori Y, Ishihara M, Node K: α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.Cardiovascular Diabetology. 16(1):86,2017

  376. Kusunose K, Yamada H, Nishio S, Ishii A, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: RV Myocardial Strain During Pre-Load Augmentation Is Associated With Exercise Capacity in Patients With Chronic HF.JACC Cardiovasc Imaging. 10(10 Pt B):1240-1249,2017

  377. Yagi S, Mitsugi M, Sangawa T, Akaike M, Sata M: Paget-Schroetter Syndrome in a Baseball Pitcher. Int Heart J. 58(4):637-640,2017

  378. Hirata Y, Kusunose K, Yamada H, Shimizu R, Torii Y, Nishio S, Saijo Y, Takao S, Soeki T, Sata M: Age-related changes in morphology of left atrial appendage in patients with atrial fibrillation. Int J Cardiovasc Imaging. 34(2):321-328,2018

  379. Hirono A, Kusunose K, Kageyama N, Sumitomo M, Abe M, Fujinaga H, Sata M: Development and validation of optimal cut-off value in inter-arm systolic blood pressure difference for prediction of cardiovascular events. J Cardiol. 71(1):24-30,2018

  380. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FBM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y: Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan).Hypertension. 70(4)790-797, 2017

  381. Yagi S, Fukuda D, Aihara KI, Akaike M, Shimabukuro M, Sata M: n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.J Atherroscler Thromb. 24(10):999-1010,2017

  382. Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Shimabukuro M, Sata M: Echocardiographic Epicardial Adipose Tissue Thickness Is Associated with Symptomatic Coronary Vasospasm during Provocative Testing.J Am Soc Echocardioqr. 30(10):1021-1027,2017

  383. Yagi S, Soeki T, Aihara K, Fukuda D, Ise T, Kadota M, Bando S, Matsuura T, Tobiume T, Yamaguchi K, Kusunose K, Yamada H, Wakatsuki T, Shimabukuro M, Akaike M, Sata M: Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome. Int Heart J. 58(5):720-723,2017

  384. Takagawa Y, Yagi S,2, Ise T, Ishii A, Nishikawa K3, Fukuda D, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Katoh S, Aihara KI, Akaike M, Sata M: Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure. Int Heart J. 58(5):746-751,2017

  385. Kusunose K, Yamada H, Nishio S, Torii Y, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: Preload Stress Echocardiography Predicts Outcomes in Patients With Preserved Ejection FractionandLow-GradientAorticStenosis.CircCardiovascImaging. 10(10), 2017

  386. Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, Salim HM, Maimaituxun G, Nishio S, Takagawa Y, Hama S, Matsuura T, Yamaguchi K, Tobiume T, Soeki T, Wakatsuki T, Aihara KI, Akaike M, Shimabukuro M, Sata M: Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus. Diabetol Metab Syndr.4;9:78,2017
    392. Yamazaki H, Yagi S, Torii Y, Amano R, Oomichi Y, Sangawa T, Fukuda D, Kadota M, Ise T, Ueno R, Hara T, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Akaike M, Sata M.: Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels. J Cardiol. 71(3):305-309,2018

  387. Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Kurashiki Y, Satomi J, Sata M, Nagahiro S: Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats. Transl Stroke Res. 9;3:306-316,2018

  388. Tomiyama H, Ishizu T, Kohro T, Matsumoto C, Higashi Y, Takase B, Suzuki T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A: Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension. Int J Cardiol. 15;253:161-166, 2018

  389. Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M: Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus. Adv Ther. 35(1):124-134,2018

  390. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y: Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study. Transl Stroke Res. 268:92-98, 2018

  391. Hibi K, Sonoda S, Kawasaki M, Otsuji Y, Murohara T, Ishii H, Sato K, Koshida R, Ozaki Y, Sata M, Morino Y, Miyamoto T, Amano T, Morita S, Kozuma K, Kimura K, Fujiwara H: Effects of Ezetimibe-Statin Combination Therapy on Coronary Atherosclerosis in Acute Coronary Syndrome. Circ J. 82;3:766, 2018

  392. Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M: Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury. Euro J Pharmacol.;820:222-228, 2018

  393. Hirata Y, Yamada H, Kusunose K, Nishio S, Torii Y, Horike Y, Sata M: Provocation of clinically significant left ventricular outflow tract obstruction by postural change in patients with sigmoid septum. J Ecocardiogr. in press

  394. Tanaka K, Sata M: Roles of Perivascular Adipose Tissue in the Pathogenesis of Atherosclerosis.Front Physiol. 9:3 , 2018

  395. Yagi S, Yamamoto Y, Nishiyama S, Sata M: An Occluded Hooklet of an Embedded Inferior Vena Cava Filter. Intem Med. 57;15:2275-2276,2018

  396. Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M: Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score. Circ J. 82;5:1369-1378.2018

  397. Davy PMC, Willcox DC, Shimabukuro M, Donlon TA, Torigoe T, Suzuki M, Higa M, Masuzaki H, Sata M, Chen R, Murkofsky R, Morris BJ, Lim E, Allsopp RC, Willcox BJ: Minimal shortening of leukocyte telomere length across age groups in a cross-sectional study for carriers of a longevity-associated FOXO3 allele.J Gerontol A Bio Sci Med Sci. 73;11:1448-1452,2018

  398. Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M: Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation. 138;16:1706-1719,2018

  399. Kusunose K, Okushi Y, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients. Circ J. 82;8:2103-2110,2018
    406. Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M: Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.Circ J. 82;7:1778-1787,2018

  400. Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M: Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation. Circ J. 82;9:2253-2258,2018

  401. Tanaka A, Kawaguchi A, Tomiyama H, Ishizu T, Matsumoto C, Higashi Y, Takase B, Suzuki T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Maemura K, Ohya Y, Furukawa T, Ito H, Yamashina A, Node K: Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension. Int J Cardiol. 272:308-313,2018

  402. Ganbaatar B, Fukuda D, Salim HM, Nishimoto S, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Sata M: Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.Atherosclerosis. 275:124-132,2018

  403. Saijo Y, Yamada H, Kusunose K, Bando M, Nishio S, Torii Y, Hirata Y, Seno H, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure. Echocardiography. 35;10:1587-1595,2018

  404. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y: Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD-J (Flow-Mediated Dilation Japan) Study A.J Am Heart Assoc.7;14,2018

  405. Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M: Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.J Atheroscler Thromb.in press

  406. Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M: Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure.Can J Cardio. 34;10:1307-1315,2018

  407. Hirata Y, Yamada H, Sata M: Epicardial Fat and Pericardial Fat Surrounding the Heart Have Different Characteristics. Circ J. 82;10:2475-2476.2018

  408. Maeda M, Oba K, Yamaguchi S, Arasaki O, Sata M, Masuzaki H, Shimabukuro M: Usefulness of Epicardial Adipose Tissue Volume to Predict Recurrent Atrial Fibrillation After Radiofrequency Catheter Ablation. Am J Cardiol. 122;10:1694-1700,2018

  409. Tanaka K, Sata M: Possible Roles of Epicardial Adipose Tissue in the Pathogenesis of Coronary Atherosclerosis. Ann Nucl Cardiol. 4;1:5-10,2018

  410. Nishimoto S, Aini K, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M: Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.Front Cardiovasc Med. 2018; 5: 144.

  411. Izumi Y, Miyamoto R, Fujita K, Yamamoto Y, Yamada H, Matsubara T, Unai Y, Tsukamoto A, Takamatsu N, Nodera H, Hayashi S, Oda M, Mori A, Nishida Y, Watanabe S, Ogawa H, Uehara H, Murayama S, Sata M, Kaji R: Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study, Front Neurol. 2018; 9: 1099.

  412. Hirata Y, Kusunose K, Yamada H, Morita S, Torii Y, Nishio S, Zheng R, Saijo Y, Fukuda D, Yagi S, Soeki T, Sata M: Left atrial functional response after a marathon in healthy amateur volunteers, Int J Cardiovasc Imaging. 2019 ; 35(4): 633-643.

  413.  Yagi S, Yamazaki H, Nishio S, Kusunose K, Yamada H, Sata M: Simultaneous Pulmonary Arterial and Venous Round Structures in Pulmonary Aspergillosis. Circ J. 2019; 83(6): 1416.

  414.  Sugasawa N, Katagi A, Kurobe H, Nakayama T, Nishio C, Takumi H, Higashiguchi F, Aihara KI, Shimabukuro M, Sata M, Kitagawa T: Inhibition of Atherosclerotic Plaque Development by Oral Administration of α-Glucosyl Hesperidin and Water-Dispersible Hesperetin in Apolipoprotein E Knockout Mice. J Am Coll Nutr. 2019; 38(1): 15-22.

  415. Teramoto T, Kiyosue A, Ishigaki Y, Harada-Shiba M, Kawabata Y, Ozaki A, Baccara-Dinet MT, Sata M: Efficacy and safety of alirocumab 150mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON, J Cardiol. 2019; 73(3): 218-227.

  416. Yagi S, Nishiyama S, Abe T, Sata M, Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome, BMJ Case Rep. 2019; 12(1). 

  417. Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama JR, Lei XF, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M: Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis, J Am Heart Assoc. 2019; 8(7): e010860.

  418. Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M: Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome, J Atheroscler Thromb. 2019; 26(3): 272-281.  

  419.   Kajikawa M, Maruhashi T, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Yusoff FM, Kihara Y, Chayama K, Goto C, Noma K, Nakashima A, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y: Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease - Post Hoc Analysis of the FMD-J Study A, Circ J. 2019; 83(5): 1064-1071. doi: 10.1253/circj. CJ-18-1082.

  420. Saijo Y, Kusunose K, Yamada N, Yamada H, Nishio S, Hirata Y, Sata M: Sequential speckle tracking imaging to detect early stage of cancer therapeutics-related cardiac dysfunction in a patient with breast cancer, J Echocardiogr. 2019;  doi: 10.1007/s12574-019-00423-2.

  421. Saito Y, Yamada H, Kusunose K, Saito K, Sata M: Noninvasive assessment of left-ventricular diastolic electromechanical coupling in hypertensive heart disease, J Echocardiogr. 2019 ;17(4):206-212. doi: 10.1007/s12574-019-00421-4.

  422. Kusunose K, Abe T, Haga A, Fukuda D, Yamada H, Harada M, Sata M: A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images, JACC Cardiovasc Imaging. 2020;13(2 Pt 1):374-381. doi: 10.1016/j.jcmg.2019.02.024.

  423. Yoshida A, Kaji T, Yamada H, Yonetani N, Sogawa E, Yamao M, Maeda K, Sata M, Irahara M: Measurement of hemodynamics immediately after vaginal delivery in healthy pregnant women by electrical cardiometry, J Med Invest. 2019; 66(1.2): 75-80. doi: 10.2152/jmi.66.75

  424. Yagi S, Sata M: Rupture of pes anserine bursa in a patient with pes anserine pain syndrome due to osteoarthritis, J Med Invest. 2019; 66(1.2): 211-212. doi: 10.2152/jmi.66.211

  425. Yagi S, Saijo Y, Matsuda T, Kanematsu Y, Sata M: Mass on the head : Spontaneous arteriovenous fistula of the superficial temporal artery, J Med Invest. 2019; 66(1.2): 209-210. doi: 10.2152/jmi.66.209

  426. Yagi S, Ueno R, Sutou K, Wakatsuki T, Yamaguchi K, Saijo Y, Hara T, Ise T, Kusunose K, Bando M, Matsuura T, Tobiume T, Yamada H, Fukuda D, Soeki T, Akaike M, Sata M: Lambda-like J wave due to acute myocardial infarction of the diagonal branch, J Med Invest. 2019; 66(1.2): 185-187. doi: 10.2152/jmi.66.18

  427. Yagi S, Kagawa K, Fujimoto E, Sata M: Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency, J Med Invest. 2019; 66(1.2): 182-184. doi: 10.2152/jmi.66.182

  428. Teramoto T, Kiyosue A, Ishigaki Y, Harada-Shiba M, Kawabata Y, Ozaki A, Baccara-Dinet MT, Sata M: Efficacy and safety of alirocumab 150mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON, J Cardiol. 2019; 73(3): 218-227. doi: 10.1016/j.jjcc.2018.10.004. Epub 2018 Nov 30

  429. Yagi S, Yamazaki H, Nishio S, Kusunose K, Yamada H, Sata M; Simultaneous Pulmonary Arterial and Venous Round Structures in Pulmonary Aspergillosis, Circ J. 2019; 83: 1416. doi.org/10.1253/circj.CJ-18-0898

  430. Ueno R, Yagi S, Bando M, Sata M: Long-surviving Anomalous Origin of the Right Pulmonary Artery from the Ascending Aorta Complicated with Pulmonary Arteriovenous Fistula, Intern Med. 2019; 15;58(18):2749-2750. doi: 10.2169/internalmedicine.2455-18

  431. Torii Y, Kusunose K, Yamada H, Nishio S, Hirata Y, Amano R, Yamao M, Zheng R, Saijo Y, Yamada N, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M: Updated Left Ventricular Diastolic Function Recommendations and Cardiovascular Events in Patients with Heart Failure Hospitalization. J Am Soc Echocardiogr. 2019; 32(10): 1286-1297 doi: 10.1016/j.echo.2019.06.006

  432. Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M: Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice. Sci Rep. 2019; 9(1): 11206. doi: 10.1038/s41598-019-47474-0.

  433. Kajikawa M, Maruhashi T, Hidaka T, Matsui S, Hashimoto H, Takaeko Y, Nakano Y, Kurisu S, Kihara Y, Yusoff FM, Kishimoto S, Chayama K, Goto C, Noma K, Nakashima A, Hiro T, Hirayama A, Shiina K, Tomiyama H, Yagi S, Amano R, Yamada H, Sata M, Higashi Y: Effect of Saxagliptin on Endothelial Function in Patients with Type 2 Diabetes: A Prospective Multicenter Study. Sci Rep. 2019; 9(1): 10206. doi: 10.1038/s41598-019-46726-3

  434. Kusunose K, Haga A, Abe T, Sata M: Utilization of Artificial Intelligence in Echocardiography. Circ J. 2019; 83(8): 1623-1629. doi: 10.1253/circj.CJ-19-0420

  435. Nakanishi A, Shunto J, Shunto R, Sata M, Bando H:  A case of subacute thyroiditis associated with complete occlusion of right coronary artery. J Diabetes Metab Disord Control. 2019; 6(3): 54‒58. DOI: 10.15406/jdmdc.2019.06.00183

  436. Kusunose K, Yamada N, Yamada H, Nishio S, Saijo Y, Hirata Y, Torii Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M: Association between Right Ventricular Contractile Function and Cardiac Events in Isolated Post-capillary and Combined Pre- and Post-capillary Pulmonary Hypertension, J Card Fail. 2020;26(1):43-51. doi: 10.1016/j.cardfail.2019.08.021

  437. Kusunose K, Yamada H, Nishio S, Hirata Y, Saijo Y, Torii Y, Yamada N, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M: Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension. JACC Cardiovasc Imaging. 2019 ;12(12):2576-2579. doi: 10.1016/j.jcmg.2019.07.002

  438. Kusunose K, Torii Y, Yamada H, Nishio S, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M:Association of Echocardiography Before Major Elective Non-Cardiac Surgery With Improved Postoperative Outcomes- Possible Implications for Patient Care. Circ J. 2019; 83(12): 2512-2519 doi: 10.1253/circj.CJ-19-0663

  439. Kusunose K, Fujiwara M, Yamada H, Nishio S, Saijo Y, Yamada N, Hirata Y, Torii Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M: Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis. Eur Heart J Cardiovasc Imaging. 2019;. pii: jez235 doi: 10.1093/ehjci/jez235

  440. Yagi S, Endo I, Murakami T, Hida T, Yamamoto Y, Soga T, Ise T, Kusunose K, Yamaguchi K, Fukuda D, Yamada H, Soeki T, Wakatsuki T, Kawahito S, Sata M: Adult onset of Immunoglobulin A vasculitis - A case report, Med Invest. 2019; 66(3.4): 344-346. doi: 10.2152/jmi.66.344.

  441. Yagi S, Zheng R, Nishiyama S, Kawabata Y, Ise T, Sugiura K, Yoshinari H, Nishisho T, Bando Y, Kagawa K, Fukuda D, Soga T, Saijo Y, Kusunose K, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Kawahito S, Akaike M, Sata M: Osteolytic primary bone lymphoma in the multiple bones, J Med Invest. 2019; 66(3.4): 347-350. doi: 10.2152/jmi.66.347.

  442. Aini K, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Sata M: Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice, Int Heart J. 2019; 60(6): 1421-1429; doi: 10.1536/ihj.19-117

  443. Rahadian A, Fukuda D, Salim HM, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M: Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice, Vascul Pharmacol. 2019 ;124:106632. doi: 10.1016/j.vph.2019.106632

  444. Tomiyama H, Ohkuma T, Ninomiya T, Nakano H, Matsumoto C, Avolio A, Kohro T, Higashi Y, Maruhashi T, Takase B, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Chikamori T, Yamashina A: Brachial-Ankle Pulse Wave Velocity Versus Its Stiffness Index β-Transformed Value as Risk Marker for Cardiovascular Disease. J Am Heart Assoc. 2019; 8(24): e013004. doi: 10.1161/JAHA.119.013004.

  445. Maruhashi T, Kajikawa M, Kishimoto S, Hashimoto H, Takaeko Y, Yamaji T, Harada T, Han Y, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y: Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery, J Am Heart Assoc. 2020; 9(2): e013915. doi: 10.1161/JAHA.119.013915

  446. Maimaituxun G, Yamada H, Fukuda D, Yagi S, Kusunose K, Hirata Y, Nishio S, Soeki T, Masuzaki H, Sata M, Shimabukuro M: Association of Local Epicardial Adipose Tissue Depots and Left Ventricular Diastolic Performance in Patients With Preserved Left Ventricular Ejection Fraction, Circ J. 2020; 84(2): 203-216. doi: 10.1253/circj.CJ-19-0793

  447. Rahadian A, Fukuda D, Salim HM, Yagi S, Kusunose K, Yamada H, Soeki T, Sata M. Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.  J Atheroscler Thromb. 2020; doi: 10.5551/jat.52100.

  448. Tanaka K, Fukuda D, Higashikuni Y, Hirata Y, Komuro I, Saotome T, Yamashita Y, Asakura T, Sata M. Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice. J Atheroscler Thromb. 2020; doi: 10.5551/jat.52720.

  449. Kusunose K, Haga A, Yamaguchi N, Abe T, Fukuda D, Yamada H, Harada M, Sata M. Deep Learning for Assessment of Left Ventricular Ejection Fraction from Echocardiographic Images.J AmSoc Ecocardiogr. 2020; pii: S0894-7317(20)30017-1. doi: 10.1016/j.echo.2020.01.009.

  450. Ganbaatar B, Fukuda D, Shinohara M, Yagi S, Kusunose K, Yamada H, Soeki T, Hirata KI, Sata M. Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein. E-deficient mice.Eur J Pharmacol. 2020 May 15;875:173040. doi: 10.1016/j.ejphar.2020.173040.

  451. Maimaituxun G, Fukuda D, Izaki H, Hirata Y, Kanayama HO, Masuzaki H, Sata M, Shimabukuro M. Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied Samples.Front Endocrinol. 2020;10:897. doi: 10.3389/fendo.2019.00897.

  452. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Yamaji T, Harada T, Han Y, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Increased arterial stiffness and cardiovascular risk prediction in controlled hypertensive patients with coronary artery disease: post hoc analysis of FMD-J (Flow-mediated Dilation Japan) Study A. Hypertens Res. 2020; doi: 10.1038/s41440-020-0420-6.

  453. Saijo Y, Kusunose K, Okushi Y, Yamada H, Toba H, Sata M. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction. Heart. 2020; pii: heartjnl-2019-316339. doi: 10.1136/heartjnl-2019-316339.


  454.  
     

          

英文書物

  1. Sugiura, S., Yamashita, H.,. Sata, M., Fujita, H., Momomura, S., Serizawa, T. & Sugi, H. Kinetic property of cardiac myosin in vitro. In: Cardiac energetics: from Emax to pressure-volume area (M..M. LeWinter, H. Suga, M.W. Watkins, editors) Kluwer Academic Publishers, Boston, 1995: 17-27.

  2. Walsh, K., Sata, M. Regulation of inflammation by Fas ligand expression on the vascular endothelium. In Sanders M.R. and Kostis, J.B. eds. Molecular Cardiology in Clinical Practice. Kluwer Academic Publishers, Boston: pp. 125-141.

  3. Sata, M, Nagai, R  Vascular regeneration and remodeling by circulating progenitor cells (Mori, H., Matsuda, H. eds. Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Springer-Verlag, Tokyo, 2005. pp. 117-127.[

  4. Sata. M, Walsh, K. Contribution of circulating progenitor cells to vascular repair and lesion formation. In H.J. Duckers, E.G. Nabel, P. W Serruys eds. Essentials of Restenosis. Humana Press Inc., Totowa, NJ. 2007 pp. 185-197.

  5. Sata M, Tanaka K, Fukuda D. Wire-mediated endovascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. In Sata M ed. Mouse Models of Vascular Diseases. Springer Japan, Tokyo, 2016. pp. 3-20.

  6. Shimamura M, Nakagami H, Sata M, Kurinami H. A model of stroke and vascular injury in the brain. In Sata M ed. Mouse Models of Vascular Diseases. Springer Japan, Tokyo, 2016. pp. 263-274.

     

     

和文書物

  1. 佐田政隆、百村伸一 強心薬の使い方 循環器ベッドサイド必携書 (豊岡照彦 監修) 永井書店

  2. 佐田政隆 Fas:Vascular Biologyナビゲーター (丸山征郎、安藤譲二、佐藤靖史 編集) メディカルレビュー社2001: 172-173

  3. 佐田政隆 動脈硬化病巣の平滑筋の起源をさぐる: 動脈硬化のしくみをさぐる (第16回「大学と科学」公開シンポジウム講演収録集 代表 北徹) グバプロ2002: 176-188

  4. 佐田政隆 細胞から見た再狭窄のメカニズム Drug-Eluting Stent (山口 徹、田村 勤 編集) 医学書院 2003: 5-11

  5. 佐田政隆 I. 循環器の生物学. 細胞の起源を知る Annual Review 循環器2004 (矢崎義雄、山口徹、高本眞一、中澤誠 編集)中外医学社 2004:7-11

  6. 佐田政隆 ES細胞・心血管幹細胞:心臓ナビゲーター (浅田祐士郎、江頭健輔、甲斐久史、古森公浩、佐田政隆、室原豊明 編集) メディカルレビュー社 2004: 56-57

  7. 田中君枝、佐田政隆 総論:血管不全フロンティア (野出孝一 編集) メディカルレビュー社2004: 27-34

  8. 田中君枝、佐田政隆 U. 疾患の病因と病態 1.血管内皮前駆細胞の機能的意義 Annual Review 循環器 2005 (矢崎義雄、山口徹、高本眞一、中澤誠 編集)中外医学社 2005:55-61

  9. 田中君枝、佐田政隆 X. 各種病態における降圧薬を中心とした併用療法の実際 3悪性腫瘍を伴う高血圧 高血圧併用療法 (堀内正嗣、浦信行、北風政史、光山勝慶、森下竜一 編集)メディカルレビュー社2005:118-119

  10. 佐田政隆 2章病態 骨髄由来細胞の役割 慢性冠動脈疾患の臨床(小川久雄 編集) 中山書店2006:48-53

  11. 田中君枝、佐田政隆  B慢性心不全の治療 21.再生医療にエビデンスはあるのか? EBM循環器疾患の治療 2008-2009 (三田村秀雄、山科章、川名正敏、桑島巌 編集)中学医学社2007:356-361

  12. 佐田政隆 薬剤による血管再生 血管の再生―血管再生医学の夜明け:近づく実用化(森下竜一 編集)真興交易(株)医書出版部2008:118-129

  13. 仁木敏之、佐田政隆 Z.心膜疾患、腫瘍 4.心内血栓 循環器疾患 最新の治療2010-2011(堀正二、永井良三 編集)南江堂 2010:213-216

  14. 田中君枝、佐田政隆 第6節バルーン傷害モデル 疾患モデルの作製と利用 循環器疾患(北徹、堀内久徳、柳田素子、猪原匡史、冨本秀和、並河徹 編集) LIFE-SCIENCE INFORMATION CENTER, 東京, 2010: 175-178

  15. 平田陽一郎、高岡稔、佐田政隆 第5章 異所性脂肪と循環器疾患 異所性脂肪−メタボリックシンドロームの新常識(小川佳宏 編集) 日本医事新報社 2010:79-103

  16. 佐田政隆 2010年の総括 血管糖尿病2011(佐田政隆、下村伊一郎、野出孝一、綿田裕孝 編集)有限会社フジメディカル出版 2011:1

  17. 島袋充生、山川研、益崎裕章、佐田政隆 血管内皮障害の病態 血管糖尿病2011(佐田政隆、下村伊一郎、野出孝一、綿田裕孝 編集)有限会社フジメディカル出版 2011:8-13

  18. 田中君枝、佐田政隆 第1章 血管構築 間葉系細胞 血管生物医学事典(日本血管生物医学会 編集)朝倉書店 2011:20-21

  19. 黒部裕嗣、佐田政隆 第6章 病態・治療 Tissue Engineering技術による血管の再生 血管生物医学事典(日本血管生物医学会 編集)朝倉書店 2011:427-428

  20. 田中君枝、佐田政隆 第II章 8 トランスレーショナルリサーチに期待する予防医学 エビデンスに基づく循環器病予防医学−慢性心不全を防ぐ予防戦略とは?−(和泉徹 監修)南山堂 2012:96-101

  21. 島袋充生、佐田政隆 心臓病と肥満−メタボリックシンドロームを中心に− 循環器疾患 最新の治療2011-2012(堀正二、永井良三 編集)南江堂 2012:507-510 

  22. 山口浩司、佐田政隆 6. 不安定プラーク破裂に関与する因子は何か? EBM循環器疾患の治療 2012-2013(小室一成、横井宏佳、山下武志、楽木宏実 編集)中外医学社 2012:26-29

  23. 田中君枝、佐田政隆 2.PPARγ 動脈硬化症の新しい診断・治療標的(倉林正彦 監修、山岸昌一 編集) メディカルレビュー社 201275-82

  24. 添木武、佐田政隆 第2章 7. むずかしくてイヤになる動脈硬化のサイエンス 増刊 レジデントノート 循環器診療の疑問、これで納得!(村上裕二編集) 羊土社 2012:146-152

  25. 竹谷善雄、佐田政隆 4. 治療薬総論 硝酸薬 今日の循環器疾患治療指針 第3版(編集 井上博、許俊鋭、檜垣實男、代田浩之、筒井裕之)医学書院 2013:162-165

  26. 田中君枝、佐田政隆 5. 動脈硬化とアレルギー・炎症 Annual Review 循環器2013(編集 小室一成、佐地勉、坂田隆造、赤阪隆史)中外医学社 2013:34-40

  27.  添木武、佐田政隆 循環器領域における新たな検査法の導入 検査診断学への展望−臨床検査指針:測定とデータ判読のポイント−(監修 第62回日本医学検査学会記念誌編集委員会 編集 野村努、正田孝明、横田浩充、香川県臨床検査技師会編集委員会) 2013;564-571

  28. 原知也、佐田政隆 血管機能を改善する効果があります そうだったんだ!脂肪酸 (編集 伊藤浩)文光堂 2013;67-70

  29. 沖美環、佐田政隆 動脈硬化を改善する効果があります そうだったんだ!脂肪酸 (編集 伊藤浩)文光堂 2013;76

  30. 田中君枝、佐田政隆 第U章 冠動脈イベントの機序を知る1 冠動脈イベントのプロセスを理解しよう (1 血管内皮機能とその異常 2 単球とリンパ球 3 動脈硬化プラークの進展 4 動脈硬化プラークの破裂 5 血栓形成を促進させるもの) 冠動脈疾患のパーフェクトマネジメント(編集 伊藤浩)南江堂 2013;8-23

  31. 佐田政隆 第U章 冠動脈イベントの機序を知る 1 冠動脈イベントのプロセスを理解しよう(TOPICS 心臓周囲脂肪組織とその意義) 冠動脈疾患のパーフェクトマネジメント(編集 伊藤浩)南江堂 2013;24-26

  32. 八木秀介、佐田政隆 甲状腺疾患と心臓 循環器疾患最新の治療2014-2015 (編集 堀正二、長井良三)2014;419-421

  33. 高島啓、伊勢孝之、佐田政隆 第4章 慢性心不全の治療 1. 内服治療  心不全治療に魚油が効く!?−ω-3不飽和脂肪酸慢性心不全治療へ− 臨床心不全のいちばん大事なところ60(編著 佐藤幸人)メディカ出版2014:236-240

  34. 田中君枝、佐田政隆 I. 虚血性心疾患 A. 急性冠症候群 血管外の組織はACSの発症に関与しているのか? EBM 循環器疾患の治療2015-2016(監修 小室一成)中外医学社 2015:25-29

  35. 福田大受、佐田政隆 23 ACE阻害薬の抗動脈硬化作用に関して教えて下さい 実はすごい!ACE阻害薬  エキスパートからのアドバイス50(編集 伊藤浩)南江堂 2015:111-11436.

  36. 佐田政隆(医学監修)、しらいしやすこ(料理監修) 血管がぐんぐん若返る えごま油の健康レシピ 辰巳出版 2015:1-96

  37. 八木秀介、佐田政隆 7 心臓病と肥満 −メタボリックシンドロームを中心に− 循環器疾患最新の治療2016-2017(監修 堀正二、編集 長井良三、伊藤浩)南江堂 2015:509-511

  38. 佐田政隆 冠動脈プラークと血管平滑筋細胞 最新冠動脈疾患学 (上)−冠動脈疾患の最新治療戦略− 日本臨牀社 2016:99-108

  39. 佐田政隆 動脈硬化と炎症、免疫、脂肪(第6回学術大会シンポジウム1 2010年6月1日 東京大学安田講堂)日本食品免疫学会学術講演記録集2010〜2014 日本食品免疫学会 2016;69-70

  40. 佐田政隆 ω3とω6のPUFAのバランス異常でなぜ動脈硬化が進行する? そうだったんだ!脂質異常症(編集 伊藤浩)文光堂 2016:111-116

  41. 佐田政隆 心外膜下脂肪はどのようなものか?どんな意義があるのか? そうだったんだ!脂質異常症(編集 伊藤浩)文光堂 2016:143-144

  42. 山口浩司、佐田政隆 2. 冠動脈疾患 糖尿病と循環器病 一歩進んだ糖尿病循環器学−Diabetic Cardiology−(監修 檜垣實男、編集 綿田裕孝、大石充)医薬ジャーナル社 2017:133-141

  43. 佐田政隆 6.血管の収縮・弛緩と血圧調節機構 内科学第11版 (矢崎義雄総編集) 朝倉書店 2017:386-387

  44. 山口浩司、佐田政隆 13 治すLEADER試験の解釈と循環器疾患への応用 Heart View (編集 吉田富生)メジカルビュー社 2017;8:99-104

  45. 高島啓、佐田政隆 ω系不飽和脂肪酸による虚血性心疾患や心不全患者の心血管イベントリスクの軽減 ビタミン91巻9号 日本ビタミン学会 2017;542-546

  46. 田中君枝、佐田政隆 その他16 動脈硬化の基礎 循環器疾患最新の治療2018-2019 南江堂 2018;395-397

  47. 高島啓、佐田政隆 ω系不飽和脂肪酸の心血管イベントリスク低減作用 脂質クオリティ(編集 有田誠)羊土社2018;180-184

  48. 高島啓、佐田政隆 ω系多価不飽和脂肪酸による心血管イベント抑制効果 心血管薬物療法(J-ISCP会誌)Vol.6No.1 国際心血管薬物療法学会日本部会 2018;29-32 

  49. 西條良仁、山田博胤、佐田政隆 トピックCTRCDの診断 実践Onco-Cardiology(小室一成監修、向井幹夫編集)中外医学社 2018:37-50

  50. 佐田政隆 4.心臓血管周囲脂肪と心臓血管病 The Lipid メジカルビュー社 2018:37-44 

  51. 佐田政隆 5)冠動脈硬化病態における心外膜脂肪の役割 心不全(第2版)上 日本臨牀社 2019:363-368

  52. 田中君枝、佐田政隆 動脈硬化と糖尿病 CARDIAC PRACTICE メディカルビュー社 2018:175-179

  53. 山田博胤、佐田政隆 腫瘍循環器外来とはどのようなものでしょうか がん患者の心臓を守る!腫瘍循環器学Q&A 文光堂 2018

  54. 田中君枝、佐田政隆:5血小板・血栓、動脈硬化診療のすべて A.成因:基礎研究、日本医師会雑誌 第148巻・特別号(2)、生涯教育シリーズ-97 磯部光章他監修・編集、日本医師会、2019;567-569

  55. 山口浩司、佐田政隆:その他XIV 動脈硬化のスクリーニング検査、伊藤浩、山下武志編集、循環器疾患最新の治療2020-2021、南江堂、2020; 357-360

  56. 佐田政隆、田中君枝:心外膜下脂肪と冠動脈硬化、伊藤浩編集、そうだったんだ脂質異常症 治療の新潮流を探る 第2版、文光堂、2020;134-135

  57. 伊藤浩、佐田政隆、田中敦史、野出孝一、室原豊明、荒木栄一、稲垣暢也、植木浩二郎、石井秀樹、今井健二郎、杉山雄太、山根俊介:糖代謝異常者における循環器病の診断・予防・治療に関するコンセンサスステートメント、日本循環器学会、日本糖尿病学会監修、日本循環器学会・日本糖尿病学会合同委員会編集、南江堂、2020

 

 

 

 

和文論文

  1. 佐田政隆服部明徳、秋下雅弘、大内尉義、折茂肇.偶然発見された解離性大動脈瘤 (Vb) の一例.診断と治療.1990:78;1399-1401.

  2. 佐田政隆、芹澤剛.hibernation stunned myocardiumMedicina. 1992:29;1254-1255.

  3. 佐田政隆、芹澤剛.心機能異常の臨床的把握法.Practitioners.1993:2;21-27.

  4. 佐田政隆.冠動脈疾患治療法の最新の話題.医学のあゆみ.1993:166;830.

  5. 佐田政隆、芹澤剛.心不全における心機能の観血的評価とその意義.日本内科学会雑誌.1994:83;42-47.

  6. 佐田政隆、芹澤剛.急性心筋梗塞における血行動態の診断?LVG 法による解析.日本臨床.1994:674;659-663.

  7. 佐田政隆 細胞死を利用した遺伝子治療.医学のあゆみ.2000:192;219-223.

  8. 佐田政隆 血管内皮による炎症細胞の血管外浸潤の制御.最新医学.2000:55;419-424.

  9. 佐田政隆、前島よし江 血管内皮細胞のFasリガンドによる炎症細胞血管外浸潤の制御.医学のあゆみ.2000:193; 646-647.

  10. 佐田政隆 酸化LDLによるFas依存性血管内皮細胞アポトーシス. 臨床免疫. 2000:33; 692-698.

  11. 佐田政隆 内皮細胞に発現するFasリガンド-新たな抗動脈硬化分子?-. 分子血管病学.2000:4;53-60.

  12. 佐田政隆永井良三. 血管内皮細胞におけるアポトーシス、動脈硬化. Cardiovascular Med-Surg. 2000:2; 32-37.

  13. 佐田政隆足立史子、前島よし江. 細胞死制御による血管病の遺伝子治療 血管医学. 2000:; 63-70.

  14. 佐田政隆 スタチンによる血管新生促進作用―脂質改善以外の新たな有益性. Molecular Medicine 2001:38;214.

  15. 佐田政隆 一つの細胞から二つの運命―同一細胞から血管内皮と平滑筋に分化. Molecular Medicine 2001:38;215.

  16. 佐田政隆 スタチンは臓器移植にも有効か? Molecular Medicine 2001:38;350.

  17. 佐田政隆 異種の内皮細胞をワクチンとする癌の新しい免疫療法. Molecular Medicine 2001:38;351

  18. 佐田政隆 骨髄から脳を創造:骨髄由来細胞から神経細胞への分化 Molecular Medicine 2001:38;472.

  19. 佐田政隆 致死性不整脈に対する遺伝子治療の可能性. Molecular Medicine 2001:38;473

  20. 佐田政隆 移植臓器血管内皮の宿主細胞による置換 Molecular Medicine 2001:38;583.

  21. 佐田政隆 血管内皮増殖因子-C, -Dによるリンパ管新生と癌転移促進. Molecular Medicine 2001:38;584.

  22. 佐田政隆 骨髄細胞が心臓を再生. Molecular Medicine 2001:38;702.

  23. 佐田政隆 骨髄細胞が動脈硬化を形成. Molecular Medicine 2001:38;703.

  24. 佐田政隆 血管内皮増殖因子による動脈硬化促進細胞の骨髄からの動員. Molecular Medicine 2001:38;835-836.

  25. 佐田政隆 流血中の血管前駆細胞移植による虚血心筋の機能改善. Molecular Medicine 2001:38;836-837.

  26. 佐田政隆 DNAマイクロアレイによる癌の診断―予後の判定と治療法の決定. Molecular Medicine 2001:38;948.

  27. 佐田政隆 スタチンは白血球受容体に結合し炎症反応を抑制する. Molecular Medicine 2001:38;949.

  28. 佐田政隆 ニコチンは血管新生を促進して癌と動脈硬化を増悪させる. Molecular Medicine 2001:38;1084.

  29. 佐田政隆 心筋細胞は分裂、増殖しうる. Molecular Medicine 2001:38;1085.

  30. 佐田政隆 レシピエント由来細胞が移植臓器を再構築. Molecular Medicine 2001:38;1200.

  31. 佐田政隆 脂肪組織由来ホルモンがインスリン感受性を改善. Molecular Medicine 2001:38;1201.

  32. 佐田政隆 臓器特異的な内皮増殖因子の発見. Molecular Medicine 2001:38;1330.

  33. 佐田政隆 骨髄から幹細胞が流れ出て梗塞心筋を再生する. Molecular Medicine 2001:38;1331-1332.

  34. 佐田政隆 血球から血管の創造――自己の内皮前駆細胞を用いた微小人工血管. Molecular Medicine 2001:38;1462-1463.

  35. 佐田政隆 大西洋をはさんだ遠隔手術――ニューヨークの医師がフランスの患者の胆嚢を摘出. Molecular Medicine 2001:38;1463-1464.

  36. 佐田政隆 アポトーシスと動脈硬化.医学のあゆみ.2001:state of arts Ver.2 ;164-166.

  37. 佐田政隆、永井良三 プラークラプチャーと平滑筋細胞.血管医学.2001: 2; 39-45.

  38. 佐田政隆 血管細胞の発生と分化.Bio Clinica .2001: 16 ; 503-509.

  39. 佐田政隆 虚血性心疾患の遺伝子治療―臨床応用はここまで進んだ―ハートナーシング2001: 14 ; 994-1000.

  40. 堀内正嗣、橋本易周、勝谷友宏、佐田政隆 座談会:プロテオームによる心血管病研究. 分子心血管病2001: 2 ; 531-541.

  41. 佐田政隆、森下竜一、江頭健輔 座談会:動脈硬化と血管新生. 血管医学2001: 2; 73-80.

  42. 佐田政隆 虚血・再灌流における白血球集積、心筋障害に対する血管内皮細胞上Fasリガンドの役割. 臨床成人病2001: 31; 1404-1406.

  43. 佐田政隆、大野実、鈴木亨 研究室紹介58:東京大学循環器内科. 血圧 2001:8;1184-1185.

  44. 佐田政隆、永井良三 骨髄由来平滑筋前駆細胞の血管病態生理における役割. Medical View Points 2001: 11. 7.

  45. 佐田政隆 血管内皮細胞におけるFasリガンドの役割. 最新医学2001: 127; 2765-2771.

  46. 佐田政隆 血管が臓器を創る. Molecular Medicine 2002:39;101-102.

  47. 佐田政隆 2種類の増殖因子を放出すつポリマーによって誘導される生理的機能をもつ血管の新生. Molecular Medicine 2002:39;229.

  48. 佐田政隆 移植臓器拒絶の非侵襲的診断. Molecular Medicine 2002:39; 357-358.

  49. 佐田政隆 幹細胞が飛んできて心臓を再生する. Molecular Medicine 2002:39; 491.

  50. 佐田政隆、平田恭信、永井良三 レシピエント由来細胞が心移植後動脈硬化症を形成する. Journal of Cardiology 2002: 39. 48-49.

  51. 佐田政隆 動脈硬化巣血管平滑筋の由来.Bio Clinica. 2002: 17 ; 91-95.

  52. 江頭健輔、浅田祐一郎、甲斐久史 佐田政隆 座談会:抗炎症による動脈硬化の予防は可能か。CHOL. 2002: 10 ; 8-13.

  53. 佐田政隆、永井良三 薬物による血管新生療法.第120回 日本医学会シンポジウム記録集 2001: 12月. 68-73

  54. 佐田政隆 クローンマウスは短命である. Molecular Medicine 2002:39; 601-602

  55. 佐田政隆、骨髄幹細胞と血管リモデリング. 実験医学 2002: 20; 115-121

  56. 佐田政隆  成体幹細胞は本当に万能か. Molecular Medicine 2002:39;723-724

  57. 佐田政隆 幹細胞が病気の原因になる?. Molecular Medicine 2002:39;862

  58. 佐田政隆 遊走してきた幹細胞による心筋の再生. 内科2002:90;176-177

  59. 佐田政隆 マラリア撲滅のためのトランスジェニック蚊. Molecular Medicine 2002:39;969

  60. 佐田政隆 動脈硬化成因に関する新しい概念-骨髄幹細胞の関与. PIRAMID 2002:T;2-7

  61. 佐田政隆 骨髄細胞と血管病. 血管医学 2002:3; 049-057

  62. 佐田政隆 スタチンによる血管新生促進作用. 血管医学 2002:3; 077-084

  63. 佐田政隆 薬剤溶出型ステントで動脈硬化を克服?. Molecular Medicine 2002:39;1086

  64. 佐田政隆 血管細胞のアポトーシス―血管平滑筋細胞と内皮細胞のアポトーシスの機序と病態生意義. 医学のあゆみ2002:202;572-576.

  65. 佐田政隆 骨髄からの平滑筋細胞. Heart View 2002:6; 59-67.

  66. 佐田政隆 スタチンは内皮前駆細胞を増加させる. 血栓と循環 2002:10;68-69

  67. 佐田政隆 骨髄細胞を利用して血管新生を制御し病気を治療. Molecular Medicine 2002:39;1204-1205.

  68. 佐田政隆 血管平滑筋細胞の分化 Bone marrow cells contribute to atherosclerosis. 分子細胞治療2002:1;33-41.

  69. 佐田政隆 血管新生や炎症部位における骨髄幹細胞の動員は1型VEGF受容体を介する。Molecular Medicine 2002:39;1332

  70. 佐田政隆 成体幹細胞は本当に「多能」なのか。Molecular Medicine 2002:39;1446

  71. 佐田政隆 Aktは細胞周期抑制因子p27をリン酸化して癌細胞の増殖を促進するMolecular Medicine 2003:40;112

  72. 佐田政隆 涙が出ないタマネギができるかもしれない。Molecular Medicine 2003:40;232-233.

  73. 佐田政隆、永井良三 骨髄由来血管前駆細胞と血管リモデリング.Inflammation and Regeneration 2003:23: 44-50.

  74. 佐田政隆 動脈硬化の病態における幹細胞の役割. ファルマシア2003:39;113-117.

  75. 佐田政隆 血管新生とスタチン. 医学のあゆみ2003:204;443-446.

  76. 佐田政隆 切れたメダカの心臓は生えかわる。Molecular Medicine 2003:40;364.

  77. 佐田政隆 繭から医療用ヒトタンパク質を紡ぐーヒトコラーゲンを産生するトランスジェニックカイコ。Molecular Medicine 2003;40:494

  78. 佐田政隆 動脈硬化病巣における平滑筋細胞の起源―新しい仮説の可能性―. The Circulation Frontier 2003:7;20-24.

  79. 田政隆 幹細胞と動脈硬化 Bio Clinica 2003:18;61-66.

  80. 佐田政隆 心筋再生がいかに関与するか 日本臨床 2003:61;761-766.

  81. 佐田政隆 骨髄幹細胞の血管細胞への分化と動脈硬化 細胞 2003:35;236-239.

  82. 佐田政隆 骨髄による肝細胞の“再生”は細胞融合にすぎない? Molecular Medicine 2003:40;724.

  83. 磯部光章、岡本洋、池田宇一、佐田政隆. (座談会)心血管病は免疫でどこまで説明できるか。分子血管病 2003:4;221-232.

  84. 佐田政隆 平田恭信、永井良三  動脈硬化プラーク構成細胞の由来とその臨床的意義 脈管学 2003:43;143-147

  85. 佐田政隆 造血幹細胞は動脈硬化病変の血管細胞に分化する 分子細胞治療学 2003:2;324-325.

  86. 佐田政隆 クローン人間は本当に作製可能か。 Molecular Medicine 2003:40;860.

  87. 佐田政隆、杉浦清了、平田恭信、永井良三  スタチンによる側副血行路発達促進作用 臨床薬理の進歩 2003:24;102-107.

  88. 佐田政隆   放射線は内皮細胞を標的とした兵糧攻めで腫瘍を縮小させる。 Molecular Medicine 2003:40;992

  89. 藤田敏郎、Bradford C. Berk、堀内正嗣、佐田政隆、吉村道博. (座談会)生活習慣病の血管保護戦略。血管医学 2003:8;111-118.

  90. 佐田政隆  臓器移植によって腫瘍も移植される。 Molecular Medicine 2003:40;1116.

  91. Liao, J.K., Sacks, F.M., 佐田政隆、北風政史. (座談会)循環器領域で望まれるスタチン像-コレステロール低下作用かPleiotropic effectsかPharma Medica 2003:21;87-93.

  92. 佐田政隆  ヒトの動脈硬化病変で確認された骨髄由来平滑筋細胞。 Molecular Medicine 2003:40;1248.

  93. 佐田政隆  自分のクローンを出産したウマ。 Molecular Medicine 2003:40;1249.

  94. 佐田政隆、永井良三 再生医療の展望 6.骨髄由来細胞による再生および病態形成。 内科学会雑誌 2003: 92; 178-185

  95. 佐田政隆 Fas と血管アポトーシス Heart View 2003:7;218-219

  96. 田中君枝、佐田政隆 末梢内皮前駆細胞数と心血管危険因子 Bio Clinica 2003:18;1206-1209

  97. 佐田政隆 細胞の由来を診る Heart View 2003:7;1444-1449

  98. 佐田政隆 骨髄幹細胞へのAkt遺伝子導入によって心筋再生を促進。 Molecular Medicine 2003:40;1512

  99. 佐田政隆 厳しいハチ社会:ミツバチにおける性決定機能の解明。 Molecular Medicine 2003:40;1514.

  100. 佐田政隆 心筋を再生させる心筋内万能細胞。 Molecular Medicine 2004:41;110.

  101. 佐田政隆 エリスロポエチンによる心筋保護効果。 Molecular Medicine 2004:41;110.

  102. 佐田政隆  動脈硬化病態生理への骨髄由来血管前駆細胞の関与. 炎症・再生 2004:24;27-34

  103. 佐田政隆  再狭窄メカニズムの新たな仮説。心臓病 News & Views 2004:17;10-11

  104. 佐田政隆  2型アンジオテンシン変換酵素はSARSウイルスの機能的受容体である。 Molecular Medicine 2004:41;244-245.

  105. 佐田政隆  一酸化窒素合成酵素は血管内皮前駆細胞の動員に重要である。Molecular Medicine 2004:41;246.

  106. 佐田政隆  「嫌なことはよく忘れる」科学的根拠。Molecular Medicine 2004:41;373-374.

  107. 佐田政隆  Notchは細胞外カルシウムセンサーとして働き、左右の臓器配置を決定づける。Molecular Medicine 2004:41;375.

  108. 佐田政隆  コレステロールがなくても生きられる?Molecular Medicine 2004:41;486.

  109. 佐田政隆 母親の食事の内容で子供の寿命は決まる。Molecular Medicine 2004:41;486-487.

  110. 佐田政隆 用語解説「不安定プラーク」循環器専門医2004:12;89

  111. 佐田政隆 骨髄細胞と動脈硬化。実験医学増刊2004:22;135

  112. 佐田政隆 幹細胞移植は心機能を改善させるが動脈硬化を増悪させる。 Molecular Medicine 2004:41;764

  113. 佐田政隆  造血幹細胞はやはり心筋には分化しない。 Molecular Medicine 2004:41;765

  114. 佐田政隆 血管病発生における骨髄細胞の関与。日本血栓止血学会誌 2004:15;215-222

  115. 佐田政隆  青魚は突然死を予防する。 Molecular Medicine 2004:41;1041

  116. 佐田政隆  珪藻はただでは食べられない:毒を用いたリベンジ。 Molecular Medicine 2004:41;1044

  117. 田中君枝、佐田政隆、永井良三 粥状動脈硬化症における血管新生の意義。Atherothrombosis 2004:7;18-23

  118. 佐田政隆 動脈硬化発生における骨髄細胞の役割 医学のあゆみ 2004:210;545-549

  119. 森下竜一、吉田雅幸、佐田政隆 (座談会)スタチンの最新エビデンスを“vascular stain”の立場から検証する―コレステロール標準治療と強化療法の先にあるもの― 日経CME2004年8月号

  120. 田中君枝、佐田政隆 動脈硬化の進展と血管新生 炎症と免疫 2004:12:586-592

  121. 佐田政隆  血は造らないが臓器を保護するエリスロポエチン Molecular Medicine 2004:41;1181

  122. 佐田政隆  野菜から魚油を摂取 Molecular Medicine 2004:41;1183

  123. 田中君枝、佐田政隆 プラーク破綻の機序−コンセンサスとコントロバーシー 脈管学 2004:44;319-324

  124. 佐田政隆  虚血が前駆細胞を引き寄せる Molecular Medicine 2004:41;1310

  125. 佐田政隆、永井良三 血管リモデリングにおける骨髄由来血管前駆細胞 分子心血管病 2004:29;511-517

  126. 佐田政隆 用語解説「心臓幹細胞(cardiac stem sell)」 循環器専門医 2004:12;284

  127. 佐田政隆  幹細胞移植でヌードマウスに毛が生えた Molecular Medicine 2004:41;1595

  128. 佐田政隆  ロイコトリエンは外膜から作用して血管を破裂に導く Molecular Medicine 2004:41;1595

  129. 佐田政隆  動脈硬化と骨髄由来細胞 現代医療 2004:36;2395-2400

  130. 佐田政隆  血中前駆細胞による血管の修復と病態形成 Therapeutic Research 2004:25;2166-2170

  131. 寺本民生、小田原雅人、佐田政隆 (座談会)実践・コレステロール低下療法、スタチンのEBMを“もの”にする 糖尿病患者の脂質管理日本醫事新報2004年4208号C1-C8

  132. 佐田政隆  骨髄細胞と再狭窄 Heart View 2005:9;50-54

  133. 佐田政隆 最新の薬物療法を語る:DES(Drug Eluting Stent)時代の薬物療法 -ARBに期待できること- 日本臨床 2005:63;155-172

  134. 佐田政隆 骨髄由来前駆細胞と血管リモデリング血圧 2005:12;81-87

  135. 佐田政隆 スタチンと血管新生 The Lipid 2005:16;51-57

  136. 佐田政隆 血中前駆細胞による血管の新生、再生、病態形成 臨床病理 2005:53;70-76

  137. 佐田政隆 骨髄由来細胞と動脈硬化 日本内科学雑誌 2005:94;369-375]

  138. 佐田政隆 骨髄幹細胞とプラーク The Lipid 2005:16;127-133

  139. 佐田政隆 プラークの不安定化と血管新生 Medical View Point 2005:26;3

  140. 佐田政隆 血管平滑筋前駆細胞と血管新生 治療学 2005:39;30-33

  141. 佐田政隆 Treat to Goal Expert Interview Medical Tribune 2005:38;37

  142. 佐田政隆 骨髄由来細胞による血管修復と病態形成 Molecular Medicine 臨時増刊号「生活習慣病の最前線」 2005:42;301-3058

  143. 田中君枝、佐田政隆 骨髄由来内皮前駆細胞―障害内皮修復細胞?動脈硬化促進細胞?−Medical Practice 2005:22;1923-1924

  144. 佐田政隆 ステント内最狭窄の細胞メカニズム。Heart View 2005:10; 46-51

  145. 佐田政隆 骨髄由来細胞は動脈硬化を促進するか、修復するか。促進の立場から。臨床高血圧 2005:12; 27-37

  146. 福田大受、佐田政隆 動脈硬化とレニン・アンジオテンシン系について。日本臨床 2006:64;805-809.

  147. 佐田政隆 骨髄由来幹細胞の意義 循環器科 特別増刊号「動脈硬化のすべて」 2006:59(supple 3);154-163

  148. 佐田政隆 動脈硬化の進展と破綻におけるRA系の役割。血圧 2006:13; 83-86

  149. 田中君枝、佐田政隆 スタチンのpleiotropic effect は臨床的に有意義かー積極的立場からー内科 2006:98;143-147

  150. 佐田政隆 動脈硬化の進展と破綻に関する最近の知見と治療戦略。Therapeutic Research 2006:27; 942-945

  151. 福田大受、佐田政隆 心筋梗塞とRAS。Angiotensin Research 2006:3; 172-177.

  152. 佐田政隆 血管細胞のアポトーシス。日本臨床 2006:64 supple5; 235-239.

  153. 田中君枝、佐田政隆 臓器移植と血管新生内科。Angiology Frontier 2006:5;16-21

  154. 堀内正嗣、佐田政隆 メタボリックシンドロームを考慮した降圧治療におけるARBの臨床的意義日経メディカル 2006:9;127-130

  155. 佐田政隆  骨髄由来幹細胞の意義。循環器科 2006:59(suppl. 3);154-163

  156. 佐田政隆、室原豊明 序文とまとめー血管新生療法の現在と展望ー 脈管学  2006:46 ; 577.

  157. 伊藤 浩、佐田政隆、石川雄一 EPAの冠動脈イベント抑制作用とエビデンス Therapeutic Research 2006:27; 2091-2094

  158. 田中君枝、佐田政隆:心臓病を合併している場合、どの薬がよいのか  治療 2006;88(4):1322-1325

  159. 田中君枝、佐田政隆:動脈硬化発症における血管炎症の意義と治療  Adiposcience 2006;3(2):191-197

  160. 田中君枝、佐田政隆:VALIANT試験  実験治療 2006;684:232-237

  161. 佐田政隆 ステント内再狭窄の細胞メカニズム Mebio 2007:24;6-13

  162. 佐田政隆 組織幹細胞と材料工学を用いた新規血管再生療法 Therapeutic Research 2007:28;325-331

  163. 佐田政隆 動脈硬化病態への骨髄由来細胞の関与 医学のあゆみ「動脈硬化学UPDATE―動脈硬化の成り立ちを理解する」 2007:221;1162-1166

  164. 松本美環、佐田政隆 イコサペンタエン酸の薬物介入によるアテローム血栓症の予防 循環器科「アテローム血栓症の包括的治療戦略」 2007:62;337-343

  165. 佐田政隆 骨髄由来平滑筋細胞とその役割 Heart View 「再生医療の現状を識る」 2007:12;62-68

  166. 佐田政隆 骨髄由来細胞の血管修復と病変形成への関与 医学のあゆみ 2007:223;1103-1107

  167. 岩田洋、佐田政隆 幹細胞を用いた心筋再生療法―メカニズムと臨床応用― Bio Clinica 2008:23;61-66

  168. 小室一成、倉林正彦、佐田政隆、松原弘明、吉村道博  (座談会)ARBの基礎データが示唆する脳・心血管イベント発症抑制への可能性  Pharma Medica 2008:26.82-83

  169. 福田大受、佐田政隆 薬剤溶出ステントと遅発性血栓症ーDESの影から光を探るー骨髄細胞からの視点:DES遅発性血栓の細胞メカニズム 血管医学  2008:9 ; 85-90.

  170. 田中君枝、佐田政隆 血管前駆細胞の基礎と臨床応用 脳神経外科速報  2008: 18; 321-326.

  171. 小室一成、伊藤裕、佐田政隆、堀内正嗣、吉村道博  (座談会)ACE阻害薬およびARBの心血管イベント発症への影響を振り返る  Pharma Medica 2008:26.184-185

  172. 田中君枝、佐田政隆 Clinical Conference COMMENT1  The Circulation Frontier 2008: 12(2);38-39

  173.  松本美環、佐田政隆 ω3多価不飽和脂肪酸と動脈硬化性疾患 The Lipid 2008:19;396-401

  174. 佐田政隆 スタチンとステント血栓症−スタチンによる内皮機能の健全化− Medical View Point 2008:29;12(2).

  175. 佐田政隆 炎症・免疫と動脈硬化 Medical Science Digest 2008:34;492-495.

  176. 佐田政隆 細胞からみたDESの弱点と薬物療法 OPTIMAL THERAPY 2008:11;6-8.

  177.  佐田政隆 細胞レベルからみたDESの弱点とステント血栓症 Coronary Intervention 2008:4;30-35.

  178. 田中君枝、佐田政隆 スタチンによる脳血管攣縮予防の可能性 Clinical Neuroscience 2008:26;1404-1405.

  179. 藤田敏郎、森下竜一、佐田政隆 動脈硬化性疾患の抑制を考慮した高血圧治療におけるARBの役割 Pharma Medica 2008:26;128-134.

  180. 平田陽一郎、福田大受、佐田政隆 心血管障害の分子メカニズム−動脈硬化とレニン・アンジオテンシン系− 分子脳血管病2009:8;24-29.

  181. 佐田政隆 動脈硬化巣の形成における血球細胞の役割 Vascular Medicine 2009:5;77-81.

  182. 佐田政隆 循環器専門医とリサーチマインド 心臓 2009:41;1.

  183. 八木秀介、佐田政隆 酸化ストレスと循環器疾患 循環制御 2008:29;231-235.

  184. 平田陽一郎、佐田政隆 スタチンの血液凝固システムに及ぼす影響 医学のあゆみ 2009:228;1067-1071

  185. 光山勝慶、佐田政隆、吉村道博、望月正武、水野雄二 冠動脈疾患の完全治療を目指して−脂質・血圧治療の最前線− Pharma Medica 2009:27;89-96.

  186. 平田陽一郎、福田大受、佐田政隆 動脈硬化 日本臨牀 2009:67;707-713.

  187. 佐田政隆 動脈硬化性疾患の予防と対策7 動脈硬化の発症と進展 循環plus 2009:9;2-6.

  188. 福田大受、佐田政隆 動脈硬化病態生理におけるレニン・アンジオテンシン系の役割 脈管学 2008:48;449-454.

  189. 田中君枝、佐田政隆 血管新生と動脈硬化 循環器専門医 2009:17;3-9.

  190. 佐田政隆、市原淳弘、西山成、三浦伸一郎 RAA系と臓器保護作用、血圧 2009:16;57-64.

  191. 立石法史、江川香、神崎範之、北川義徳、柴田浩志、木曽良信、榎本操一郎、福田大受、永井良三、佐田政隆 ケルセチン配糖体のマウス食餌性肥満モデルに及ぼす影響−ケルセチンの脂肪分解促進作用− 薬理と治療 2009:37;123-131.

  192. 平田陽一郎、松本美環、佐田政隆 多価不飽和脂肪酸と疾患心血管系−n-3多価不飽和脂肪酸と動脈硬化性疾患 治療学8多価不飽和脂肪酸 2009:43;834-837.

  193. 平田陽一郎、佐田政隆 心疾患とバソプレシン受容体拮抗薬 Heart View 10 2009:13;1167-1170.

  194. 森下竜一、水野杏一、板倉弘重、吉村道博、佐田政隆 日本人に適したスタチン治療戦略を考える 大規模観察研究LEM Studyの概要を踏まえて Nikkei Medical 2009:502;130-133.

  195. 佐田政隆 血管細胞のアポトーシス 日本臨牀 2009:67;520-524.

  196. 八木秀介、佐田政隆 運動誘発性肺動脈性肺高血圧症に対するボセンタンの効果 モダンフィジシャン 2009:29;46-47.

  197. 佐田政隆 循環器疾患の再生医療update−現状と展望−:序文 循環器科 2009:66;351-352.

  198. 平田陽一郎、佐田政隆 ARBのエビデンス:オルメサルタン  診断と治療 2009:97;156-162.

  199. 平田陽一郎、佐田政隆 RA系抑制と糖尿病合併症  糖尿病 2009:52;753-755.

  200. 平田陽一郎、佐田政隆 血管リモデリングと血管周囲脂肪組織 Adiposcience 2009:6;155-159.

  201. 江頭健輔、森下竜一、佐田政隆、野村政壽 心血管疾患予防の新しいストラテジー−コレステロール吸収制御の重要性 第1回飽食の時代、これからの心血管イベント−コレステロール吸収抑制の重要性 血管医学 2009:10;366-371.

  202.   佐田政隆 循環器疾患の予防と生活習慣 四国医学雑誌 2009:65;105-110.

  203. 近藤可菜、高島啓、八木秀介、赤池雅史、岩瀬俊、楠瀬賢也、仁木敏之、山口浩司、小柴邦彦、竹谷善雄、冨田紀子、山田博胤、添木武、若槻哲三、佐田政隆 重症心不全患者における酸素療法とAdaptive-servo ventilator の効果の検討(肺動脈性肺高血圧に伴う右心不全に対してのAdaptive-servo ventilatorの効果) 四国医学雑誌 2009:65;187-190.

  204. 木下肇、神原保、黒部裕嗣、元木達夫、菅野幹雄、吉田誉、北市隆、佐田政隆、松本俊夫、北川哲也 エリスロポエチン誘導末梢血単核球細胞移植が奏功した重症虚血性潰瘍を伴うBuerger病の1例  日本心臓血管外科学会雑誌 2010:39;29-33.

  205. 筒井裕之、堀内正嗣、大屋祐輔、佐田政隆 アリスキレンの高血圧患者における心保護作用への期待 PROGRESS IN MEDICINE  2010:30;419-425.

  206. 森下竜一、東幸仁、佐田政隆、吉田雅幸 (座談会)血管内皮機能からPAD診療を考える−セロトニンによる動脈硬化進展の悪循環を断ち切る− Anti-aging Science 2010:2;121-128.

  207. 筒井裕之、相川眞範、佐田政隆、宮田昌明 (座談会)LDL-C低下療法の重要性と臨床におけるエゼチミブの役割 Nikkei Medical  2010:508;78-79.

  208. 佐田政隆 エゼチミブの多面的な作用 Medical Tribune 2010:43;74.

  209. 平野勉、佐田政隆、小林淳二、後藤田貴也、小川渉 (座談会)エゼチミブの臨床的ベネフィットを検討する Medical Tribune 2010:43;74-75.

  210. 佐田政隆 プラーク破綻の分子機構 心臓 第42巻 第4号:552-557.

  211. 山口浩司、佐田政隆 狭心症の薬物療法 スタチンに関する最近の話題-Strong statinとvascular statinをどのように選択するのか?- Medical Practice 2010 : 27;825-831.

  212. 山下静也、前村浩二、江頭健輔、Brain Tomlinson、佐田政隆(座談会)コレステロール吸収阻害がもたらす臨床的ベネフィットを検証する 日経メディカル2010:4;143-145.

  213. 佐田政隆:特集 異所性脂肪 待たれる脂肪入れ替え術の臨床試験 Japan Medicine MONTHLY 2010:4; 7.

  214. 森下竜一、佐田政隆、野村政壽(座談会)心血管疾患予防の新しいストラテジー 飽食の時代の脳・心血管イベント抑制におけるコレステロール吸収阻害の意義 Medical Tribune 2010:43;32-33.

  215.  佐田政隆 動脈硬化とRA系 Hypertens Scope:2010:9;5-6.

  216. 森下竜一、朔 啓二郎、佐田政隆、吉村道博(座談会)高齢者の脂質管理の視点からスタチン治療を考える Anti-aging Science:2010:2;37-44.

  217. 堀内正嗣、松原弘明、佐田政隆(座談会)メタボリックシンドローム合併高血圧 におけるARBへの期待 Nikkei Medical  2010:7;93-96.

  218. 山口浩司、佐田政隆 血管保護をふまえた脂質異常症の薬物治療 MEDICAMENT NEWS 第2021号:8-11.

  219. 佐田政隆 特集:循環器病診療における最新の診かた,考え方 急性心筋梗塞の初期治療−救命の連鎖− 四国医学雑誌 2010:66;59-62

  220. 山田博胤、楠瀬賢也、西尾進、添木武、佐田政隆 特集:循環器病診療における最新の診かた,考え方 心房細動と塞栓症−何時,どのような治療を始めるか?− 四国医学雑誌 2010:66;63-70.

  221. 元木達夫、黒部裕嗣、平田陽一郎、菅野幹雄、吉田誉、神原保、北市隆、佐田政隆、北川哲也 総説(第24回徳島医学会賞受賞論文):ピオグリタゾン投与による腹部大動脈瘤における抗動脈硬化作用 四国医学雑誌 2010:66;91-94.

  222. 平田陽一郎、高岡稔、佐田政隆 異所性脂肪−血管周囲脂肪組織が血管リモデリングに与える影響−綜合臨床 2010:59;1906-1910.

  223. 堀内正嗣、佐田政隆、室原豊明(座談会)テルミサルタンのARB class effect を超えた効果 Pharma Medica 2010:28;93-98

  224. 平田陽一郎、高岡稔、佐田政隆 肥満と動脈硬化の関係−血管周囲脂肪組織の役割− The role of periadventitial adipose tissue in vascular remodeling 細胞 2010;42:459-463

  225. 平田陽一郎、福田大受、佐田政隆 動脈硬化とレニン・アンジオテンシン系 日本臨牀 2011;69:55-59

  226. 檜垣實男、山岸昌一、佐田政隆 (座談会)メタボリックシンドロームを伴う高血圧の治療戦略 ミカルディスとミカロム配合錠への期待 Nikkei Medical 2011;519:107-110
    堀内正継、吉村道博、光山勝慶、佐田政隆 (座談会)Ca拮抗薬のRAAS抑制作用を探る−特にN型Ca拮抗薬の臓器障害抑制にフォーカスをあてて− THERAPEUTIC RESEARCH 2011;32:135-142

  227. 長井幸二郎、楠瀬賢也、西尾進、竹谷善雄、山田博胤、佐田政隆、近藤直樹、岸史、岸誠司、荒岡利和、松浦元一、美馬晶、安部秀斉、村上太一、中村雅将、土井俊夫 片腎の高齢者腎機能障害患者において超音波検査で腎動脈狭窄症を指摘され、経皮的腎血管拡張術で高血圧、腎機能の著明な改善がみられた1例 日本腎臓学会誌 2011;53:68-74

  228. 島袋充生、山川研、益崎裕章、佐田政隆 食後高血糖と血管内皮機能 月刊糖尿病 2011;3:39-46

  229. 平田陽一郎、佐田政隆 RAS系阻害薬の使い方 Medical Practice 2011;28:839-843

  230. 島袋充生、山川研、益崎裕章、佐田政隆 肥満症と異所性脂肪、脂肪毒性 日本内科学会雑誌 2011;100:983-988

  231. 佐田政隆 被災地医療支援の日本の現状 呼吸と循環 2011;59:543

  232. 八木秀介、佐田政隆 アルドステロンと認知機能 血圧 2011;18:8-9

  233. 島袋充生、佐田政隆 海外文献紹介 慢性関節リウマチと糖尿病における動脈硬化症の程度の比較 Angiology Frontier 2011;10:62-63

  234. 佐田政隆 (監訳) Abbie L. Cawoodほか n-3 PUFAのうち、EPAがアテローム性プラークに取り込まれ、炎症性低下および安定性増強に関与 動脈硬化予防 2011;10:92-94

  235. 佐田政隆 心筋梗塞を起こし易い体質と対応策−動脈硬化の病態におけるVasa VasorumとACE2− 日本体質医学会雑誌 2011;73:137-144

  236. 光山勝慶、平田健一、佐田政隆 (座談会)動脈硬化研究の新展開 Cardiovascular Frontier 2011;2:7-12

  237. 平田陽一郎、高岡稔、佐田政隆 動脈硬化と血管周囲脂肪組織 Cardiovascular Frontier 2011;2:14-18

  238. 平田陽一郎、高岡稔、佐田政隆 動脈硬化と慢性炎症−血管周囲脂防組織のあらたな役割− 糖尿病 2011;54:483-486

  239. 佐田政隆、松岡優 【巻頭言】特集 心筋梗塞から身を守る −発作が起こる前と起こってからできること− 四国医学雑誌 2011;67:103

  240. 佐田政隆 スタチン製剤の新作用 日本医師会雑誌 2011;140:1232

  241. 島袋充生、塩田あすか、山川研、益崎裕章、佐田政隆 【海外文献紹介】2型糖尿病患者における代謝因子、脂肪細胞、PAI-1レベル:Look AHEAD試験 Angiology Frontier 2011;10:68

  242. 八木秀介、佐田政隆 鉱質コルチコイドの作用と機序 ICUCCU 2011;35:605-611

  243. 田中君枝、佐田政隆 動脈硬化における血管新生・再生 綜合臨牀 2011;60:2011-2014

  244. 佐田政隆 動脈硬化の病態における慢性炎症の役割 日本薬理学雑誌 こころとからだ 2011;138:182-186

  245. 原知也、佐田政隆 心臓血管障害をどう診るか EDと内皮機能障害を中心に medicina 2011; 48:1886-1888

  246. 東邦康智、佐田政隆 PDE5阻害薬の新しい臨床応用の可能性 medicina 2011;48:1957-1960

  247. 島袋充生、佐田政隆 糖尿病における内膜の障害とそのメカニズム 月刊糖尿病 2011;3:27-31

  248. 寺島充康、山岸正和、佐田政隆、七里守 座談会「DES時代の術後の管理」−内皮機能の観点からイベント抑制を考える− OPTIMAL THERAPY 2011;4:4-8

  249. 島袋充生、佐田政隆、山川研、益崎裕章 コルチゾールと脂質代謝 The Lipid 2012;23:35-41

  250.  佐田政隆 慢性炎症としての動脈硬化 Cardiovascular Frontier 2012;3:43-49

  251. 佐田政隆、横山光宏、板倉弘重、山下智也 (座談会)循環器領域における脂肪酸バランス(EPA/AA比)の重要性を考える−JELIS脂肪酸サブ解析からみえてくる新たな治療戦略− Mebio 2012;29:14-24

  252. 原知也、佐田政隆 (新着論文解説)NT5E遺伝子変異と動脈石灰化 O.li.v.e. 2012;2:28-34

  253. 田中君枝、佐田政隆 糖尿病と血管老化 Anti-aging Science 2012;4:6-9

  254. 島袋充生、益崎裕章、佐田政隆 大血管障害抑制の視点からみた速攻型インスリン分泌刺劇薬 Angiology Frontier 2012;11:21-26

  255. 久岡白陽花、上田由佳、前田香代子、西川幸治、坂東左知子、林修司、竹内秀和、仁木敏之、楠瀬賢也、山口浩司、冨田紀子、岩瀬俊、竹谷善雄、山田博胤、添木武、若槻哲三、高田信二郎、赤池雅史、安井夏生、佐田政隆 (若手優秀演題セッション)尿中アルブミン排泄量に及ぼす心臓リハビリテーションの効果 心臓リハビリテーション 2012;17:159-161

  256. 伊勢孝之、佐田政隆 心不全予防としての睡眠呼吸障害の診断と介入 臨床医のための循環器診療 2012;16:16-18

  257. 吉田守美子、粟飯原賢一、上田由佳、伊勢孝之、池田康将、倉橋清衛、木内美瑞穂、遠藤逸郎、藤中雄一、岩瀬俊、赤池雅史、佐田政隆、松本俊夫 ロスバスタチンによる脂質低下作用非依存的な形態的および機能的頸動脈硬化改善作用 Progress in Medicine 2012;32:315-320

  258. 小室一成、苅尾七臣、森下竜一、佐田政隆 (座談会)心血管イベント抑制を目指す高血圧治療における“メタボサルタン”への期待 日経メディカル 2012;4:135-138

  259. 小室一成、苅尾七臣、堀内正嗣、佐田政隆 (座談会) 脳心血管イベント抑制に着目した高血圧治療とは−ミカルディスのポテンシャル− 日本医事新報 2012;4591:C1-C4

  260. 添木武、木谷光宏、佐田政隆 循環器専門医が考えるCa拮抗薬の選択ポイント(動脈硬化) 循環Plus 2012;12:7-9

  261. 原知也、佐田政隆 ACSの概念と成因 月刊 循環器 CIRCULATION 2012;2:6-17

  262. 田中君枝、佐田政隆 インスリン抵抗性と動脈硬化:炎症の関与 循環器内科 2012;71:401-405

  263.  佐田政隆 冠動脈疾患における心外膜脂肪の意義 心臓 2012;44:965-969

  264. 室原豊明、葛谷雅文、佐田政隆、大屋祐輔 (座談会)血管老化の基礎と臨床 Cardiac Practice 2012;23:71-78

  265.  山口浩司、佐田政隆 高血圧症に対するRAAS抑制薬の有用性 日本臨牀 2012;70:1571-1576

  266. 佐田政隆 脂肪組織の慢性炎症と循環器疾患 炎症と免疫 2012205):28-32

  267. 坂東美佳、山田博胤、西尾進、玉井利奈、平田有紀奈、弘田大智、中川摩耶、林修司、冨田紀子、發知淳子、小笠原梢、高島啓、山崎宙、坂東左知子、伊勢孝之、仁木敏之、上田由佳、山口浩司、岩瀬俊、竹谷善雄、添木武、若槻哲三、佐田政隆、兼松康久、里見淳一郎、永廣信治 脂質低下療法による頸動脈プラーク安定化の評価:超音波integrated backscatterを用いたカラーマッピングシステムの開発と臨床応用 四国医学雑誌 症例報告(第28回徳島医学会賞受賞論文)201268147-152

  268. 佐田政隆 虚血性心疾患と血管内皮機能 心臓 2012;44:1219-1222

  269. 佐田政隆 異所性脂肪と動脈硬化 動脈硬化予防 2012;11:42-47

  270. 佐田政隆 特集 腎性高血圧と動脈硬化 企画にあたって 腎・高血圧の最新治療 2012;1:6

  271. 福田大受、佐田政隆 動脈硬化とRAS Angiotensin Research 2012;9:7-12

  272.  沖(松本)美環、佐田政隆 特集 不安定プラークの病態と診断 n-3系多価不飽和脂肪酸とプラークの安定化作用 月刊循環器 CIRCULATION 2012;3:84-90

  273. 佐田政隆 冠動脈疾患の最新の動向(第26回日本臨床内科医学会 教育講演)日本臨床内科医学会誌 2012;27:412-417

  274. 佐田政隆 特集:ω3系脂肪酸の魅力にせまる ω3系脂肪酸の多面的な作用 心・血管系 実験治療 2012;708:21-28

  275. 八木秀介、福田大受、添木武、島袋充生、佐田政隆 RAS研究−ラボの最前線− 徳島大学大学院ヘルスバイオサイエンス研究部 循環器内科学・心臓血管病態医学 Angiotension Research 2013;10:59-63

  276. 佐田政隆 特集3 循環器疾患における新たなる知見 循環器plus 2013;13:2-6

  277. 高島啓、伊勢孝之、上田由佳、岩瀬俊、八木秀介、前田香代子、西川幸治、小笠原梢、坂東美佳、坂東左知子、冨田紀子、仁木敏之、發知淳子、山口浩司、竹谷善雄、山田博胤、添木武、若槻哲三、加藤真介、赤池雅史、安井夏生、佐田政隆 心臓リハビリテーションは酸化LDLを低下させる 心臓リハビリテーション 2013;18:130-133 

  278. 佐田政隆 複合心血管病変に対する治療戦略−内科の立場から− 日本冠疾患学会雑誌 2013;19:36

  279. 伊勢孝之、佐田政隆 専門医トレーニング問題U 循環器専門医 2013;21:132-134

  280. 楠瀬賢也、佐田政隆 用語解説TAVR(transcatheter aortic valve replacement) 循環器専門医 2013;21:16

  281. 八木秀介、石田昌義、佐田政隆 用語解説 マイクロRNAと循環器疾患 循環器専門医 2013;21:97

  282. 山口浩司、佐田政隆 球形吸着炭:クレメジン®は心血管疾患を制御できるか 腎・高血圧の最新治療 2013;2:92-97

  283. 山口浩司、佐田政隆 ACSの病態 月刊 循環器 CIRCULATION 2013;3:25-31

  284. 山口浩司、佐田政隆 血管保護をふまえた脂質異常症・高血圧の薬物治療 J-ISCP会誌 心血管薬物療法 2013;1:3-9

  285. 島袋充生、Munkhbaatar Dagvasumberel、石田昌義、松本幸子、小塚智沙代、平良伸一郎、屋比久浩市、八木秀介、福田大受、山田博胤、添木武、若槻哲三、親泊政一、益崎裕章、佐田政隆 生活の質(QOL:Quality of life)を高める医療最前線 −難治な病気に光明が見えた!− 異所性脂肪と2型糖尿病・心臓血管病 四国医学雑誌 2013;1:21-28

  286. 佐田政隆 特集 慢性炎症から血管疾患をみる 特集にあたって Vascular Medicine 2013;9:12

  287. 平田陽一郎、佐田政隆 心臓周囲脂肪組織の炎症から冠動脈疾患をみる Vascular Medicine 2013;9:29-34

  288. 佐田政隆 プラーク不安定化の分子機序(第77回日本循環器学会学術集会レポート@ シンポジウム2)医学のあゆみ 2013;245:615-617

  289. 山口浩司、佐田政隆 虚血性心疾患と降圧治療 循環器内科 特集 標的臓器保護からみた高血圧治療 2013;73:667-671

  290. 佐田政隆 今、動脈硬化はこう予防する ω3不飽和脂肪酸 Mebio 2013;30:98-107

  291. 西尾進、山田博胤、佐田政隆 頸動脈エコー検査による頸動脈内膜中膜複合体肥厚度(IMT)の評価 Cardio-Renal Diabetes 2013;2:4-7

  292. 福田大受、佐田政隆 RAA系と血管内皮機能・血管リモデリング Fluid Management Renaissance  2013;3:34-42

  293. 佐田政隆 オメガ3系多価不飽和脂肪酸の作用機序 動脈硬化抑制の多面的作用を考える CardioVascular Contemporary 2013;2:14-19

  294. 添木武、佐田政隆 高血圧の炎症・免疫バイオマーカー 血圧 2013;20:30-34

  295. 佐田政隆 (特集長期予後を見据えたアプローチ4)心腎連関を考慮した高血圧治療−将来の心血管イベント抑制に向けて 循環plus 2013;14:2-6

  296.  田中君枝、佐田政隆 糖尿病による動脈硬化のメカニズムはどこまで解明されたか? Heart View 2014;18:47-53

  297. 石井亜由美、伊勢孝之、西川幸治、後藤強、八木秀介、岩瀬俊、加藤真介、佐田政隆 徳島大学病院での心臓リハビリテーションの現状 Cardiac rehabilitation in Tokushima University Hospital 心臓リハビリテーション 2014;19:161-162

  298. 佐田政隆 2. 冠動脈疾患の診断・治療・予防の進歩 日本内科学会雑誌 2014;103:687-69

  299. 木恵理、佐田政隆 妊娠を契機に発見され、出産が可能であった先天性アンチトロンビンV欠損      症の1例 循環器専門医 2014;22:109-115

  300. 佐田政隆 心外膜脂肪と冠動脈疾患 The Lipid 2014;25:13-18

  301. 佐田政隆 異所性脂肪としての血管周囲脂肪組織の役割と臨床的意味 Cardio-Lipidology 2014;8:12-17

  302. 佐田政隆 J-ISCP会誌「心血管薬物療法」第二巻発刊にあたり J-ISCP会誌 心血管薬物療法 2014;2:2

  303. 島袋充生、佐田政隆 異所性脂肪と心臓脂肪:心臓血管病における新たな病態 J-ISCP会誌 心血管薬物療法 2014;2:35-40

  304. 佐田政隆 特集 保存期腎不全の集学的治療 企画にあたって 腎・高血圧の最新治療 2014;3:128

  305. 八木秀介、佐田政隆 文献紹介“Stenting and medical therapy for atherosclerosis renal-artery stenosis N Engl J Med 370:13-22, 2014” 腎・高血圧の最新治療 2014;3:170-171

  306. 八木秀介、佐田政隆 血圧日内変動を考慮したRAAS抑制薬による高血圧治療 日本臨牀 2014;721466-1471

  307.   田中君枝、佐田政隆 粥状動脈硬化 臨床循環器 CIRCULATION 2014;4:45-53

  308. 佐田政隆 私の健康法 臨床高血圧 CLINICAL HYPERTENSION 2014;20:70-71

  309. 今田久美子、八木秀介、山口浩司、若槻哲三、伊勢孝之、太田理絵、門田宗之、高島啓、松浦朋美、飛梅威、岩瀬俊、山田博胤、添木武、赤池雅史、佐田政隆 心不全を合併した腎血管性高血圧に対する経皮的腎動脈形成術の有効性(第11回若手奨励賞受賞論文)四国医学雑誌 2014;70:87-92

  310. 田中君枝、佐田政隆 特集老化からみた循環器疾患 高齢者の動脈硬化治療 循環器内科 2014;76:289-295

  311. 佐田政隆 冠動脈疾患における心外膜脂肪の役割 Medical Science Digest 2015;41:16-19

  312. 本操一郎、墨 誠、佐田政隆 小口径人工血管 7-2 ラットへの移植評価 工業材料 2015;63:68-72

  313. 楠瀬賢也、佐田政隆 atrial appendage occlusion(左心耳閉鎖デバイス) 循環器専門医 2015;23:86

  314. 伊勢孝之、高木恵理、岩瀬俊、楠瀬賢也、山口浩司、八木秀介、山田博胤、添木武、若槻哲三、佐田政隆 心臓サルコイドーシス再燃に対してメトトレキサートの併用が有効であった1例 日本内科学会雑誌 2015;104:1175-1179

  315. 田中君枝、佐田政隆 PDE5阻害薬の臨床 2)PDE5阻害薬と血管機能 腎臓内科・泌尿器科 2015;2:54-61

  316. 佐田政隆 特集 血管機能検査を臨床に活かす 序文 循環器内科 2015;78:221

  317. 田中君枝、佐田政隆 巻頭総説 動脈硬化病変における血管周囲脂肪組織と血管外膜微小血管の役割 血管 2015;38:95-107

  318. 佐田政隆 特集 臓器連関 企画にあたって 腎・高血圧の最新治療 2016;5:4

  319. 石井亜由美、西川幸治、伊勢孝之、門田宗之、八木秀介、岩瀬俊、木下肇、阪田美穂、早渕康信、北川哲也、赤池雅史、加藤真介、佐田政隆 単心室症患児の回診術後にフェイススケールを用いて心臓リハビリテーションを試みた1症例 心臓 2016;48:181-186

  320. 田中君枝、佐田政隆 血管のアンチエイジング Medical Science Digest 2016;42:9-12

  321. 橋本洋一郎、平野照之、長谷川泰弘、佐田政隆、藤城光弘 大出血ハイリスク例における抗凝固療法 Cardio-Coagulation 2016;3:6-14

  322. 山下静也、Peter Libby、横手幸太郎、吉田雅幸、大内乗有、筒井裕之、佐田政隆 アテローム血栓症と動脈硬化性疾患−ACS発症リスク因子のパラダイムシフト− TOTAL VASCULAR MANAGEMENT 2016;1:8-15

  323. 島袋充生、益崎裕章、佐田政隆 V アディポサイエンス・クリニカル A異所性脂肪のフロンティア Diabetes Frontier 2016;3:343-349 

  324. 佐田政隆 第45回 日本心脈管作動物質学会 血圧 2016;23:90-91

  325. 石井亜由美、西川幸治、伊勢孝之、門田宗之、八木秀介、岩瀬俊、木下肇、阪田美穂、早渕康信、北川哲也、赤池雅史、加藤真介、佐田政隆 単心室症患児の開心術後にフェイススケールを用いて心臓リハビリテーションを試みた1症例 心臓 2016;48:181-186

  326. 平田有紀奈、佐田政隆 ECHO・CTで診る異所性脂肪 TOTAL VASCULAR MANAGEMENT 2016;2:4-7

  327. 原知也、佐田政隆 抗凝固薬の抗動脈硬化作用への可能性 TOTAL VASCULAR MANAGEMENT 2016;3:30-34

  328. 重松宏、山下静也、佐田政隆 スペシャリストインタビュー PADの包括的治療 TOTAL VASCULAR MANAGEMENT 2016;3:48-54

  329. 平田有紀奈、佐田政隆 ECHO・CTで診る異所性脂肪 TOTAL VASCULAR MANAGEMENT 2016;2:4-7

  330. 佐田政隆 冠動脈硬化と心臓周囲脂肪 呼吸と循環 2016;64:791-797

  331. 山田博胤、田中秀和、宮原俊介、尾形竜郎、楠瀬賢也、西尾進、鳥居裕太、平田有紀奈、大北裕、佐田政隆 表在エコー図検査と心エコー図検査のコラボレーションにより感染性心内膜炎が迅速に診断できた僧帽弁逸脱症の1例:Staphylococcus warneriによる自己弁への感染性心内膜炎 超音波医学 2016;43:581-586

  332. 佐田政隆 いまから寒さに備え血管の健康を保つ まいんど 2016;28:18-19

  333. 福田大受、佐田政隆 肥満によって増加するDNA断片の遊離が,脂肪組織の炎症とインスリン抵抗性を惹起する 尿酸と血糖 2016;2:37-39

  334.  田中君枝、佐田政隆 U.PPARαと疾患 2.動脈硬化とPPARα The Lipid 2016;27:47-53

  335. 山口浩司、佐田政隆 4. 虚血性心疾患を治す b. 労作性狭心症での使い方 Heart View 2016;20:124-129

  336. 佐田政隆 総論(特集 循環器疾患と異所性脂肪)CARDIAC PRACTICE 2016;27:15

  337. 佐田政隆、小川佳宏、島袋充生、橋尚彦 座談会 異所性脂肪と循環器疾患 CARDIAC PRACTICE 2016;27:63-67

  338. 菅澤典子、西雄千佳、中山泰介、黒部裕嗣、宅見央子、東口文治、粟飯原賢一、島袋充生、佐田政隆、北川哲也 糖転移ヘスペリジン/分散ヘスペレチンの動脈硬化病巣進展に対する抑制効果についての検討 日本病態栄養学会誌 2016;19:351-360

  339. 八木秀介、佐田政隆 非薬物降圧治療の可能性−RDN, デバイス,遠隔モニタリング 医学のあゆみ 2017;260:484-485

  340.  高島啓、佐田政隆 ω3系不飽和脂肪酸製剤による心血管二次予防のエビデンス 日本内科学会雑誌 2017;106:226-231

  341. 佐田政隆 巻頭総説 冠動脈硬化における心外膜脂肪の役割 血管 日本心脈管作動物質学会VOL40 NO.4/2017

  342. 佐田政隆:心臓血管周囲脂肪と心臓血管病、The Lipid 2018; 29(4): 371-378

  343. 佐田政隆:心不全の分子機序 (9) 多臓器連関の基礎研究 5) 冠動脈硬化病態における心外膜脂肪の役割、日本臨牀 2018; 76(増刊号9): 363-368

  344. 田中君枝、佐田政隆:動脈硬化と糖尿病、CARDIAC PRACTICE 2018; 29(3): 175-179

  345. 高島啓, 佐田政隆:ω3系不飽和脂肪酸の心血管イベントリスク低減作用、実験医学 2018; 36(10): 1750-1754

  346. 平田有紀奈, 西尾進, 鳥居裕太, 天野里江, 山尾雅美, 西條良仁, 楠瀬賢也, 山田博胤, 佐田政隆:糖尿病患者の冠動脈有意狭窄予測における心外膜下脂肪厚計測の有用性、超音波検査技術 2018; 43(3), 231-238.

  347. 八木秀介、佐田政隆:SGLT2阻害薬の心血管保護作用、医学のあゆみ 2018; 266(4): 264-268

  348. 高橋未奈, 飛梅威, 松本和久, 松浦朋美, 添木武, 藤本裕太, 原田貴文, Zheng Robert, 數藤久美子, 西條良仁, 上野理絵, 川端豊, 坂東美佳, 山田なお, 伊藤浩敬, 轟貴史, 伊勢孝之, 楠瀬賢也, 山口浩司, 八木秀介, 福田大受, 山田博胤, 若槻哲三, 佐田政隆:症例報告(第20回若手奨励賞受賞論文) 大動脈弁人工弁(機械弁)置換術後遠隔期に生じたOMI-VT stormに対し経心房中隔的に施行したカテーテルアブレーションが著効した1例、四国医学雑誌 = Shikoku acta medica 2018; 74(5・6), 201-208.

  349. 鳥居裕太, 佐田政隆, 西尾進, 天野里江, 湯浅麻美, 松本力三, 平田有紀奈, 山尾雅美, 高尾正一郎, 坂東良美:超音波検査が治療効果判定に有用であった腎原発悪性リンパ腫の1例、超音波検査技術, 2019; 44(1), 56-62.

  350. 佐田政隆: EPA・DHAと心血管疾患, 日本食品安全協会会誌, 2019; 14(2): 93-102

  351. 田中君枝、平田陽一郎、福田大受、佐田政隆:医学と医療の最前線 動脈硬化研究の最近の進歩、日本内科学会雑誌、2019;108(10)、1607-1615

  352. 佐田政隆、田中君枝:心外膜脂肪と心疾患、循環器専門医 2019;23、73-79

  353. 佐田政隆:編集後記、循環器疾患、2019;23、174

  354. 島啓、佐田政隆:X心臓疾患 心臓膿瘍(心嚢内膿瘍)、別冊日本臨床領域別症候群シリーズ No.5循環器症候群(第3版)T ―その他の循環器疾患を含めて― 2019; 588-591

  355. 山口浩司、佐田政隆:特集Endovascular Therapyはどこまできたか 識る6 いかにEVT後の再狭窄?、Heart View、2020;24(1)、39-44

  356. 佐田政隆:動脈硬化性疾患におけるΩ3脂肪酸の役割、Medical Science Digest, 2020; 46(3), 137-14



  357.  

 

海外招待講演

  1. Masataka Sata “Bone marrow-derived progenitor cells contribute to vascular repair and atherosclerosis." Annual Spring Conference of the Korean Society of Circulation. Cheju, Korea, 2003. April 17. 2003.

  2. Masataka Sata “Bone marrow-derived progenitor cells contribute to vascular repair and atherosclerosis." 1sr Euregio-Symposium Workshop on Atherosclerosis-Molecular Basis of an Inflammatory Disease.Vaals, Netherlands, 2003. September 27. 2003.

  3. Masataka Sata “Circulating progenitors contribute to vascular repair and remodeling” 4th Taipei vascular molecular biology symposium, Taipei, September 11th , 2004.
  4. Masataka Sata “Potential Roles of Circulating Vascular Progenitor Cells in Progression and Remodeling of Atherosclerotic Lesions" The 48th Annual Scientific Session of Korean Society of Circulation. Seoul, Korea, October 14th, 2004.
  5. Masataka Sata “Smooth muscle stem cells" Swedish National Network for Cardiovascular Research Conclusion Symposium, Sweden, Götenborg, November 18th, 2004.
  6.  Masataka Sata “Do blood cells turn into vessels?" International Cardiovascular Symposium-Clinical Implications of Stem Cells in Cardiovascular Disease, Chang Gung Memorial Hospital, Keelung, Taiwan, April 9, 2005.
  7. Masataka Sata “Use of animal models to elucidate the role of stem cells in the cardiovascular system" (Plenary Lecture 1 Atherosclerosis at the forefront) European Atherosclerosis Society 75th EAS Congress, Prague, Czech Republic, April 24, 2005.
  8. Masataka Sata “Bone Marrow-Derived Stem Cells in Vascular Disease” (Cardiovascular Seminar.06 Stem Cell and Vascular Diseases) American Heart Association Scientific Sessions 2005, Dallas, November 13, 2005.
  9. Masataka Sata “Circulating progenitors contribute to vascular repair and lesion formation” (Symposium 13: Vascular Biology II) 5th Congress of Asian-Pacific Society of Atherosclerosis and Vascular Disease, April 14, 2006.
  10. Masataka Sata “Vascular Regeneration Utilizing Somatic Stem Cells and Novel Biomaterials” 6th Taipei vascular molecular biology symposium, Taipei, Taiwan, August 26th , 2006.
  11. Masataka Sata “Maintenance of vascular homeostasis by bone marrow-derived progenitors” The 32nd Autumn Congress of Korean Diabetes Association, Gyeongju, Korea, November 10th , 2006.
  12. Masataka Sata “Maintenance of vascular homeostasis by bone marrow-derived progenitors” Professor E. Carwile LeRoy Memorial International Workshop on Scleroderma Secretariat, Tokyo, May 19th , 2007.
  13. Masataka Sata “Potential role of periadventitial adipose tissue in regulation of vascular homeostasis and remodeling” The SEOUL (Stem cell, angiogEnesis, HypertensiOn, Heart FailUre, Vascular BioLogy) Conference, Seoul, October 6th , 2007.

  14. Masataka Sata “Maintenace of Vascular Homeostasis by Circulating Progenitors and Periadvential Adipose Tissue” The New Frontiers in Biomedical Science Conference (Mackay Memorial Hospital), Taipei, November 18th , 2007.
  15. Masataka Sata “Vascular Regeneration Utilizing Circulating Progenitors and Novel Biomaterials” The Second International Cell Therapy Conference, Seoul, Korea, November 20th , 2008.
  16. Masataka Sata “Strategy to prevent cardiovasucular events in patients with metabolic syndrome:Insights from atherosclero research and hypertension management. The 6th International Conference on the Biology, Chemistry and Therapeutic Applications of Nitric Oxide, Kyoto, June16, 2010.
  17. Masataka Sata Vascular injury and repair: beyond the endothelium. ESC CONGRESS 2010 Sockholm,Sweden,August 28 to September 1,2010.
  18. Masataka Sata “Epicardial adipose tissue plays a role in the pathogenesis of Atherosclerosis” APSC Subspecialty Congress-Intervention and Imaging 2012, Taipei, Taiwan, May 4 to 6, 2012.
  19. Masataka Sata “Inflammation in atherosclerosis and adipose tissue” The 12th Biennial International Endotoxin & Innate Immunity Society (IEIIS) Meeting 2012, Tokyo, Japan, October 23 to 26, 2012.
  20. Masataka Sata “Novel insights into the pathogenesis of atherosclerosis : epicardial adipose tissue vasa vasorum, and anti-aging genes” 2014 “Metabosartan” Expert Summit, Taipei, Taiwan, March 16, 2014.
  21. Masataka Sata “Epicardial adipose tissue plays a role in the pathogenesis of atherosclerosis” The 18th International Vascular Biology Meeting, Kyoto Japan, April 14 to17, 2014.
  22. Masataka Sata “The role of NOAC in atherosclerotic disease” The Annual Scientific Meeting of Taiwan Society of Lipids & Atherosclerosis 2015 and The 15th Taipei International Vascular Biology Symposium, Taipei, Taiwan, September 12-13, 2015
  23. Masataka Sata “The role of innate immunity in the pathogenesis of atherosclerosis” The Annual Scientific Meeting of Taiwan Society of Lipids & Atherosclerosis 2015 and The 15th Taipei International Vascular Biology Symposium, Taipei, Taiwan, September 12-13, 2015
  24. Masataka Sata “How do you treat AF patients with CAD and what does the evidence tell us?” The Annual Scientific Meeting of Taiwan Society of Lipids & Atherosclerosis 2015 and The 15th Taipei International Vascular Biology Symposium, Taipei, Taiwan, September 12-13, 2015
  25. Masataka Sata “The Functional Implication of Novel Inflammatory Mediators on the Atherogenesis and Metabolic Derangement” The 59th Annual Scientific Meeting of The Korean Society of Cardiology, Goyang, Korea, October 16-17, 2015
  26. Masataka Sata. “Role of innate immunity in chronic inflammation in arterial wall and adipose tissue.” 19th International Vascular Biology Meeting, Boston, America, October 30-November 3, 2016
  27. Sata M. Role of epicardial fat in cardiovascular disease. ESC2018,Munich,August 25-28,2018
  28. Sata M, SGL T2 and CHF, The 49th Annual Convention & Scientific Session of the Taiwan Society of Cardiology, Taippei, Taiwan, May, 19, 2019

     

(令和2年7月2日現在)

 

Return to Top Page